Gene	"Gene synonym"	Ensembl	"Gene description"	Uniprot	Chromosome	Position	"Protein class"	Evidence	"HPA evidence"	"UniProt evidence"	"NeXtProt evidence"	"MS evidence"	"RNA tissue specificity"	"RNA tissue distribution"	"RNA tissue specificity score"	"RNA tissue specific NX"	"RNA cell line specificity"	"RNA cell line distribution"	"RNA cell line specificity score"	"RNA cell line specific NX"	"RNA cancer specificity"	"RNA cancer distribution"	"RNA cancer specificity score"	"RNA cancer specific FPKM"	"RNA brain regional specificity"	"RNA brain regional distribution"	"RNA brain regional specificity score"	"RNA brain regional specific NX"	"RNA blood cell specificity"	"RNA blood cell distribution"	"RNA blood cell specificity score"	"RNA blood cell specific NX"	"RNA blood lineage specificity"	"RNA blood lineage distribution"	"RNA blood lineage specificity score"	"RNA blood lineage specific NX"	"RNA mouse brain regional specificity"	"RNA mouse brain regional distribution"	"RNA mouse brain regional specificity score"	"RNA mouse brain regional specific pTPM"	"RNA pig brain regional specificity"	"RNA pig brain regional distribution"	"RNA pig brain regional specificity score"	"RNA pig brain regional specific pTPM"	Antibody	"Reliability (IH)"	"Reliability (Mouse Brain)"	"Reliability (IF)"	"Subcellular location"	"Secretome location"	"Blood concentration - Conc. blood IM [pg/L]"	"Blood concentration - Conc. blood MS [pg/L]"	"Subcellular main location"	"Subcellular additional location"	"Antibody RRID"	"Pathology prognostics - Breast cancer"	"Pathology prognostics - Cervical cancer"	"Pathology prognostics - Colorectal cancer"	"Pathology prognostics - Endometrial cancer"	"Pathology prognostics - Glioma"	"Pathology prognostics - Head and neck cancer"	"Pathology prognostics - Liver cancer"	"Pathology prognostics - Lung cancer"	"Pathology prognostics - Melanoma"	"Pathology prognostics - Ovarian cancer"	"Pathology prognostics - Pancreatic cancer"	"Pathology prognostics - Prostate cancer"	"Pathology prognostics - Renal cancer"	"Pathology prognostics - Stomach cancer"	"Pathology prognostics - Testis cancer"	"Pathology prognostics - Thyroid cancer"	"Pathology prognostics - Urothelial cancer"	"Tissue RNA - adipose tissue [NX]"	"Tissue RNA - adrenal gland [NX]"	"Tissue RNA - amygdala [NX]"	"Tissue RNA - appendix [NX]"	"Tissue RNA - basal ganglia [NX]"	"Tissue RNA - bone marrow [NX]"	"Tissue RNA - breast [NX]"	"Tissue RNA - cerebellum [NX]"	"Tissue RNA - cerebral cortex [NX]"	"Tissue RNA - cervix, uterine [NX]"	"Tissue RNA - colon [NX]"	"Tissue RNA - corpus callosum [NX]"	"Tissue RNA - ductus deferens [NX]"	"Tissue RNA - duodenum [NX]"	"Tissue RNA - endometrium 1 [NX]"	"Tissue RNA - epididymis [NX]"	"Tissue RNA - esophagus [NX]"	"Tissue RNA - fallopian tube [NX]"	"Tissue RNA - gallbladder [NX]"	"Tissue RNA - heart muscle [NX]"	"Tissue RNA - hippocampal formation [NX]"	"Tissue RNA - hypothalamus [NX]"	"Tissue RNA - kidney [NX]"	"Tissue RNA - liver [NX]"	"Tissue RNA - lung [NX]"	"Tissue RNA - lymph node [NX]"	"Tissue RNA - midbrain [NX]"	"Tissue RNA - olfactory region [NX]"	"Tissue RNA - ovary [NX]"	"Tissue RNA - pancreas [NX]"	"Tissue RNA - parathyroid gland [NX]"	"Tissue RNA - pituitary gland [NX]"	"Tissue RNA - placenta [NX]"	"Tissue RNA - pons and medulla [NX]"	"Tissue RNA - prostate [NX]"	"Tissue RNA - rectum [NX]"	"Tissue RNA - retina [NX]"	"Tissue RNA - salivary gland [NX]"	"Tissue RNA - seminal vesicle [NX]"	"Tissue RNA - skeletal muscle [NX]"	"Tissue RNA - skin 1 [NX]"	"Tissue RNA - small intestine [NX]"	"Tissue RNA - smooth muscle [NX]"	"Tissue RNA - spinal cord [NX]"	"Tissue RNA - spleen [NX]"	"Tissue RNA - stomach 1 [NX]"	"Tissue RNA - testis [NX]"	"Tissue RNA - thalamus [NX]"	"Tissue RNA - thymus [NX]"	"Tissue RNA - thyroid gland [NX]"	"Tissue RNA - tongue [NX]"	"Tissue RNA - tonsil [NX]"	"Tissue RNA - urinary bladder [NX]"	"Tissue RNA - vagina [NX]"	"Tissue RNA - B-cells [NX]"	"Tissue RNA - dendritic cells [NX]"	"Tissue RNA - granulocytes [NX]"	"Tissue RNA - monocytes [NX]"	"Tissue RNA - NK-cells [NX]"	"Tissue RNA - T-cells [NX]"	"Tissue RNA - total PBMC [NX]"	"Cell RNA - A-431 [NX]"	"Cell RNA - A549 [NX]"	"Cell RNA - AF22 [NX]"	"Cell RNA - AN3-CA [NX]"	"Cell RNA - ASC diff [NX]"	"Cell RNA - ASC TERT1 [NX]"	"Cell RNA - BEWO [NX]"	"Cell RNA - BJ [NX]"	"Cell RNA - BJ hTERT+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ [NX]"	"Cell RNA - BJ hTERT+ SV40 Large T+ RasG12V [NX]"	"Cell RNA - CACO-2 [NX]"	"Cell RNA - CAPAN-2 [NX]"	"Cell RNA - Daudi [NX]"	"Cell RNA - EFO-21 [NX]"	"Cell RNA - fHDF/TERT166 [NX]"	"Cell RNA - HaCaT [NX]"	"Cell RNA - HAP1 [NX]"	"Cell RNA - HBEC3-KT [NX]"	"Cell RNA - HBF TERT88 [NX]"	"Cell RNA - HDLM-2 [NX]"	"Cell RNA - HEK 293 [NX]"	"Cell RNA - HEL [NX]"	"Cell RNA - HeLa [NX]"	"Cell RNA - Hep G2 [NX]"	"Cell RNA - HHSteC [NX]"	"Cell RNA - HL-60 [NX]"	"Cell RNA - HMC-1 [NX]"	"Cell RNA - HSkMC [NX]"	"Cell RNA - hTCEpi [NX]"	"Cell RNA - hTEC/SVTERT24-B [NX]"	"Cell RNA - hTERT-HME1 [NX]"	"Cell RNA - HUVEC TERT2 [NX]"	"Cell RNA - K-562 [NX]"	"Cell RNA - Karpas-707 [NX]"	"Cell RNA - LHCN-M2 [NX]"	"Cell RNA - MCF7 [NX]"	"Cell RNA - MOLT-4 [NX]"	"Cell RNA - NB-4 [NX]"	"Cell RNA - NTERA-2 [NX]"	"Cell RNA - PC-3 [NX]"	"Cell RNA - REH [NX]"	"Cell RNA - RH-30 [NX]"	"Cell RNA - RPMI-8226 [NX]"	"Cell RNA - RPTEC TERT1 [NX]"	"Cell RNA - RT4 [NX]"	"Cell RNA - SCLC-21H [NX]"	"Cell RNA - SH-SY5Y [NX]"	"Cell RNA - SiHa [NX]"	"Cell RNA - SK-BR-3 [NX]"	"Cell RNA - SK-MEL-30 [NX]"	"Cell RNA - T-47d [NX]"	"Cell RNA - THP-1 [NX]"	"Cell RNA - TIME [NX]"	"Cell RNA - U-138 MG [NX]"	"Cell RNA - U-2 OS [NX]"	"Cell RNA - U-2197 [NX]"	"Cell RNA - U-251 MG [NX]"	"Cell RNA - U-266/70 [NX]"	"Cell RNA - U-266/84 [NX]"	"Cell RNA - U-698 [NX]"	"Cell RNA - U-87 MG [NX]"	"Cell RNA - U-937 [NX]"	"Cell RNA - WM-115 [NX]"	"Blood RNA - basophil [NX]"	"Blood RNA - classical monocyte [NX]"	"Blood RNA - eosinophil [NX]"	"Blood RNA - gdTCR [NX]"	"Blood RNA - intermediate monocyte [NX]"	"Blood RNA - MAIT T-cell [NX]"	"Blood RNA - memory B-cell [NX]"	"Blood RNA - memory CD4 T-cell [NX]"	"Blood RNA - memory CD8 T-cell [NX]"	"Blood RNA - myeloid DC [NX]"	"Blood RNA - naive B-cell [NX]"	"Blood RNA - naive CD4 T-cell [NX]"	"Blood RNA - naive CD8 T-cell [NX]"	"Blood RNA - neutrophil [NX]"	"Blood RNA - NK-cell [NX]"	"Blood RNA - non-classical monocyte [NX]"	"Blood RNA - plasmacytoid DC [NX]"	"Blood RNA - T-reg [NX]"	"Blood RNA - total PBMC [NX]"	"Brain RNA - amygdala [NX]"	"Brain RNA - basal ganglia [NX]"	"Brain RNA - cerebellum [NX]"	"Brain RNA - cerebral cortex [NX]"	"Brain RNA - hippocampal formation [NX]"	"Brain RNA - hypothalamus [NX]"	"Brain RNA - midbrain [NX]"	"Brain RNA - olfactory region [NX]"	"Brain RNA - pons and medulla [NX]"	"Brain RNA - thalamus [NX]"
BX088645.1		ENSG00000283378			9	61330717-61453030	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Group enriched"	"Detected in some"	16	"blood: 21.7;bone marrow: 14.1"	"Cell line enhanced"	"Detected in some"		"A549: 21.0;SiHa: 4.6;TIME: 6.6;WM-115: 18.5"									"Cell type enriched"	"Detected in some"	13	"neutrophil: 21.7"	"Lineage enriched"	"Detected in single"	182	"granulocytes: 21.7"																																					0.1	0.0		0.0		14.1	0.0		0.5	0.1	0.0			0.0	0.0	0.0	0.2	0.0	0.0	1.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.2		0.2	0.0		0.0	0.0	0.0	0.0	0.0	0.1		0.3	0.0	0.5			0.1		0.0	0.0		0.1	0.0	21.7	0.0	0.0	0.0	0.0	0.9	21.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.0	2.3	0.3	1.6	0.0	0.0	0.2	0.0	2.3	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.5	1.3	0.0	0.0	0.2	0.1	0.0	0.0	1.2	0.6	0.0	0.3	2.4	0.0	0.7	0.3	0.6	4.6	0.1	1.4	0.1	0.1	6.6	0.0	0.7	0.0	0.1	0.0	0.0	0.0	0.0	0.0	18.5	0.0	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.7	0.0	0.0	0.0	0.0	0.0										
AL031777.3		ENSG00000282988			6	26195595-26199293	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in many"	10	"lymphoid tissue: 184.8"	"Cell line enhanced"	"Detected in some"		"K-562: 7.8;SiHa: 7.4;U-2 OS: 5.6;U-266/70: 9.4;U-266/84: 6.1"									"Cell type enriched"	"Detected in many"	4	"neutrophil: 18.7"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 18.7"									HPA041189	Uncertain									"HPA041189: AB_2677357"																		1.3	1.3	0.1	10.9	0.2	13.1	4.8	0.3	0.7	3.9	3.4	0.0	2.2	0.7	1.0	2.2	7.1	1.2	1.9	4.2	0.0		1.0	1.1	3.5	12.7	0.0	0.1	2.4	1.2	0.7	0.0	3.4	0.4	2.9	0.9	0.9	1.1	3.2	0.7	0.7	3.2	1.5	2.6	8.5	1.7	4.3	0.1	184.8	0.9	3.9	11.4	4.0	0.0	2.7	1.1	18.7	1.0	0.6	1.1	0.7	0.8	0.5	0.2	0.7	0.2	0.1	0.0	0.7	0.1	1.4	0.4	0.6	0.9	0.8	2.4	0.0	1.2	0.3	0.0	0.0	2.6	0.3	0.7	2.4	1.5	0.0	0.2	0.8	1.1	0.0	0.8	0.5	0.2	7.8	1.6	0.0	1.1	2.8	1.7	0.2	2.3	0.7	0.2	4.3	0.0	0.0	0.9	0.2	7.4	0.0	0.5	4.7	0.0	0.8	0.8	5.6	0.0	0.2	9.4	6.1	0.9	0.5	2.2	0.3	4.3	0.0	1.2	0.3	0.3	0.4	0.9	0.6	0.6	0.4	2.7	0.5	0.8	18.7	0.6	1.0	1.1	1.1	0.7										
FCGR3B	"CD16, CD16b, FCG3, FCGR3"	ENSG00000162747	"Fc fragment of IgG receptor IIIb"	O75015	1	161623196-161631963	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	8	"blood: 334.5"	"Cell line enhanced"	"Detected in single"		"K-562: 1.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	95	"neutrophil: 334.5"	"Lineage enriched"	"Detected in many"	95	"granulocytes: 334.5"														"Secreted to blood"						"unprognostic (1.60e-1)"	"unprognostic (1.36e-1)"	"unprognostic (1.59e-3)"	"unprognostic (4.16e-2)"	"unprognostic (1.15e-1)"	"unprognostic (6.52e-2)"	"unprognostic (3.97e-2)"	"unprognostic (6.96e-3)"	"unprognostic (2.53e-2)"	"unprognostic (1.02e-1)"	"unprognostic (1.07e-1)"	"unprognostic (8.67e-2)"	"unprognostic (5.16e-2)"	"unprognostic (1.35e-1)"	"unprognostic (8.37e-3)"	"unprognostic (2.28e-1)"	"unprognostic (9.24e-2)"	9.9	0.8	1.8	30.8	1.5	13.8	1.5	0.9	1.8	0.9	0.8	0.5	0.2	0.0	0.4	0.5	1.7	2.8	6.8	4.6	1.2	0.9	0.9	2.9	15.2	16.9	5.0	0.5	1.2	1.2	0.0	0.6	4.5	1.9	1.5	0.0	1.3	0.9	0.9	0.8	1.4	0.8	2.0	4.0	44.3	1.3	1.5	0.9	0.6	0.8	0.2	0.9	11.1	4.7	0.0	0.1	334.5	3.5	0.1	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.4	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.2	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.5	0.5	1.2	0.0	0.0	0.0	0.2	0.1	0.0	0.0	0.1	334.5	0.1	3.5	0.0	0.0	0.5	1.8	1.5	0.9	1.8	1.2	0.9	5.0	0.5	1.9	0.9
TAS2R40	GPR60	ENSG00000221937	"Taste 2 receptor member 40"	P59535	7	143222037-143223079	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in some"	8	"blood: 6.3;lymphoid tissue: 4.1"	"Cell line enhanced"	"Detected in single"		"SK-BR-3: 1.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 6.3"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 6.3"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in many"																															0.1	0.2	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.1	0.6	0.1	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0		0.0	0.0	0.0	0.0	0.2		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0	0.1	3.9	0.0	0.0			0.0		0.0	0.0	0.0	0.0	0.0	6.3	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	1.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.3	0.0	0.0	0.0	0.0	0.0										
TEX54		ENSG00000283268	"Testis expressed 54"		11	62832319-62832803	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"			"Group enriched"	"Detected in some"	8	"blood: 47.4;testis: 21.2"	"Low cell line specificity"	"Detected in some"											"Cell type enriched"	"Detected in many"	8	"neutrophil: 47.4"	"Lineage enriched"	"Detected in all"	16	"granulocytes: 47.4"																																					1.0	0.0	0.0	0.1	0.9	0.4	0.0	0.0	4.2	0.0	0.6	1.5	0.0	0.0	0.8	1.2	0.7	0.0	0.0	0.1	1.7		0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.0	0.0	0.0	0.8	0.5	0.0	1.0	0.2	0.5	21.2	0.7	0.0	0.5	0.0	0.5	1.5	0.0	2.3	2.3	47.4	2.9	1.3	2.9	0.3	0.3	0.0	2.3	2.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	1.0	2.6	0.8	0.4	0.0	2.6	0.0	0.0	0.0	2.4	0.8	0.0	2.6	0.9	0.8	0.0	1.0	0.0	0.0	0.6	0.0	0.0	0.0	1.5	0.0	0.0	1.3	1.3	0.4	1.6	1.0	0.0	2.8	0.0	0.5	1.0	0.0	0.0	1.8	0.3	0.7	0.0	1.5	0.7	0.7	1.9	0.0	2.4	0.8	1.1	0.0	0.0	1.8	6.1	2.9	5.9	1.6	2.0	2.7	1.7	1.7	1.4	0.8	2.3	2.9	2.1	47.4	1.3	0.8	2.3	1.1	0.3										
AC107959.5		ENSG00000284956			8	23084403-23115536	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	7	"blood: 69.8"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 13.3;HDLM-2: 16.3"									"Cell type enriched"	"Detected in some"	9	"neutrophil: 69.8"	"Lineage enriched"	"Detected in single"	153	"granulocytes: 69.8"																																					0.3	2.0	0.0	1.5	0.0	3.1	0.0	0.8	0.5	0.0	0.0	0.0	0.0	0.2	0.0	0.1	0.5	0.0	2.7	0.0	0.0		3.5	0.0	0.4	0.0	0.7	0.0	0.4	0.0	0.0	1.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.5	0.0	9.7	0.5	0.0	0.2	0.0	1.0	0.0	0.0	0.0	0.1	69.8	0.4	0.0	0.0	0.1	2.6	3.7	0.7	13.3	0.0	1.7	2.8	0.0	0.5	0.2	2.1	0.4	1.1	2.7	4.0	0.9	0.1	0.4	0.5	1.9	16.3	1.6	0.0	2.0	7.5	1.6	0.5	5.7	1.7	2.1	0.7	0.7	2.5	0.7	0.0	0.6	0.0	0.0	0.7	3.5	0.5	0.1	0.9	0.3	0.8	0.1	0.1	0.1	0.2	1.9	4.8	1.8	0.3	1.3	4.7	6.7	6.7	0.8	6.3	4.7	0.2	5.2	1.2	4.0	0.6	0.4	8.1	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	69.8	0.0	0.3	0.0	0.0	0.1										
CSNK1A1L	MGC33182	ENSG00000180138	"Casein kinase 1 alpha 1 like"	Q8N752	13	37103259-37105664	"Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in some"	7	"blood: 10.5;testis: 9.0"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	40	"neutrophil: 10.5"	"Lineage enriched"	"Detected in single"	42	"granulocytes: 10.5"									HPA051334			Uncertain	Cytosol				Cytosol		"HPA051334: AB_2681446"	"unprognostic (1.23e-2)"		"unprognostic (1.59e-1)"	"unprognostic (3.19e-2)"	"unprognostic (3.54e-2)"	"unprognostic (2.40e-2)"		"unprognostic (5.40e-2)"	"unprognostic (8.90e-2)"	"unprognostic (3.47e-1)"	"unprognostic (1.47e-3)"	"unprognostic (4.50e-1)"	"unprognostic (2.02e-1)"	"unprognostic (2.28e-3)"	"unprognostic (3.45e-1)"	"unprognostic (2.38e-1)"		0.0	0.0	0.0	0.3	0.0	1.4	0.0	0.0	0.1	0.0	0.0			0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0		0.0	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	9.0			0.0		0.0	0.0	0.0	0.1	0.2	10.5	0.2	0.1	0.2	0.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.4	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.3	0.3	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.1	0.0	0.0	0.6	0.2	0.1	0.1	0.1	0.2	0.1	0.1	0.1	0.1	0.2	0.1	0.2	0.1	10.5	0.1	0.2	0.1	0.2	0.2										
HIST2H2AA4	H2A/r	ENSG00000272196	"Histone cluster 2 H2A family member a4"	Q6FI13	1	149851061-149851624	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in many"	6	"blood: 164.8;lymphoid tissue: 101.1"	"Cell line enhanced"	"Detected in many"		"SiHa: 26.8;U-266/70: 66.9;U-266/84: 59.4"	"Cancer enhanced"	"Detected in single"		"ovarian cancer: 0.5"					"Cell type enriched"	"Detected in all"	5	"neutrophil: 164.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 164.8"									HPA041189	Supported									"HPA041189: AB_2677357"					"unprognostic (1.63e-1)"					"unprognostic (1.77e-1)"		"unprognostic (1.76e-1)"		"unprognostic (8.47e-2)"				4.5	6.5	0.0	9.8	1.2	9.0	2.5	0.3	2.6	5.2	5.7	1.5	2.5	5.7	5.5	3.4	9.1	2.4	4.2	4.0	0.7		3.0	2.5	8.8	7.1	0.1	0.0	4.3	5.0	0.0	0.5	6.5	1.6	9.5	0.0	2.1	4.2	2.6	3.5	5.8	5.4	0.9	0.8	8.4	4.2	21.6	0.1	101.1	1.9	4.8	11.5	5.8	2.3	9.3	17.2	164.8	17.9	3.5	4.2	18.8	3.8	9.6	1.2	2.2	0.0	1.2	3.1	8.1	0.0	0.0	0.0	6.4	3.9	0.0	9.1	0.0	5.2	0.0	0.0	0.0	5.2	12.6	1.2	7.9	4.3	0.0	1.1	7.4	0.0	0.0	0.0	0.0	0.0	8.2	19.3	0.0	24.3	4.1	1.2	3.6	10.0	3.7	1.5	6.6	0.0	2.0	9.7	4.1	26.8	7.4	2.1	12.7	2.6	0.0	2.7	20.5	3.7	1.0	66.9	59.4	4.5	0.0	6.1	3.1	24.2	17.9	32.8	3.2	10.5	3.3	5.9	2.8	3.0	12.0	9.3	2.2	2.0	164.8	3.5	12.4	17.2	4.2	18.8										
TNFRSF10C	"CD263, DcR1, LIT, TRAILR3, TRID"	ENSG00000173535	"TNF receptor superfamily member 10c"	O14798	8	23102590-23117437	"Cancer-related genes, CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	6	"blood: 173.4"	"Group enriched"	"Detected in some"	5	"BEWO: 37.1;HUVEC TERT2: 30.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 173.4"	"Lineage enriched"	"Detected in many"	113	"granulocytes: 173.4"									CAB025635	Enhanced									"CAB025635: "	"unprognostic (2.63e-1)"	"unprognostic (4.49e-3)"	"unprognostic (7.21e-3)"	"unprognostic (2.07e-2)"	"unprognostic (3.55e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.81e-2)"	"unprognostic (2.11e-3)"	"unprognostic (5.56e-2)"	"unprognostic (4.37e-2)"	"unprognostic (8.98e-2)"	"unprognostic (1.94e-3)"	"unprognostic (2.74e-3)"	"unprognostic (4.83e-1)"	"unprognostic (1.84e-1)"	"unprognostic (1.34e-3)"	"unprognostic (6.54e-2)"	5.5	1.5	1.9	14.0	3.6	12.6	2.0	1.4	3.9	2.9	1.5	0.7	0.1	1.2	1.5	1.2	1.4	3.7	13.5	5.6	1.9	1.1	2.8	3.2	13.7	28.4	9.2	0.0	2.4	2.1	2.5	4.5	12.8	3.1	2.7	1.8	1.7	1.7	0.8	2.3	0.8	2.2	1.9	4.4	26.4	1.8	1.4	2.3	0.8	4.4	0.5	0.9	5.2	1.9	0.0	0.3	173.4	1.5	0.0	0.0	0.4	0.4	1.4	0.5	2.4	0.0	0.3	37.1	1.5	0.0	0.1	0.1	0.0	1.4	0.1	0.7	1.4	0.2	0.1	0.1	0.1	2.5	0.5	0.1	0.3	1.1	3.6	0.2	1.0	4.1	0.3	0.7	0.3	30.9	0.0	0.0	0.2	1.0	0.0	0.9	1.6	0.0	0.1	0.1	0.0	5.9	0.1	0.0	0.0	0.1	0.2	0.7	5.1	0.2	6.5	0.6	1.2	1.4	0.1	1.5	0.8	0.0	2.2	0.3	0.9	2.7	1.5	25.4	0.0	0.8	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	173.4	0.0	1.1	0.0	0.0	0.4	1.9	3.6	1.4	3.9	1.9	1.1	9.2	0.0	3.1	2.3
AC106774.10		ENSG00000284552			5	17486231-17486829	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enriched"	"Detected in some"	5	"blood: 12.2"	"Cell line enriched"	"Detected in single"	10	"U-937: 8.3"									"Cell type enriched"	"Detected in single"	122	"neutrophil: 12.2"	"Lineage enriched"	"Detected in single"	122	"granulocytes: 12.2"																																					0.0	0.0		1.5		0.7	0.0		0.0	0.0	0.0			0.0	0.0	2.6	0.0	0.2	0.8	0.0			0.0	0.0	0.1	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.1	0.0		1.2	0.0	0.0			0.0		0.0	0.0		0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.2	0.0	0.0	0.0	0.0	0.0										
CEACAM4	CGM7	ENSG00000105352	"Carcinoembryonic antigen related cell adhesion molecule 4"	O75871	19	41618971-41627074	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 41.5;bone marrow: 22.5;lymphoid tissue: 30.2"	"Cell line enriched"	"Detected in some"	6	"U-937: 9.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 41.5"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 41.5"																				"unprognostic (1.10e-2)"	"unprognostic (1.52e-2)"	"unprognostic (1.24e-1)"	"unprognostic (4.48e-1)"	"unprognostic (3.20e-2)"	"unprognostic (3.83e-2)"	"unprognostic (9.11e-2)"	"unprognostic (5.59e-2)"	"unprognostic (1.79e-2)"	"unprognostic (1.97e-1)"	"unprognostic (1.04e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.09e-9)"	"unprognostic (3.65e-2)"	"unprognostic (2.95e-2)"	"unprognostic (1.47e-1)"	"unprognostic (4.34e-1)"	1.8	0.5	0.2	5.5	0.5	22.5	0.5	0.1	1.0	0.4	0.5	0.1	0.2	0.4	0.4	3.3	1.0	1.0	1.6	3.4	0.9	0.3	2.2	1.2	6.4	30.2	1.7	0.1	0.5	1.5	0.0	0.7	1.1	0.9	0.9	0.3	1.6	0.9	0.2	0.3	0.3	1.4	1.2	1.2	27.5	0.8	0.6	0.3	1.0	0.4	0.0	1.4	0.9	0.5	0.1	7.9	41.5	10.3	0.0	3.5	3.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	9.3	0.0	0.0	10.3	1.8	0.0	7.5	0.0	0.1	0.4	0.0	7.9	0.0	0.2	0.0	41.5	0.0	3.2	0.0	3.5	3.5	0.2	0.5	0.1	1.0	0.9	0.3	1.7	0.1	0.9	0.3
CXCR2	"CD182, CMKAR2, IL8RB"	ENSG00000180871	"C-X-C motif chemokine receptor 2"	P25025	2	218125289-218137253	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 216.1"	"Group enriched"	"Detected in some"	11	"BEWO: 12.1;HL-60: 6.7;HMC-1: 14.1;THP-1: 12.8;U-937: 12.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	59	"neutrophil: 216.1"	"Lineage enriched"	"Detected in many"	109	"granulocytes: 216.1"	"Low region specificity"	"Detected in single"							"CAB016268, HPA031999, HPA032017"	Enhanced		Supported	"Nucleoplasm,Plasma membrane,Microtubules,Mitotic spindle"				"Plasma membrane"	"Nucleoplasm, Microtubules, Mitotic spindle"	"CAB016268: AB_626893, HPA031999: AB_2674105, HPA032017: AB_2674112"	"unprognostic (4.89e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.63e-2)"	"unprognostic (1.10e-2)"	"unprognostic (1.58e-1)"	"unprognostic (3.13e-1)"	"unprognostic (1.33e-1)"	"unprognostic (2.13e-1)"	"unprognostic (5.96e-2)"	"unprognostic (1.22e-2)"	"unprognostic (5.67e-2)"	"unprognostic (1.41e-1)"	"unprognostic (7.54e-2)"	"unprognostic (1.04e-1)"	"unprognostic (7.23e-2)"	"unprognostic (8.18e-2)"	"unprognostic (5.48e-2)"	9.3	0.9	1.3	25.6	1.5	4.0	0.6	1.2	1.3	5.2	0.6	0.5	2.5	0.0	0.8	1.1	18.1	3.3	5.2	4.3	1.5	0.6	0.7	4.6	16.7	40.5	6.6	0.0	1.2	1.7	0.0	0.7	4.5	1.7	1.9	0.3	1.8	3.3	2.6	0.6	3.0	0.7	1.4	4.1	30.6	1.0	1.1	0.7	0.6	0.6	4.8	10.1	5.4	6.4	0.0	1.6	216.1	1.9	0.4	1.9	1.0	0.0	0.0	0.1	0.0	0.0	0.0	12.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.2	0.0	0.0	0.0	0.1	0.0	0.0	0.0	6.7	14.1	0.0	0.1	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.3	1.0	0.2	0.0	0.3	0.0	1.0	0.0	0.7	0.0	0.0	0.0	0.1	0.0	0.0	12.8	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	12.6	0.0	3.6	1.9	3.2	1.9	0.5	0.0	0.0	0.0	0.4	0.8	0.0	0.0	0.7	216.1	0.4	0.2	1.6	0.0	1.0	1.3	1.5	1.2	1.3	1.5	0.6	6.6	0.0	1.7	0.7
FPR2	"ALXR, FMLP-R-II, FMLPX, FPR2A, FPRH2, FPRL1, HM63, LXA4R"	ENSG00000171049	"Formyl peptide receptor 2"	P25090	19	51752026-51770526	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 128.2;lymphoid tissue: 32.2"	"Cell line enriched"	"Detected in some"	18	"U-937: 25.4"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	10	"neutrophil: 128.2"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 128.2"									HPA029154	Approved									"HPA029154: AB_10602133"	"unprognostic (3.11e-1)"	"unprognostic (5.20e-2)"	"unprognostic (1.71e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.07e-1)"	"unprognostic (1.65e-1)"	"unprognostic (1.81e-1)"	"unprognostic (1.19e-1)"	"unprognostic (1.00e-1)"	"unprognostic (1.23e-1)"	"unprognostic (5.04e-2)"	"unprognostic (3.90e-4)"	"unprognostic (3.41e-5)"	"unprognostic (1.08e-2)"	"unprognostic (4.69e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.90e-1)"	7.9	1.1	0.6	30.7	2.1	8.7	0.8	0.4	1.9	0.6	0.8	0.8	0.0	0.4	0.6	0.2	1.0	2.6	3.3	5.0	1.9	0.6	1.3	2.4	17.3	32.2	2.8	0.0	1.6	1.1	0.0	1.1	4.4	2.3	0.6	0.1	1.1	1.0	0.0	1.1	0.4	1.1	3.3	3.0	29.1	1.2	2.5	1.6	0.8	1.0	0.9	0.3	4.4	2.2	0.0	1.7	128.2	12.7	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.0	0.9	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.1	0.0	0.2	0.1	0.1	0.2	0.7	0.0	0.2	0.0	0.0	0.0	0.2	0.3	0.0	0.0	0.1	0.1	0.0	0.1	0.0	0.0	0.2	0.5	0.2	0.0	0.0	0.0	0.0	0.0	1.4	0.0	0.1	0.0	0.1	0.0	0.2	0.0	0.0	0.8	25.4	0.0	0.4	12.7	0.6	0.0	11.3	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	128.2	0.0	7.5	0.3	0.0	3.9	0.6	2.1	0.4	1.9	1.9	0.6	2.8	0.0	2.3	1.6
HIST1H4A	H4FA	ENSG00000278637	"Histone cluster 1 H4 family member a"	P62805	6	26021679-26021990	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"lymphoid tissue: 87.7"	"Cell line enhanced"	"Detected in many"		"MOLT-4: 13.6;NB-4: 9.9;REH: 12.4"	"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	4	"neutrophil: 14.0"	"Lineage enriched"	"Detected in many"	10	"granulocytes: 14.0"									"CAB021887, HPA042201"	Supported					30000000	30000000			"CAB021887: AB_2279758, HPA042201: "	"unprognostic (5.71e-2)"	"unprognostic (3.41e-1)"	"unprognostic (3.49e-2)"	"unprognostic (2.36e-2)"	"unprognostic (1.75e-1)"	"unprognostic (1.75e-2)"		"unprognostic (1.23e-1)"		"unprognostic (1.23e-3)"				"unprognostic (9.76e-2)"	"unprognostic (5.99e-2)"		"unprognostic (6.42e-2)"	0.5	0.5	0.0	5.2	0.0	7.1	2.1	16.7	3.2	0.6	1.5	0.0	0.0	5.2	1.5	1.8	3.7	0.3	1.2	3.2	0.0		0.5	0.1	2.0	3.5	0.0	1.8	1.4	0.8	0.1	0.0	0.8	0.2	0.4	1.0	1.6	0.8	1.0	0.8	0.9	1.1	3.6	0.1	2.5	0.7	2.6	0.0	87.7	2.5	3.6	9.6	2.0	0.0	0.8	0.9	14.0	1.0	1.2	1.4	0.2	3.7	1.7	3.5	0.0	0.8	0.0	0.0	0.3	1.3	1.6	2.3	0.0	5.6	2.6	0.9	0.0	4.9	2.6	0.0	0.5	0.4	1.8	2.5	1.5	0.0	0.0	0.6	6.0	0.0	0.0	0.5	0.0	1.6	1.3	4.1	0.0	1.5	13.6	9.9	2.3	0.0	12.4	2.2	2.2	0.0	0.4	4.2	1.8	1.6	6.1	0.1	3.2	2.7	0.0	3.0	7.7	3.0	3.0	1.5	2.4	0.0	1.4	4.1	5.8	0.0	1.0	3.4	1.3	0.8	0.2	0.4	1.1	0.3	0.9	0.8	0.4	0.3	14.0	1.2	0.2	0.4	1.4	0.2										
HIST2H2BF		ENSG00000203814	"Histone cluster 2 H2B family member f"	Q5QNW6	1	149782689-149812373	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in all"	5	"lymphoid tissue: 117.6"	"Cell line enhanced"	"Detected in many"		"U-266/70: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	11	"neutrophil: 21.7"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 21.7"	"Not detected"	"Not detected"							"CAB007814, HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"CAB007814: AB_598159, HPA042205: , HPA043013: AB_2678269, HPA048671: AB_2680488"	"unprognostic (9.02e-3)"	"unprognostic (7.78e-2)"	"unprognostic (5.30e-4)"	"unprognostic (3.00e-1)"	"unprognostic (1.21e-1)"	"unprognostic (2.17e-1)"	"unprognostic (2.08e-2)"	"unprognostic (8.33e-2)"	"unprognostic (3.46e-2)"	"unprognostic (5.36e-2)"	"unprognostic (3.87e-5)"	"unprognostic (3.72e-2)"	"unprognostic (3.54e-7)"	"unprognostic (1.84e-1)"	"unprognostic (2.59e-2)"	"unprognostic (9.42e-3)"	"unprognostic (7.62e-2)"	5.6	17.7	3.9	14.9	3.5	3.7	7.1	8.5	5.6	17.4	3.8	3.7	3.2	1.5	5.6	6.2	7.1	7.9	3.6	12.1	3.4	2.4	5.0	4.2	14.6	27.5	3.2	3.8	24.2	6.2	2.6	4.4	5.1	3.2	16.7	2.5	3.5	3.7	5.5	1.2	10.9	3.4	6.0	7.7	12.7	7.9	5.9	3.1	117.6	4.4	6.3	16.7	6.1	21.5	2.0	0.8	21.7	1.1	0.6	0.8	0.2	0.4	0.6	0.5	0.6	4.5	3.0	0.3	7.7	4.0	5.9	5.2	0.3	2.2	0.4	0.6	4.4	1.3	0.1	0.5	4.6	1.2	0.9	0.4	1.5	0.0	6.6	0.2	1.7	5.4	0.0	7.6	1.9	3.3	1.2	2.3	0.8	0.9	3.1	3.7	0.4	1.0	0.3	1.1	0.7	2.8	0.4	2.6	7.2	4.1	3.5	0.3	1.3	9.6	1.4	1.5	0.0	11.2	2.0	31.4	1.0	1.3	5.2	0.3	3.3	0.0	1.0	0.2	0.6	0.8	0.7	0.6	0.8	0.3	0.8	2.0	0.4	0.3	21.7	0.6	1.1	0.8	0.2	0.2	3.9	3.5	8.5	5.6	3.4	2.4	3.2	3.8	3.2	3.1
OR11G2		ENSG00000196832	"Olfactory receptor family 11 subfamily G member 2"	Q8NGC1	14	20190894-20201075	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enriched"	"Detected in some"	5	"blood: 5.9"	"Cell line enriched"	"Detected in single"	14	"HEL: 7.1"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	6	"neutrophil: 5.9"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 5.9"																																					0.4	0.2	0.1	0.4	0.1	1.0	0.1	0.1	0.2	0.3	0.1			0.4	0.3	0.6	0.1	0.2	0.5	0.1	0.1	0.1	0.1	0.1	0.2	0.0	0.1		0.2	0.4	0.0	0.1	0.2		0.2	0.0		0.5	0.0	0.5	0.8	0.2	0.0	0.1	0.7	0.2	1.2			0.4		0.0	0.2	0.1	0.3	0.2	5.9	0.3	0.4	0.2	0.0	0.0	0.1	0.1	0.3	0.0	0.0	0.5	0.1	0.0	0.1	0.0	0.1	0.1	0.1	0.1	0.1	0.1	0.0	0.1	0.0	0.2	0.2	7.1	0.3	0.1	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.1	0.3	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.0	0.3	0.2	0.0	0.0	0.3	0.0	0.2	0.1	0.1	0.0	0.1	0.1	0.1	0.2	0.8	0.3	1.0	0.1	0.1	0.0	0.1	0.1	0.1	0.0	0.3	0.2	0.2	5.9	0.4	0.2	0.2	0.0	0.0										
VNN2	"FOAP-4, GPI-80"	ENSG00000112303	"Vanin 2"	O95498	6	132743870-132763459	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	5	"blood: 85.2;lung: 36.4;lymphoid tissue: 43.6"	"Cell line enriched"	"Detected in some"	8	"Daudi: 34.9"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 85.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 85.2"					"Low region specificity"	"Detected in single"									270000	270000				"unprognostic (2.13e-1)"	"unprognostic (1.15e-1)"	"unprognostic (9.60e-3)"	"unprognostic (5.71e-2)"	"unprognostic (2.14e-1)"	"unprognostic (5.61e-3)"	"unprognostic (1.98e-3)"	"unprognostic (4.38e-1)"	"unprognostic (3.07e-1)"	"unprognostic (3.46e-1)"	"unprognostic (2.84e-1)"	"unprognostic (8.30e-2)"	"prognostic unfavourable (2.72e-7)"	"unprognostic (1.62e-1)"	"unprognostic (8.17e-2)"	"unprognostic (2.01e-1)"	"unprognostic (5.45e-2)"	10.1	1.4	1.1	9.5	1.1	10.8	1.4	1.4	1.4	1.8	1.9	0.8	0.0	0.7	0.9	3.1	2.1	4.3	10.2	10.5	1.1	1.1	2.8	5.6	36.4	39.8	3.8	0.3	2.1	2.4	0.0	1.2	8.6	1.5	2.4	0.9	1.8	1.3	0.2	1.0	0.7	3.6	2.4	2.2	43.6	2.8	3.6	0.6	3.4	1.4	0.7	17.7	7.3	10.9	6.4	2.2	85.2	10.9	5.8	6.7	5.7	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	34.9	0.6	0.0	0.0	0.0	0.0	0.0	4.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.6	0.0	0.0	0.0	0.6	0.0	0.0	0.1	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.6	0.9	0.0	0.0	1.5	10.9	0.0	4.2	2.4	1.7	6.4	1.4	4.9	2.2	5.5	4.5	6.7	85.2	5.8	1.5	0.4	0.9	5.7	1.1	1.1	1.4	1.4	1.1	1.1	3.8	0.3	1.5	0.6
ZNF658	"DKFZp572C163, FLJ32813, MGC35232"	ENSG00000274349	"Zinc finger protein 658"	Q5TYW1	9	66856426-66932141	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	5	"blood: 20.9"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"							"Cell type enriched"	"Detected in some"	11	"neutrophil: 20.9"	"Lineage enriched"	"Detected in many"	11	"granulocytes: 20.9"									"HPA047730, HPA048668"	Uncertain		Approved	Nucleoplasm				Nucleoplasm		"HPA047730: AB_2680136, HPA048668: AB_2680487"	"unprognostic (9.54e-2)"	"unprognostic (1.60e-1)"	"unprognostic (9.06e-3)"	"unprognostic (1.97e-1)"	"unprognostic (1.02e-1)"	"unprognostic (3.32e-2)"	"unprognostic (1.45e-1)"	"unprognostic (1.38e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.40e-1)"	"unprognostic (2.75e-3)"	"unprognostic (8.04e-2)"	"unprognostic (1.18e-4)"	"unprognostic (2.68e-2)"	"unprognostic (6.99e-2)"	"unprognostic (1.06e-2)"	"unprognostic (1.71e-1)"	0.5	0.8		0.1		0.0	2.8		1.4	1.6	0.6			0.3	1.5	0.8	1.4	1.8	0.1	1.8			1.5	0.5	0.9	0.5			3.5	1.1	2.4		0.1		1.8	0.7		1.6	1.4	1.9	4.5	0.0	0.9		1.1	0.6	1.2			2.1		0.9	0.9		1.3	0.4	20.9	0.5	1.8	1.4	0.1	2.7	4.7	4.6	8.7	4.7	5.7	3.5	2.2	4.0	3.0	3.4	0.4	2.1	6.4	2.4	2.1	7.5	3.7	4.3	3.3	0.2	2.3	1.0	3.9	1.0	5.2	3.9	2.3	4.5	9.7	2.9	4.3	5.9	1.2	1.3	3.9	1.6	3.2	2.0	3.9	8.1	0.3	7.4	2.3	3.3	7.2	6.7	4.0	3.4	1.9	3.4	2.7	10.2	1.3	3.9	5.1	3.5	2.6	0.8	3.7	1.5	1.8	1.4	4.1	0.5	0.5	1.5	0.6	0.4	0.1	0.6	0.9	0.8	0.2	1.3	1.4	0.7	20.9	1.8	0.4	0.4	0.5	0.1										
CSF3R	"CD114, GCSFR"	ENSG00000119535	"Colony stimulating factor 3 receptor"	Q99062	1	36466043-36483278	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Group enriched"	"Detected in many"	4	"blood: 167.3;bone marrow: 88.9;lymphoid tissue: 71.4;placenta: 152.7"	"Group enriched"	"Detected in some"	18	"BEWO: 34.1;NB-4: 9.2;THP-1: 22.4;U-937: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 167.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 167.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in many"			"CAB017116, HPA048086"	Enhanced				"Intracellular and membrane"					"CAB017116: , HPA048086: "	"unprognostic (5.57e-3)"	"unprognostic (8.05e-2)"	"unprognostic (7.23e-2)"	"unprognostic (3.87e-2)"	"unprognostic (2.88e-1)"	"unprognostic (2.92e-2)"	"unprognostic (2.86e-2)"	"unprognostic (1.35e-1)"	"unprognostic (1.83e-1)"	"unprognostic (5.65e-2)"	"unprognostic (2.47e-1)"	"unprognostic (3.44e-1)"	"prognostic unfavourable (5.72e-4)"	"unprognostic (6.33e-2)"	"prognostic unfavourable (3.79e-4)"	"unprognostic (2.03e-1)"	"unprognostic (2.31e-2)"	8.5	1.5	2.9	39.5	3.2	88.9	2.4	0.7	2.9	1.1	1.1	4.2	0.4	0.6	0.7	1.1	1.2	6.9	4.3	5.6	2.6	2.0	1.7	4.5	26.9	27.5	7.2	1.1	1.1	1.3	0.3	1.1	152.7	3.8	1.3	0.5	2.1	1.6	0.5	0.6	0.3	1.6	3.1	7.1	71.4	2.2	1.4	3.3	1.1	1.0	0.4	0.9	4.6	3.9	0.0	8.2	167.3	22.1	0.2	0.0	10.3	0.0	0.0	0.0	0.0	0.0	0.0	34.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.7	0.8	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	9.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.0	22.4	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	21.6	0.0	0.0	22.1	0.6	0.0	4.8	0.0	0.0	0.0	0.0	8.2	0.0	0.0	0.0	167.3	0.2	1.8	0.2	0.0	10.3	2.9	3.2	0.7	2.9	2.6	2.0	7.2	1.1	3.8	3.3
CXCR1	"CD181, CDw128a, CKR-1, CMKAR1, IL8RA"	ENSG00000163464	"C-X-C motif chemokine receptor 1"	P25024	2	218162845-218166995	"Cancer-related genes, CD markers, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in many"	4	"blood: 144.6"	"Cell line enriched"	"Detected in single"	26	"HMC-1: 11.3"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	16	"neutrophil: 144.6"	"Lineage enriched"	"Detected in many"	59	"granulocytes: 144.6"	"Not detected"	"Not detected"							HPA031991	Uncertain									"HPA031991: AB_2674103"	"unprognostic (2.80e-1)"	"unprognostic (2.91e-2)"	"unprognostic (3.53e-2)"	"unprognostic (5.74e-2)"	"unprognostic (1.19e-1)"	"unprognostic (1.68e-1)"	"unprognostic (2.14e-2)"	"unprognostic (3.36e-2)"	"unprognostic (2.32e-1)"	"unprognostic (1.57e-1)"	"unprognostic (8.27e-2)"	"unprognostic (2.15e-2)"	"unprognostic (2.88e-1)"	"unprognostic (5.47e-2)"	"unprognostic (2.97e-1)"	"unprognostic (1.30e-1)"	"unprognostic (8.85e-2)"	11.5	0.4	0.8	21.1	0.7	7.3	0.6	0.9	2.6	0.6	0.6	0.2	0.0	0.0	0.5	0.1	1.3	2.8	3.6	3.8	0.9	0.6	0.7	2.9	20.3	33.4	5.9	0.0	1.7	1.2	0.0	0.8	2.1	2.3	0.9	0.1	1.4	0.6	0.0	1.0	0.5	0.6	1.4	3.4	33.7	1.0	1.4	0.7	0.1	0.9	0.6	0.4	4.5	4.1	0.0	0.0	144.6	0.2	0.1	2.4	0.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	11.3	0.0	0.4	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	8.7	0.2	0.2	2.4	0.0	0.0	0.0	0.2	0.6	0.0	0.0	0.0	0.9	144.6	0.1	0.2	0.0	0.0	0.7	0.8	0.7	0.9	2.6	0.9	0.6	5.9	0.0	2.3	0.7
HIST1H2BC	"H2B.1, H2B/l, H2BFL"	ENSG00000180596	"Histone cluster 1 H2B family member c"	P62807	6	26114873-26123926	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Group enriched"	"Detected in all"	4	"blood: 115.7;lymphoid tissue: 143.2"	"Cell line enhanced"	"Detected in many"		"SiHa: 32.9;U-2 OS: 23.0;U-266/70: 19.0;U-266/84: 23.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	20	"neutrophil: 115.7"	"Lineage enriched"	"Detected in all"	26	"granulocytes: 115.7"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: "	"unprognostic (8.30e-3)"	"unprognostic (2.60e-2)"	"unprognostic (2.37e-2)"	"unprognostic (9.26e-2)"	"unprognostic (3.20e-2)"	"unprognostic (5.08e-2)"	"unprognostic (4.72e-1)"	"unprognostic (6.45e-2)"	"unprognostic (9.22e-2)"	"unprognostic (1.10e-1)"	"prognostic unfavourable (9.01e-4)"	"unprognostic (2.08e-1)"	"prognostic unfavourable (1.75e-5)"	"unprognostic (5.41e-2)"	"unprognostic (7.38e-2)"	"unprognostic (2.49e-1)"	"unprognostic (6.60e-3)"	7.8	5.8	5.5	21.3	7.1	31.3	10.7	2.1	5.9	12.9	11.5	5.9	12.8	5.2	4.1	13.1	20.9	10.8	8.1	5.8	6.5	4.6	8.4	20.2	15.3	11.4	5.4	4.1	5.6	9.6	1.7	9.9	17.5	3.8	31.7	4.1	5.9	12.4	18.6	20.0	10.0	6.0	4.3	10.4	11.7	10.6	9.4	4.5	143.2	6.4	8.7	23.4	12.9	14.3	4.3	2.8	115.7	1.3	1.2	1.8	2.7	2.9	1.7	0.9	0.9	0.9	0.5	1.1	2.9	1.1	2.0	1.6	2.4	1.8	1.1	5.6	1.0	2.2	1.2	1.2	1.0	2.6	1.0	0.9	2.7	4.1	1.1	1.4	3.7	12.3	0.7	0.8	0.5	0.7	16.6	9.3	3.8	3.3	3.1	3.0	0.9	5.4	1.4	1.3	6.9	3.4	0.7	4.2	1.3	32.9	2.5	1.1	14.0	1.3	2.4	2.4	23.0	1.5	1.2	19.0	23.3	5.5	1.0	3.6	1.6	4.5	1.1	5.8	1.2	1.3	1.6	2.3	1.8	1.7	0.8	4.3	1.4	1.0	115.7	1.2	1.2	2.8	1.1	2.7	5.5	7.1	2.1	5.9	6.5	4.6	5.4	4.1	3.8	4.5
HIST1H2BJ	"H2B/r, H2BFR"	ENSG00000124635	"Histone cluster 1 H2B family member j"	P06899	6	27125897-27132750	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enriched"	"Detected in many"	4	"lymphoid tissue: 124.3"	"Cell line enhanced"	"Detected in many"		"K-562: 41.2;Karpas-707: 24.3;SiHa: 37.1;U-2 OS: 41.1;U-266/70: 35.0;U-266/84: 43.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 13.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 13.6"									"HPA042205, HPA043013, HPA048671"	Supported		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA042205: AB_2677900, HPA043013: AB_2678269, HPA048671: "	"unprognostic (4.02e-2)"	"prognostic favourable (1.51e-4)"	"unprognostic (8.58e-2)"	"unprognostic (2.34e-2)"	"unprognostic (1.18e-1)"	"unprognostic (1.26e-2)"	"unprognostic (3.03e-1)"	"unprognostic (2.98e-1)"	"unprognostic (1.88e-1)"	"unprognostic (1.49e-2)"	"unprognostic (1.90e-3)"	"unprognostic (2.23e-1)"	"unprognostic (3.57e-4)"	"unprognostic (8.67e-2)"	"unprognostic (5.80e-2)"	"unprognostic (1.57e-2)"	"unprognostic (6.16e-2)"	4.1	2.2	1.5	30.0	2.4	10.7	11.3	0.9	1.9	12.8	6.2	1.6	3.9	2.1	3.1	5.9	12.8	5.1	2.8	6.0	2.5	1.7	1.9	3.9	7.3	12.0	3.2	0.9	1.3	5.1	0.6	1.2	5.1	2.9	8.0	3.0	0.5	4.0	4.8	5.9	2.9	2.8	2.8	5.9	12.0	5.1	30.5	2.2	124.3	2.7	10.1	22.3	5.2	9.4	2.2	1.0	13.6	0.6	0.7	2.4	14.7	3.7	4.7	1.4	1.3	7.1	0.5	1.8	2.1	1.2	8.3	3.6	4.0	2.2	0.6	6.7	2.2	2.7	2.0	1.8	4.6	4.4	3.5	1.1	5.3	0.2	0.6	0.4	3.0	3.4	0.2	1.7	0.8	0.4	41.2	24.3	2.2	2.0	1.7	2.4	1.7	4.4	0.9	1.2	3.7	1.0	1.4	9.2	1.0	37.1	2.5	1.0	0.1	1.5	1.0	2.1	41.1	1.6	0.9	35.0	43.1	9.9	0.5	11.6	1.0	1.8	0.6	0.7	0.5	0.5	0.8	1.6	0.7	0.3	0.4	2.2	0.4	0.5	13.6	0.7	0.2	1.0	2.4	14.7	1.5	2.4	0.9	1.9	2.5	1.7	3.2	0.9	2.9	2.2
MTRNR2L11		ENSG00000270188	"MT-RNR2-like 11"	S4R3Y5	1	237943724-237945275	"Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 64.8;skeletal muscle: 46.5"	"Cell line enhanced"	"Detected in many"		"HeLa: 65.5;Hep G2: 41.9"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 64.8"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 64.8"														"Secreted to blood"										"unprognostic (1.07e-1)"					"unprognostic (9.70e-2)"			"unprognostic (4.49e-2)"	"unprognostic (5.26e-2)"				9.9	11.8	3.7	0.9	3.8	1.4	5.5	2.1	8.5	2.0	7.0	1.4	3.7	2.9	2.0	3.1	2.0	2.0	0.2	12.4	4.2	2.3	11.1	7.2	3.0	2.8	2.2	2.6	2.0	3.3	0.0	2.0	1.3	4.6	2.1	3.1	0.9	4.4	6.5	46.5	2.0	3.5	0.7	3.3	2.0	4.3	4.0	3.0	0.8	2.0	7.4	0.3	2.0	2.0	5.9	3.4	64.8	7.0	2.9	3.1	8.2	7.0	16.5	7.7	21.7	6.6	1.7	6.2	11.7	0.9	0.6	0.9	6.9	10.2	12.0	7.5	2.3	21.4	0.2	1.5	0.6	5.2	11.6	12.1	65.5	41.9	2.2	3.3	9.7	6.7	2.3	0.8	2.9	0.9	8.4	7.2	2.0	6.0	3.3	11.5	2.0	3.0	6.4	6.2	4.9	4.5	9.7	2.9	5.2	4.6	5.4	8.6	6.6	10.6	19.0	8.8	6.2	7.0	3.3	5.5	1.8	4.9	4.8	11.8	2.1	14.8	7.0	16.1	1.4	3.2	1.7	5.5	2.2	1.9	2.7	5.9	3.1	3.1	64.8	2.9	3.1	3.4	2.0	8.2	3.7	3.8	2.1	5.1	4.2	2.3	2.2	2.6	4.6	3.0
VMP1	"EPG3, TANGO5, TMEM49"	ENSG00000062716	"Vacuole membrane protein 1"	Q96GC9	17	59707192-59842255	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enriched"	"Detected in all"	4	"blood: 193.2"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 193.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 193.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA030773, HPA064780"	Approved		Approved	"Nucleoli,Endoplasmic reticulum"				"Endoplasmic reticulum"	Nucleoli	"HPA030773: AB_10602248, HPA064780: "	"unprognostic (2.29e-1)"	"unprognostic (2.32e-1)"	"unprognostic (4.09e-2)"	"prognostic unfavourable (1.56e-5)"	"unprognostic (3.14e-2)"	"unprognostic (3.17e-1)"	"prognostic unfavourable (8.02e-4)"	"unprognostic (1.39e-1)"	"unprognostic (2.41e-1)"	"unprognostic (2.98e-1)"	"unprognostic (8.43e-2)"	"unprognostic (4.21e-2)"	"prognostic unfavourable (2.77e-8)"	"unprognostic (1.88e-1)"	"unprognostic (1.11e-2)"	"unprognostic (1.14e-2)"	"unprognostic (7.96e-3)"	22.0	37.8	20.4	21.9	24.9	13.0	18.6	20.0	28.7	18.2	32.0	27.8	16.7	40.5	18.3	15.4	22.9	14.4	25.2	19.6	21.7	22.3	22.9	43.0	22.4	20.1	23.1	15.6	16.5	22.9	19.0	20.1	27.9	29.8	17.3	29.3	20.0	17.8	13.9	19.8	19.2	39.7	14.3	26.4	36.6	19.0	17.6	16.2	14.4	18.1	12.5	16.8	19.5	17.6	3.3	10.9	193.2	39.9	3.8	4.1	24.7	20.4	41.2	13.4	20.7	28.7	17.7	21.6	32.6	23.3	20.4	27.4	27.0	29.5	11.8	48.8	22.0	25.5	15.5	18.7	25.4	30.2	19.5	15.1	23.6	28.4	28.0	17.1	18.6	27.0	16.0	26.2	22.3	21.6	19.8	20.9	21.0	56.4	15.9	9.0	15.1	21.3	8.8	23.5	24.3	25.2	23.9	9.6	21.9	18.6	15.8	21.6	32.8	14.7	30.4	27.4	26.2	21.7	26.9	32.4	37.2	16.4	30.2	10.5	27.6	7.0	35.1	4.4	3.8	24.4	4.0	3.3	3.7	4.0	10.9	2.8	3.5	3.8	193.2	3.8	39.9	3.6	4.1	24.7	20.4	24.9	20.0	28.7	21.7	22.3	23.1	15.6	29.8	16.2
VNN3	HSA238982	ENSG00000093134	"Vanin 3"	Q9NY84	6	132722787-132734765	"Enzymes, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Group enriched"	"Detected in many"	4	"blood: 39.5;bone marrow: 29.8;liver: 29.4"	"Cell line enhanced"	"Detected in some"		"Daudi: 2.5;EFO-21: 3.7;hTCEpi: 2.3"	"Cancer enhanced"	"Detected in some"		"liver cancer: 3.9"	"Not detected"	"Not detected"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 39.5"	"Lineage enriched"	"Detected in single"	40	"granulocytes: 39.5"														"Secreted to blood"						"unprognostic (3.20e-2)"	"unprognostic (2.70e-1)"	"unprognostic (7.92e-3)"	"unprognostic (1.71e-2)"	"unprognostic (3.05e-3)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.01e-1)"	"unprognostic (2.42e-2)"	"unprognostic (7.68e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.63e-1)"	"unprognostic (5.84e-8)"	"unprognostic (1.25e-2)"	"unprognostic (1.52e-1)"	"unprognostic (9.32e-2)"	"unprognostic (1.56e-1)"	1.1	0.1	0.4	3.3	0.4	29.8	0.2	0.2	0.6	2.4	1.2	0.2	0.2	0.0	0.2	0.8	0.9	2.4	1.3	1.0	0.4	0.0	0.3	29.4	6.1	1.2	0.4	0.2	1.2	0.2	0.0	0.2	5.8	0.3	0.5	0.0	0.4	1.1	0.2	0.2	0.1	0.2	0.2	0.2	7.6	0.4	0.3	0.2	0.2	0.3	2.4	0.7	0.6	0.3	0.0	0.0	39.5	0.9	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.1	2.5	3.7	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.4	2.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.4	0.0	0.0	6.3	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	39.5	0.0	0.0	0.0	0.0	0.1	0.4	0.4	0.2	0.6	0.4	0.0	0.4	0.2	0.3	0.2
A3GALT2	"A3GALT2P, IGB3S, IGBS3S"	ENSG00000184389	"Alpha 1,3-galactosyltransferase 2"	U3KPV4	1	33306766-33321098	"Enzymes, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in some"			"Group enriched"	"Detected in some"	4	"HeLa: 5.1;SiHa: 3.2"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	15	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	15	"granulocytes: 2.1"	"Low region specificity"	"Detected in single"			"Not detected"	"Not detected"														"unprognostic (1.86e-2)"	"unprognostic (2.36e-2)"		"unprognostic (2.39e-1)"	"unprognostic (1.18e-1)"	"unprognostic (2.61e-3)"		"unprognostic (4.96e-2)"	"unprognostic (6.83e-2)"	"unprognostic (5.81e-2)"	"unprognostic (1.23e-1)"	"unprognostic (1.89e-1)"	"unprognostic (4.90e-8)"	"unprognostic (1.17e-1)"		"unprognostic (1.12e-2)"	"unprognostic (7.87e-2)"	0.7	0.1	0.1	1.2	0.2	1.3	0.4	1.3	0.9	0.4	0.2			0.0	0.5	0.0	0.2	0.2	1.4	0.1	0.2	0.1	0.4	0.1	0.5	0.1	0.0		0.4	0.1	0.0	0.4	0.1		0.6	0.0		0.2	0.4	0.2	0.1	0.1	0.2	0.2	0.8	0.3	2.1			0.4		0.0	0.2	0.1	0.0	0.0	2.1	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.3	0.2	5.1	0.0	0.2	0.0	0.0	0.7	0.2	0.2	0.6	0.0	0.0	0.0	0.2	0.0	0.3	0.2	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.1	3.2	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.1	0.0	0.0	0.0	0.0	0.0										
ABTB1	"BPOZ, Btb3, BTBD21, EF1ABP"	ENSG00000114626	"Ankyrin repeat and BTB domain containing 1"	Q969K4	3	127672935-127680920	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 107.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 107.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 107.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA035022, HPA035023"	Uncertain		Supported	Nucleoli,Cytosol				Cytosol	Nucleoli	"HPA035022: AB_10669998, HPA035023: AB_10602104"	"unprognostic (6.76e-2)"	"unprognostic (9.18e-3)"	"unprognostic (2.11e-2)"	"unprognostic (6.34e-2)"	"unprognostic (6.51e-2)"	"unprognostic (2.00e-3)"	"unprognostic (4.43e-2)"	"unprognostic (2.12e-2)"	"unprognostic (9.81e-2)"	"unprognostic (4.48e-3)"	"unprognostic (4.55e-3)"	"unprognostic (2.86e-1)"	"prognostic unfavourable (1.13e-4)"	"unprognostic (2.88e-1)"	"unprognostic (1.81e-2)"	"unprognostic (3.98e-2)"	"unprognostic (7.92e-3)"	20.4	13.7	11.7	17.7	20.1	42.3	14.2	43.4	27.2	15.4	14.3	13.8	12.9	12.3	15.6	10.9	9.6	13.1	17.6	20.4	10.9	8.2	11.4	8.3	15.5	22.1	9.7	15.8	15.8	11.2	7.8	15.3	12.0	11.4	13.5	4.9	12.4	15.2	14.5	25.1	11.6	13.0	13.3	7.5	41.4	11.7	5.9	12.5	17.8	10.2	9.1	10.4	14.6	17.4	2.9	3.8	107.3	8.6	3.2	5.8	5.1	3.1	7.5	0.7	1.5	7.2	6.8	5.7	5.0	8.6	3.4	4.8	0.2	6.6	1.4	8.9	3.8	1.4	0.0	3.7	0.8	14.5	2.1	2.3	13.4	1.8	5.7	0.3	7.0	8.5	4.0	3.5	0.9	3.6	0.1	10.2	3.7	5.0	3.4	9.8	0.6	8.3	2.1	4.2	9.7	5.1	1.9	7.0	4.6	3.6	4.3	18.1	1.1	2.5	6.5	3.6	3.0	6.4	1.6	8.3	2.7	0.4	8.4	2.9	5.6	4.5	8.6	20.5	2.4	6.2	2.3	2.5	2.6	2.3	3.8	2.9	2.2	1.9	107.3	3.2	5.4	2.4	5.8	5.1	11.7	20.1	43.4	27.2	10.9	8.2	9.7	15.8	11.4	12.5
AC099489.1		ENSG00000188897			16	11359845-11523588	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in many"		"blood: 7.2;lymphoid tissue: 9.9;skin 1: 6.2"	"Cell line enhanced"	"Detected in some"		"Daudi: 6.5;HDLM-2: 7.0;U-266/70: 3.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	12	"neutrophil: 7.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 7.2"					"Low region specificity"	"Detected in single"			HPA042154	Uncertain									"HPA042154: AB_2677877"	"unprognostic (4.69e-2)"	"unprognostic (3.80e-2)"	"unprognostic (7.24e-2)"	"unprognostic (5.91e-2)"	"unprognostic (1.21e-3)"	"unprognostic (7.91e-2)"	"unprognostic (9.18e-2)"	"unprognostic (6.08e-2)"	"unprognostic (8.04e-2)"	"unprognostic (5.10e-2)"	"unprognostic (1.87e-1)"	"unprognostic (3.04e-1)"	"unprognostic (3.72e-6)"	"unprognostic (3.18e-1)"	"unprognostic (1.18e-1)"	"unprognostic (1.23e-1)"	"unprognostic (4.33e-5)"	1.5	0.0	0.3	6.4	0.2	2.0	0.8	0.1	0.1	0.5	0.1			0.0	0.5	0.2	0.1	1.6	0.6	0.7	0.4	0.1	1.1	1.1	2.4	0.9	0.5		0.3	0.5	0.0	0.3	0.3		1.0	0.0		5.0	0.6	1.3	6.2	0.3	0.0	0.5	9.9	0.7	2.8			0.3		0.2	0.7	0.3	0.2	0.0	7.2	0.0	0.0	0.5	0.0	0.1	0.8	0.8	0.4	0.0	0.0	0.1	0.0	0.2	0.0	0.1	0.0	0.8	6.5	2.3	0.0	0.0	0.0	0.0	0.0	7.0	0.5	0.0	0.4	0.0	0.2	0.0	1.3	0.0	1.8	0.0	0.0	0.1	0.5	0.8	0.0	0.2	0.2	2.1	0.7	0.0	0.6	0.3	2.3	0.0	0.4	0.7	0.4	0.0	0.9	0.9	0.0	0.2	0.3	0.1	0.1	0.3	0.0	3.6	0.2	0.2	0.0	0.7	0.6	0.1	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.1	0.0	0.2	0.5	0.3	7.2	0.0	0.0	0.0	0.1	0.0										
AC233724.6		ENSG00000249156			5	17610496-17611583	"Predicted intracellular proteins"	"Evidence at transcript level"	"Evidence at transcript level"				"Tissue enhanced"	"Detected in some"		"blood: 2.1;testis: 1.3"	"Group enriched"	"Detected in some"	7	"HEK 293: 1.7;U-2 OS: 5.6"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	21	"neutrophil: 2.1"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 2.1"																																		"unprognostic (2.61e-1)"			0.0	0.0		0.3		0.0	0.0		0.0	0.0	0.1			0.0	0.0	0.0	0.0	0.0	0.0	0.0			0.0	0.0	0.0	0.0			0.0	0.0	0.0		0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.7		0.0	0.0	1.3			0.0		0.0	0.3		0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.6	0.0	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.1	0.0	0.0	0.0	0.0	0.0										
ALPL	"HOPS, TNSALP"	ENSG00000162551	"Alkaline phosphatase, liver/bone/kidney"	P05186	1	21509372-21578412	"Cancer-related genes, Disease related genes, Enzymes, Plasma proteins, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.3;liver: 52.7;lung: 45.1"	"Cell line enhanced"	"Detected in some"		"HSkMC: 52.2;hTEC/SVTERT24-B: 40.8;LHCN-M2: 29.7;SCLC-21H: 26.0"	"Cancer enhanced"	"Detected in all"		"testis cancer: 199.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	91	"neutrophil: 73.3"	"Lineage enriched"	"Detected in single"	127	"granulocytes: 73.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA007105, HPA008765, CAB020829"	Enhanced		Approved	Cytosol	"Intracellular and membrane"	7300000	7300000	Cytosol		"CAB020829: , HPA007105: AB_1078137, HPA008765: AB_1078138"	"unprognostic (3.89e-2)"	"unprognostic (1.27e-1)"	"unprognostic (5.57e-2)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (7.57e-4)"	"unprognostic (3.05e-3)"	"unprognostic (6.50e-3)"	"unprognostic (1.01e-1)"	"prognostic unfavourable (7.08e-4)"	"unprognostic (1.17e-2)"	"unprognostic (2.48e-3)"	"unprognostic (1.74e-1)"	"unprognostic (7.28e-2)"	"unprognostic (1.73e-2)"	"unprognostic (2.27e-1)"	"unprognostic (9.70e-3)"	"unprognostic (2.58e-1)"	15.9	22.7	4.5	17.6	6.0	2.6	10.6	2.2	7.8	2.2	2.1	4.1	0.7	1.9	3.7	1.1	2.0	5.7	2.8	10.9	5.7	4.2	29.7	52.7	45.1	28.1	5.3	4.8	1.2	4.3	2.4	4.1	2.2	7.7	2.6	1.3	18.3	3.1	6.6	0.9	1.8	2.7	2.5	3.8	19.6	1.8	2.9	2.7	0.5	3.7	1.7	3.9	7.1	8.4	0.5	0.0	73.3	0.0	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.2	1.9	3.3	0.1	0.7	0.2	0.4	0.2	0.0	0.6	2.2	0.0	0.0	8.9	0.0	0.1	0.0	0.6	0.0	1.1	1.0	0.5	0.0	0.2	52.2	0.0	40.8	0.1	0.0	0.0	0.0	29.7	0.0	0.0	0.0	11.9	0.0	0.0	1.1	0.0	0.0	0.0	26.0	0.3	0.0	0.0	0.1	0.0	0.0	0.0	1.5	1.2	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.2	0.0	0.0	0.8	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	73.3	0.0	0.0	0.0	0.0	0.0	4.5	6.0	2.2	7.8	5.7	4.2	5.3	4.8	7.7	2.7
ARGFX		ENSG00000186103	"Arginine-fifty homeobox"	A6NJG6	3	121570704-121586634	"Predicted intracellular proteins, Transcription factors"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 3.6;testis: 2.2"	"Cell line enhanced"	"Detected in some"		"K-562: 1.7;Karpas-707: 1.5;U-698: 1.9"	"Cancer enriched"	"Detected in single"	119	"testis cancer: 6.4"					"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.6"	"Lineage enriched"	"Detected in single"	4	"granulocytes: 3.6"									HPA043049	Uncertain									"HPA043049: AB_2678288"															"unprognostic (6.00e-2)"			0.3	0.1	0.2	0.5	0.2	0.9	0.2	0.1	0.2	0.1	0.1			0.0	0.2	0.1	0.0	0.1	0.3	0.3	0.2	0.2	0.0	0.4	0.1	0.1	0.1		0.1	0.5	0.0	0.1	0.0		0.1	0.0		0.2	0.1	1.1	0.8	0.4	0.0	0.1	0.5	0.1	2.2			0.1		0.0	0.2	0.1	0.4	0.2	3.6	0.8	0.7	0.3	0.2	0.0	0.0	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.3	0.0	0.0	1.3	0.2	0.0	0.2	0.3	0.0	0.0	0.2	1.0	0.5	0.7	0.0	0.4	0.0	1.1	0.0	0.3	0.4	0.0	0.0	1.7	1.5	0.4	0.0	0.0	0.1	0.4	1.0	0.3	0.0	0.3	0.0	0.0	0.0	0.5	0.4	0.6	0.0	0.4	0.5	0.0	0.2	0.5	0.0	0.5	1.2	0.5	1.9	0.0	0.2	0.2	0.8	0.3	0.4	0.2	0.4	0.2	0.4	0.1	0.1	0.2	0.4	0.2	0.3	3.6	0.7	0.8	0.2	0.1	0.2										
CD300LD	"CD300D, CMRF35A4"	ENSG00000204345	"CD300 molecule like family member d"	Q6UXZ3	17	74579365-74592283	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in some"		"blood: 8.5;bone marrow: 3.2"	"Cell line enhanced"	"Detected in some"		"HMC-1: 4.4;RPMI-8226: 2.7"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in some"	7	"neutrophil: 8.5"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 8.5"									HPA027756	Uncertain									"HPA027756: AB_10601097"			"unprognostic (8.03e-2)"											"unprognostic (3.30e-1)"				0.3	0.2	0.1	2.2	0.1	3.2	0.2	0.2	0.3	0.4	0.2			0.0	0.2	0.0	0.2	0.4	0.3	0.3	0.1	0.1	0.1	0.2	0.9	0.7	0.1		0.1	0.1	0.0	0.1	0.1		0.1	0.0		1.1	0.0	0.1	1.6	0.9	0.1	0.1	1.4	0.2	1.7			0.1		0.6	0.4	0.1	0.5	0.7	8.5	0.7	0.8	1.3	0.2	0.4	0.3	0.5	1.0	0.6	0.0	0.3	0.0	0.0	0.0	0.1	0.3	0.4	0.5	0.3	0.5	0.5	0.3	0.5	0.0	0.5	0.2	0.2	1.5	0.7	0.0	1.1	4.4	0.6	0.4	0.3	0.5	0.0	0.5	1.7	0.2	1.4	0.2	0.6	0.5	0.6	0.4	0.6	2.7	0.5	0.8	0.5	0.5	0.7	0.4	0.0	0.6	0.1	0.5	0.6	0.5	1.1	0.0	0.8	0.3	0.6	0.2	0.3	0.3	0.8	0.4	0.4	0.4	0.7	0.2	0.3	0.3	0.2	0.7	0.5	0.5	0.4	8.5	0.8	0.4	0.5	1.3	0.2										
CEACAM3	"CD66d, CGM1"	ENSG00000170956	"Carcinoembryonic antigen related cell adhesion molecule 3"	P40198	19	41796437-41811553	"CD markers, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 60.0;bone marrow: 35.4"	"Cell line enhanced"	"Detected in single"		"PC-3: 3.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 60.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 60.0"									HPA011041	Approved									"HPA011041: AB_1078481"	"unprognostic (1.60e-1)"	"unprognostic (1.14e-1)"	"unprognostic (2.23e-2)"	"unprognostic (2.95e-2)"	"unprognostic (2.19e-1)"	"unprognostic (8.09e-3)"	"unprognostic (1.44e-1)"	"unprognostic (2.85e-1)"	"unprognostic (1.49e-1)"	"unprognostic (3.19e-2)"	"unprognostic (1.62e-1)"	"unprognostic (8.07e-2)"	"unprognostic (1.32e-2)"	"unprognostic (1.32e-1)"	"unprognostic (4.68e-2)"	"unprognostic (8.44e-2)"	"unprognostic (2.83e-1)"	0.9	0.3	0.3	3.6	0.8	35.4	0.7	0.2	0.8	0.6	1.0	0.0	0.0	0.2	0.4	0.2	1.2	0.7	0.4	5.1	0.4	0.3	0.4	1.1	14.0	11.5	1.8	0.1	0.7	1.0	0.2	0.3	4.6	0.5	0.3	0.3	1.4	0.8	0.2	1.5	0.2	0.6	0.4	0.3	10.7	0.4	0.9	0.2	1.6	0.5	0.3	2.7	0.8	0.6	0.0	0.8	60.0	8.9	0.0	0.0	0.6	0.0	0.6	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.6	0.8	0.0	0.0	3.9	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	60.0	0.0	8.9	0.0	0.0	0.6	0.3	0.8	0.2	0.8	0.4	0.3	1.8	0.1	0.5	0.2
CNTNAP3	"CASPR3, CNTNAP3A, FLJ14195, KIAA1714"	ENSG00000106714	"Contactin associated protein like 3"	Q9BZ76	9	39072767-39288315	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 10.6;esophagus: 9.5"	"Cell line enhanced"	"Detected in some"		"A549: 12.4;AF22: 15.1;TIME: 9.5;WM-115: 25.2"	"Low cancer specificity"	"Detected in single"							"Cell type enriched"	"Detected in single"	22	"neutrophil: 10.6"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.6"									HPA047731	Uncertain				"Intracellular and membrane"					"HPA047731: AB_2680137"	"unprognostic (9.06e-3)"	"unprognostic (3.07e-2)"	"unprognostic (5.74e-2)"	"unprognostic (7.89e-2)"	"unprognostic (7.03e-2)"	"unprognostic (2.33e-3)"	"unprognostic (4.58e-2)"	"unprognostic (1.34e-2)"	"unprognostic (1.51e-1)"	"unprognostic (2.94e-2)"	"unprognostic (1.11e-1)"	"unprognostic (3.04e-1)"	"unprognostic (1.29e-1)"	"unprognostic (1.15e-2)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-3)"	"unprognostic (1.93e-3)"	2.9	0.1	1.2	0.3	4.8	1.0	2.6	0.4	2.5	0.8	2.4			0.6	0.2	0.2	9.5	1.6	1.1	4.1	1.2	1.3	1.1	0.0	0.8	0.0	0.8		0.0	0.0	0.0	0.3	1.7		1.6	1.4		2.8	1.7	0.0	8.3	1.0	2.5	1.1	2.4	0.1	1.9			1.3		0.3	0.5	1.9	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.7	12.4	15.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.0	0.5	0.0	3.1	1.2	2.9	0.0	0.0	1.1	0.0	3.3	0.3	0.1	0.1	0.0	0.4	2.8	0.0	1.1	5.9	0.0	0.0	0.2	0.0	0.0	0.0	2.6	3.8	0.0	0.4	3.4	0.3	0.5	1.4	0.5	4.4	0.0	2.4	0.0	2.1	9.5	0.0	1.6	0.0	0.4	0.0	0.0	0.0	0.0	0.0	25.2	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.6	0.0	0.0	0.0	0.0	0.0										
CNTNAP3B		ENSG00000154529	"Contactin associated protein like 3B"	Q96NU0	9	41890314-42129510	"Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in some"		"A549: 18.1;AF22: 25.9;WM-115: 17.4"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	9	"neutrophil: 7.5"	"Lineage enriched"	"Detected in single"	76	"granulocytes: 7.5"									HPA047731	Uncertain									"HPA047731: AB_2680137"	"unprognostic (2.68e-2)"	"unprognostic (9.63e-3)"	"unprognostic (2.20e-2)"	"unprognostic (2.87e-1)"	"unprognostic (1.99e-2)"	"unprognostic (6.69e-2)"	"unprognostic (7.20e-3)"	"unprognostic (5.70e-2)"	"unprognostic (2.27e-1)"	"unprognostic (7.20e-2)"	"unprognostic (3.74e-3)"	"unprognostic (1.64e-1)"	"unprognostic (7.74e-2)"	"unprognostic (5.78e-3)"	"unprognostic (7.93e-3)"	"unprognostic (2.90e-2)"	"unprognostic (2.05e-4)"	4.1	0.6	1.1	0.3	2.2	0.0	4.7	0.5	2.2	1.5	1.1			0.4	1.3	0.0	7.3	1.9	1.3	2.5	1.3	1.4	4.9	1.0	2.1	0.0	0.9		0.4	0.3	0.0	1.2	2.4		1.0	1.7		1.9	1.1	0.7	6.5	0.6	1.9	0.9	1.6	0.5	1.1			0.8		0.1	2.0	1.4	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.1	18.1	25.9	0.0	0.8	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.6	0.0	0.4	0.1	2.2	1.5	1.4	0.0	0.0	0.9	0.0	3.2	1.6	0.5	0.9	0.0	2.0	2.1	0.2	0.3	4.2	0.4	0.1	0.0	0.1	0.0	0.0	2.5	5.5	0.0	0.4	7.0	0.8	0.5	1.9	0.2	0.7	0.0	3.5	0.0	2.5	4.5	0.1	1.7	0.1	0.5	0.0	0.0	0.0	0.0	0.8	17.4	0.0	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	7.5	0.0	0.0	0.0	0.0	0.0										
COQ7	"CAT5, CLK-1"	ENSG00000167186	"Coenzyme Q7, hydroxylase"	Q99807	16	19067599-19080095	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 45.2"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 45.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA067252, HPA071922"	Approved		Approved	"Nucleoplasm,Plasma membrane"				"Plasma membrane"	Nucleoplasm	"HPA067252: AB_2685813, HPA071922: AB_2686473"	"unprognostic (1.37e-1)"	"unprognostic (6.89e-3)"	"unprognostic (1.59e-2)"	"unprognostic (6.08e-2)"	"unprognostic (2.44e-2)"	"unprognostic (9.03e-2)"	"unprognostic (1.31e-1)"	"unprognostic (4.42e-2)"	"unprognostic (1.15e-1)"	"unprognostic (7.27e-3)"	"unprognostic (2.15e-1)"	"unprognostic (8.32e-2)"	"prognostic favourable (8.23e-12)"	"unprognostic (2.19e-1)"	"unprognostic (2.76e-1)"	"unprognostic (3.14e-2)"	"unprognostic (5.27e-2)"	9.1	14.2	13.5	7.8	12.9	4.0	12.6	11.3	18.5	11.2	12.8	12.8	15.2	11.4	14.7	17.4	11.9	15.0	13.9	21.1	12.1	13.0	13.5	11.4	14.6	11.1	12.2	12.0	19.4	12.2	23.7	15.1	9.4	12.9	17.1	12.5	16.5	11.3	14.7	37.3	7.5	12.1	11.1	12.4	8.7	11.8	34.7	10.7	9.4	15.3	24.7	7.6	12.1	10.0	5.1	5.3	45.2	4.0	4.1	4.4	1.8	12.4	13.4	11.6	6.8	6.6	7.0	9.8	7.3	6.0	10.0	10.4	8.5	10.4	9.5	35.6	5.6	13.2	16.2	9.1	7.2	8.0	16.3	5.0	12.3	26.0	8.1	12.0	11.2	5.8	8.1	9.3	6.8	8.1	13.8	8.9	7.0	22.4	12.5	9.7	8.8	7.2	15.3	12.9	12.1	8.7	8.4	16.9	9.7	6.8	15.1	8.5	13.8	16.4	8.8	10.7	6.2	7.7	10.5	8.3	13.4	10.4	11.4	7.0	6.8	10.8	4.0	5.8	3.5	3.5	3.3	5.1	3.2	3.1	4.3	5.0	4.4	3.9	45.2	4.1	3.9	5.3	2.0	1.8	13.5	12.9	11.3	18.5	12.1	13.0	12.2	12.0	12.9	10.7
CREB5	"CRE-BPA, H_GS165L15.1"	ENSG00000146592	"CAMP responsive element binding protein 5"	Q02930	7	28299321-28825894	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 53.3;brain: 38.0"	"Cell line enhanced"	"Detected in many"		"HL-60: 31.6;Karpas-707: 13.2;U-2 OS: 13.9;U-2197: 15.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 53.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 53.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"HPA050020, HPA061622"			Approved	"Nucleoplasm,Vesicles,Plasma membrane"				"Nucleoplasm, Plasma membrane"	Vesicles	"HPA050020: AB_2680993, HPA061622: AB_2684569"	"unprognostic (3.59e-2)"	"unprognostic (3.80e-1)"	"unprognostic (1.06e-1)"	"unprognostic (6.46e-2)"	"unprognostic (1.01e-1)"	"unprognostic (4.90e-3)"	"unprognostic (2.01e-3)"	"unprognostic (2.87e-1)"	"unprognostic (3.31e-1)"	"unprognostic (1.04e-1)"	"unprognostic (3.49e-1)"	"unprognostic (2.67e-1)"	"unprognostic (4.91e-3)"	"unprognostic (6.61e-2)"	"unprognostic (3.95e-1)"	"unprognostic (1.60e-1)"	"unprognostic (1.52e-3)"	20.0	3.6	12.1	15.4	19.5	11.5	9.0	10.4	17.8	4.6	5.6	38.0	0.9	2.8	16.3	6.9	7.7	4.7	23.1	10.4	16.7	8.7	6.6	4.6	9.5	6.1	17.9	12.1	2.4	7.0	1.5	2.8	19.5	18.3	3.1	4.3	1.1	6.5	3.0	6.2	5.5	4.2	9.8	14.6	12.6	3.2	2.3	22.7	0.0	3.8	7.0	2.5	5.5	5.0	0.3	4.8	53.3	7.8	0.0	0.0	1.5	0.0	0.3	3.9	0.2	0.2	5.6	0.1	0.3	0.8	2.3	3.5	2.2	1.4	9.7	0.7	0.9	0.4	0.1	3.3	7.4	0.0	2.6	10.5	2.0	0.2	0.2	31.6	0.4	0.7	0.7	10.0	10.8	1.5	1.2	13.2	0.8	0.0	0.0	0.0	4.8	3.9	0.2	3.6	0.2	4.8	1.0	0.4	2.8	0.1	0.2	1.1	0.1	0.7	0.4	4.6	13.9	15.2	4.4	0.8	2.2	0.1	5.1	0.2	7.8	0.0	7.8	0.0	0.0	2.7	0.0	0.3	0.0	0.0	4.8	0.0	0.0	0.0	53.3	0.0	0.8	0.0	0.0	1.5	12.1	19.5	10.4	15.6	16.7	8.7	17.9	12.1	18.3	22.7
CXCL1	"FSP, GRO1, GROa, MGSA, MGSA-a, NAP-3, SCYB1"	ENSG00000163739	"C-X-C motif chemokine ligand 1"	P09341	4	73869393-73871242	"Cancer-related genes, Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 124.8"	"Group enriched"	"Detected in some"	6	"BJ hTERT+: 78.9;EFO-21: 201.6;RPTEC TERT1: 72.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in single"	253	"neutrophil: 25.3"	"Lineage enriched"	"Detected in single"	253	"granulocytes: 25.3"														"Secreted to blood"						"prognostic favourable (7.83e-4)"	"prognostic unfavourable (7.23e-4)"	"unprognostic (5.24e-3)"	"unprognostic (1.27e-1)"	"unprognostic (1.33e-2)"	"unprognostic (4.23e-3)"	"prognostic unfavourable (2.91e-4)"	"unprognostic (1.36e-1)"	"unprognostic (1.37e-1)"	"unprognostic (2.33e-1)"	"unprognostic (5.45e-2)"	"unprognostic (2.04e-2)"	"prognostic unfavourable (1.60e-4)"	"unprognostic (1.17e-1)"	"unprognostic (5.30e-2)"	"unprognostic (7.41e-2)"	"unprognostic (9.41e-2)"	12.0	0.8	1.3	22.5	2.2	14.8	4.1	0.8	1.4	49.2	7.7	1.0	0.7	4.3	0.9	2.1	27.8	6.1	11.2	12.1	1.7	1.3	8.9	4.2	23.0	10.9	3.1	1.0	3.8	13.0	0.0	0.7	26.1	3.9	8.7	7.1	2.1	8.1	4.1	3.2	0.8	10.8	1.2	3.8	124.8	3.1	2.1	1.7	1.7	0.7	7.9	22.6	29.9	6.6	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.3	0.4	0.0	0.0	0.4	1.3	0.0	2.1	78.9	1.9	2.0	0.0	1.4	0.0	201.6	0.1	4.0	0.0	0.3	10.2	0.2	0.0	0.0	0.1	0.0	0.4	0.0	0.0	1.0	0.1	14.2	1.1	15.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	72.8	1.7	0.0	0.0	0.1	0.0	3.9	0.0	0.1	18.2	0.0	0.6	3.9	0.1	0.0	0.1	0.3	0.2	0.0	2.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	25.3	0.0	0.0	0.0	0.0	0.0	1.3	2.2	0.8	1.4	1.7	1.3	3.1	1.0	3.9	1.7
CXCL6	"CKA-3, GCP-2, SCYB6"	ENSG00000124875	"C-X-C motif chemokine ligand 6"	P80162	4	73836497-73849064	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 59.6"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 16.8;EFO-21: 40.5;HUVEC TERT2: 26.4;RPTEC TERT1: 31.4"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	107	"neutrophil: 10.7"	"Lineage enriched"	"Detected in single"	107	"granulocytes: 10.7"														"Secreted to blood"						"unprognostic (4.35e-4)"	"unprognostic (4.47e-2)"	"unprognostic (6.09e-2)"	"unprognostic (4.60e-2)"	"unprognostic (1.98e-2)"	"unprognostic (1.17e-1)"	"unprognostic (3.49e-3)"	"unprognostic (2.62e-1)"	"unprognostic (2.05e-1)"	"unprognostic (2.02e-2)"	"unprognostic (3.75e-2)"	"unprognostic (9.02e-2)"	"prognostic unfavourable (4.82e-4)"	"unprognostic (2.47e-1)"	"unprognostic (4.88e-1)"	"unprognostic (2.72e-1)"	"unprognostic (4.48e-2)"	3.5	0.1	0.1	5.7	0.2	0.5	0.3	0.1	0.2	7.4	3.7	0.0	1.7	3.1	0.1	0.9	1.6	1.7	16.3	2.7	0.5	0.1	4.4	4.6	8.9	0.9	0.3	0.3	0.7	9.4	0.0	0.2	0.0	1.3	3.5	0.1	0.3	2.4	4.7	0.1	0.1	5.2	0.0	0.5	59.6	0.3	1.4	0.0	1.4	0.1	0.6	2.2	13.7	3.1	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	1.4	5.4	0.0	0.9	16.8	0.1	0.2	0.0	0.0	0.0	40.5	0.0	3.4	0.0	0.0	2.6	0.3	0.0	0.0	0.0	0.0	0.3	0.0	0.0	3.3	0.1	8.5	0.0	26.4	0.0	0.0	0.0	0.0	0.0	0.0	0.9	0.9	0.0	0.0	0.0	31.4	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.5	0.3	0.1	0.0	0.1	0.1	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	10.7	0.0	0.0	0.0	0.0	0.0	0.1	0.2	0.1	0.2	0.5	0.1	0.3	0.3	1.3	0.0
DUSP1	"CL100, HVH1, MKP-1, PTPN10"	ENSG00000120129	"Dual specificity phosphatase 1"	P28562	5	172768090-172771195	"Cancer-related genes, Enzymes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HHSteC: 43.1;hTCEpi: 75.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 326.0"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 326.0"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA069577			Approved	Nucleoli,Cytosol				Nucleoli	Cytosol	"HPA069577: AB_2686156"	"unprognostic (1.51e-1)"	"unprognostic (1.24e-1)"	"unprognostic (9.73e-2)"	"unprognostic (8.17e-2)"	"unprognostic (4.64e-1)"	"unprognostic (1.58e-3)"	"unprognostic (4.18e-2)"	"unprognostic (6.94e-2)"	"unprognostic (3.11e-1)"	"unprognostic (1.43e-2)"	"unprognostic (2.23e-1)"	"unprognostic (1.51e-2)"	"unprognostic (2.76e-2)"	"prognostic unfavourable (3.11e-5)"	"unprognostic (2.69e-1)"	"unprognostic (2.35e-2)"	"unprognostic (1.41e-3)"	158.4	78.0	12.4	68.5	14.0	89.7	91.8	17.4	14.9	81.4	37.1	32.4	48.5	9.4	55.4	71.6	82.7	94.8	138.8	49.2	12.5	11.4	29.8	115.4	135.0	43.5	30.6	9.7	69.4	34.4	26.6	40.8	93.7	29.3	67.1	34.2	61.0	38.1	192.8	54.8	116.1	27.6	65.0	29.5	36.1	53.6	45.9	18.7	10.8	90.4	104.1	46.9	69.0	109.7	2.4	11.5	326.0	31.8	4.5	9.8	14.0	2.1	5.4	1.7	2.3	37.5	22.0	2.9	34.9	10.2	23.5	9.5	5.9	2.5	0.7	10.2	24.5	0.9	1.6	8.6	11.0	19.1	4.6	0.4	11.9	2.5	43.1	0.2	0.8	21.0	75.3	10.6	17.3	7.3	1.7	13.7	15.1	2.5	1.1	1.0	1.5	1.6	40.5	3.2	6.3	16.7	1.1	7.4	3.1	9.4	16.1	1.2	1.3	0.4	19.2	16.7	8.3	16.2	2.6	2.8	1.6	0.6	14.8	0.3	0.6	33.3	24.6	69.8	3.9	25.0	9.8	2.4	3.5	4.0	11.5	2.1	1.7	1.9	326.0	4.5	31.8	0.6	2.8	14.0	12.4	14.0	17.4	14.9	12.5	11.4	30.6	9.7	29.3	18.7
FCGR2A	"CD32, CD32A, CDw32, FCG2, FCGR2, FCGR2A1, IGFR2"	ENSG00000143226	"Fc fragment of IgG receptor IIa"	P12318	1	161505430-161524013	"CD markers, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 182.8"	"Cell line enhanced"	"Detected in some"		"HEL: 14.0;HMC-1: 28.2;K-562: 8.3;NB-4: 7.9;THP-1: 30.0;U-937: 12.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 182.8"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 182.8"									"HPA010718, HPA010776, HPA014730"	Enhanced		Supported	"Golgi apparatus,Plasma membrane"		55000000	55000000	"Plasma membrane"	"Golgi apparatus"	"HPA010718: AB_1078463, HPA010776: , HPA014730: AB_2669074"	"unprognostic (2.57e-2)"	"unprognostic (1.16e-1)"	"unprognostic (1.48e-2)"	"unprognostic (4.12e-2)"	"unprognostic (5.89e-2)"	"unprognostic (6.17e-2)"	"unprognostic (1.24e-2)"	"unprognostic (1.17e-1)"	"unprognostic (7.63e-2)"	"unprognostic (1.17e-3)"	"unprognostic (2.43e-2)"	"unprognostic (2.91e-1)"	"prognostic unfavourable (6.49e-7)"	"unprognostic (8.85e-3)"	"unprognostic (6.47e-3)"	"unprognostic (1.54e-1)"	"unprognostic (3.42e-2)"	36.8	12.6	13.2	44.6	19.2	18.6	8.2	2.2	10.1	9.1	7.1	10.0	0.0	3.8	4.7	6.6	5.5	11.6	17.0	11.3	17.0	8.9	11.5	7.1	44.1	50.0	25.9	1.7	8.0	5.8	2.8	6.1	47.5	19.6	7.0	9.9	10.8	8.3	4.8	7.3	3.0	7.3	17.6	30.9	43.4	5.9	4.8	19.2	3.2	6.3	2.5	4.4	19.3	4.5	0.2	7.0	182.8	27.2	0.0	0.0	10.6	0.0	0.0	0.0	1.2	0.0	0.2	0.0	0.0	0.3	0.0	0.0	0.0	0.0	1.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	14.0	0.2	0.0	0.3	4.0	28.2	0.3	0.0	0.0	0.0	0.0	8.3	0.2	0.0	0.0	0.2	7.9	0.0	0.6	0.1	0.6	3.8	0.0	0.0	0.0	0.0	0.0	0.0	2.3	0.0	30.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.3	0.2	12.9	3.5	0.1	27.2	31.6	0.0	20.7	0.0	0.2	0.0	0.0	7.0	0.1	0.0	0.0	182.8	0.0	16.7	0.2	0.0	10.6	13.2	19.2	2.2	10.1	17.0	8.9	25.9	1.7	19.6	19.2
FPR1	"FMLP, FPR"	ENSG00000171051	"Formyl peptide receptor 1"	P21462	19	51745172-51804110	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 213.3;lymphoid tissue: 64.4"	"Cell line enriched"	"Detected in some"	5	"U-87 MG: 34.2"	"Cancer enhanced"	"Detected in all"		"glioma: 23.0"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 213.3"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 213.3"	"Not detected"	"Not detected"							"HPA046550, HPA061744"	Approved		Approved	"Nucleoplasm,Nucleoli,Golgi apparatus"				"Golgi apparatus"	"Nucleoplasm, Nucleoli"	"HPA046550: AB_2679694, HPA061744: AB_2684600"	"unprognostic (5.54e-2)"	"unprognostic (4.16e-2)"	"unprognostic (1.88e-1)"	"unprognostic (1.22e-1)"	"unprognostic (8.50e-2)"	"unprognostic (1.38e-1)"	"unprognostic (1.96e-1)"	"unprognostic (1.14e-1)"	"unprognostic (1.15e-1)"	"unprognostic (5.48e-3)"	"unprognostic (4.59e-2)"	"unprognostic (8.34e-2)"	"prognostic unfavourable (2.21e-4)"	"unprognostic (6.03e-2)"	"unprognostic (4.52e-3)"	"unprognostic (1.54e-2)"	"unprognostic (1.70e-3)"	22.6	3.7	5.2	52.2	12.4	54.5	2.9	1.1	6.3	2.6	2.4	5.9	0.0	1.1	2.3	2.3	3.3	8.4	9.6	11.2	15.7	4.3	6.0	7.5	28.8	58.4	15.5	0.8	1.9	3.5	0.8	2.3	13.0	9.7	1.8	1.2	2.4	2.4	0.9	3.2	1.1	2.2	12.8	14.3	64.4	3.2	2.9	10.1	0.9	2.7	0.7	3.2	7.9	4.6	0.0	8.9	213.3	36.3	0.0	0.0	16.9	0.3	0.5	0.2	0.3	0.4	1.1	0.3	0.2	0.0	0.3	1.0	0.2	0.3	0.6	0.3	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.5	0.4	0.6	2.7	0.2	0.4	2.4	0.1	0.8	0.8	0.0	0.1	0.3	6.9	0.5	0.1	0.2	0.2	0.4	0.2	0.4	0.0	0.6	0.3	0.1	0.2	0.4	0.0	0.3	0.6	0.6	0.5	1.1	0.2	0.0	1.6	0.1	0.0	0.3	34.2	0.8	0.1	13.0	36.3	10.0	0.0	15.9	0.0	0.0	0.0	0.0	8.9	0.0	0.0	0.0	213.3	0.0	9.5	0.3	0.0	16.9	5.2	12.4	1.1	6.3	15.7	4.3	15.5	0.8	9.7	10.1
FRAT2		ENSG00000181274	"FRAT2, WNT signaling pathway regulator"	O75474	10	97332497-97334709	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Cancer enhanced"	"Detected in all"		"testis cancer: 70.3"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 29.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 29.3"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA049763	Uncertain		Approved	Nucleoplasm,Mitochondria				Nucleoplasm	Mitochondria	"HPA049763: AB_2680868"	"unprognostic (4.93e-2)"	"unprognostic (1.28e-2)"	"unprognostic (2.13e-1)"	"unprognostic (1.46e-1)"	"unprognostic (4.04e-3)"	"unprognostic (1.87e-2)"	"prognostic unfavourable (3.02e-4)"	"unprognostic (3.17e-3)"	"unprognostic (2.60e-1)"	"unprognostic (8.02e-2)"	"unprognostic (4.60e-2)"	"unprognostic (3.25e-2)"	"prognostic favourable (2.55e-4)"	"unprognostic (7.87e-3)"	"unprognostic (4.83e-2)"	"unprognostic (2.34e-1)"	"unprognostic (9.08e-2)"	5.0	3.8	5.7	8.7	7.5	23.8	9.7	8.6	9.4	5.7	18.8	4.8	10.2	21.9	6.0	5.9	13.2	6.4	7.2	7.7	6.1	4.9	5.8	15.6	12.0	22.4	5.6	2.0	3.0	16.5	4.8	3.2	9.6	7.7	8.8	14.0	5.4	22.4	4.9	8.7	17.8	20.3	3.7	5.9	28.0	11.5	14.9	7.3	9.0	8.1	8.3	11.1	7.9	13.2	1.2	1.9	29.3	3.7	0.6	1.1	1.1	5.3	2.1	3.5	15.7	2.5	2.1	13.1	1.2	4.4	1.9	1.9	3.3	6.3	6.5	4.3	1.2	10.1	9.2	4.7	1.5	9.7	14.0	8.7	4.6	7.2	1.5	13.9	10.5	1.6	10.2	1.8	5.9	4.7	7.6	2.1	0.9	8.7	6.0	17.7	21.8	8.8	6.2	1.4	9.2	4.5	4.8	6.4	5.2	1.5	9.6	6.0	14.5	22.1	2.1	1.1	1.4	0.8	3.1	5.8	5.9	3.2	1.3	24.2	0.4	3.3	3.7	7.1	0.6	2.3	0.3	0.5	0.7	0.9	1.9	1.2	1.1	0.7	29.3	0.6	3.5	0.4	0.3	1.1	5.7	7.5	8.6	9.4	6.1	4.9	5.6	2.0	7.7	7.3
GK	"GK1, GKD"	ENSG00000198814	"Glycerol kinase"	P32189	X	30653359-30731456	"Disease related genes, Enzymes, Potential drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 51.4;intestine: 37.9;kidney: 35.4;liver: 40.7"	"Cell line enhanced"	"Detected in many"		"Hep G2: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 51.4"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 51.4"									HPA060687	Supported									"HPA060687: AB_2684343"	"unprognostic (8.78e-3)"	"unprognostic (8.41e-3)"	"unprognostic (1.28e-2)"	"unprognostic (3.77e-2)"	"unprognostic (3.15e-1)"	"unprognostic (4.15e-3)"	"unprognostic (5.52e-2)"	"unprognostic (1.42e-2)"	"unprognostic (3.85e-1)"	"unprognostic (8.56e-3)"	"unprognostic (1.30e-2)"	"unprognostic (1.58e-2)"	"prognostic favourable (3.24e-9)"	"unprognostic (1.59e-1)"	"unprognostic (9.35e-2)"	"unprognostic (4.57e-3)"	"unprognostic (4.11e-3)"	2.8	4.9	2.4	17.0	7.6	1.6	1.8	2.5	4.7	3.0	7.5	2.7	1.5	28.4	2.5	4.0	4.9	2.7	7.9	4.9	4.6	2.6	35.4	40.7	11.7	8.1	3.8	2.5	2.0	1.9	3.2	5.3	2.3	4.1	1.9	3.4	2.9	6.6	0.6	1.4	3.1	37.9	1.9	6.0	6.4	2.0	2.0	2.2	5.4	2.2	3.8	4.5	4.3	1.7	1.7	4.0	51.4	6.6	1.2	3.2	1.6	2.5	2.0	2.7	4.7	1.7	6.4	1.1	6.2	22.1	4.6	5.2	3.3	2.4	7.4	1.0	2.4	0.1	5.0	2.0	6.1	4.7	5.6	4.3	4.2	26.8	10.6	8.0	9.4	3.9	3.1	14.5	13.8	3.6	2.3	10.5	1.2	3.7	6.2	8.6	4.5	2.4	8.6	4.2	7.6	3.4	8.7	2.9	3.6	5.5	5.6	12.3	6.4	5.8	1.4	3.3	1.4	0.1	2.8	5.5	5.9	7.2	5.8	5.3	3.3	1.3	6.6	2.2	0.5	2.0	0.4	0.8	0.9	0.6	4.0	1.7	0.5	0.6	51.4	1.2	2.4	1.2	3.2	1.6	2.4	7.6	2.5	4.7	4.6	2.6	3.8	2.5	4.1	2.2
GNG10		ENSG00000242616	"G protein subunit gamma 10"	P50151	9	111661335-111670246	"Predicted intracellular proteins, RAS pathway related proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 75.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 75.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"														"unprognostic (3.25e-1)"	"unprognostic (1.15e-1)"	"unprognostic (2.21e-2)"	"unprognostic (3.99e-2)"	"unprognostic (4.68e-2)"	"prognostic unfavourable (3.21e-5)"	"unprognostic (3.62e-1)"	"unprognostic (7.60e-2)"	"unprognostic (1.20e-2)"	"unprognostic (2.35e-1)"	"unprognostic (6.14e-2)"	"unprognostic (8.91e-2)"	"unprognostic (5.78e-2)"	"unprognostic (8.83e-2)"	"unprognostic (1.50e-1)"	"unprognostic (3.27e-2)"	"unprognostic (1.42e-1)"	32.3	33.1	36.9	31.0	31.9	25.3	20.1	11.9	30.5	21.4	18.5	17.3	7.7	12.5	21.6	16.8	15.2	16.9	20.6	23.2	29.9	30.4	19.7	24.7	21.5	34.2	27.6	20.1	16.6	17.1	25.9	34.6	28.1	18.6	28.3	16.3	17.4	20.1	15.4	11.1	7.5	18.5	23.5	26.8	32.3	16.4	11.8	18.3	11.8	20.3	11.9	13.8	32.5	15.1	2.1	7.3	75.4	8.7	1.7	4.6	4.7	22.9	11.5	9.7	14.9	36.4	25.8	16.3	23.8	30.1	23.3	21.5	17.6	16.7	1.2	10.0	30.9	17.2	17.8	23.3	27.1	7.9	18.7	2.9	12.9	13.4	23.8	9.2	8.2	23.4	16.8	20.6	27.7	26.8	9.8	6.0	37.7	15.1	6.1	7.5	17.2	27.0	4.6	45.5	1.2	43.4	14.6	15.3	12.9	23.9	11.6	21.9	26.3	14.8	18.6	21.4	17.6	43.3	25.3	3.7	7.3	2.6	31.0	22.4	13.8	3.0	8.7	11.8	2.0	7.8	3.2	1.6	2.7	2.5	7.3	2.1	2.9	2.1	75.4	1.7	6.5	4.6	4.6	4.7	36.9	31.9	11.9	30.5	29.9	30.4	27.6	20.1	18.6	18.3
HCAR2	"GPR109A, HCA2, HM74A, NIACR1, Puma-g, PUMAG"	ENSG00000182782	"Hydroxycarboxylic acid receptor 2"	Q8TDS4	12	122701293-122703343	"FDA approved drug targets, G-protein coupled receptors, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell line enriched"	"Detected in some"	6	"HaCaT: 50.7"	"Group enriched"	"Detected in many"	8	"cervical cancer: 12.6;head and neck cancer: 16.1;lung cancer: 6.4;urothelial cancer: 9.2"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	6	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 50.9"									HPA028660	Approved		Supported	"Cell Junctions"				"Cell Junctions"		"HPA028660: AB_10602139"	"unprognostic (5.43e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.77e-1)"	"unprognostic (2.05e-1)"	"unprognostic (6.65e-2)"	"unprognostic (1.33e-1)"	"unprognostic (3.33e-3)"	"unprognostic (7.26e-2)"	"unprognostic (2.17e-1)"	"unprognostic (1.77e-2)"	"unprognostic (7.10e-2)"	"unprognostic (7.33e-2)"	"unprognostic (4.83e-4)"	"unprognostic (5.76e-2)"	"unprognostic (5.07e-2)"	"unprognostic (1.54e-1)"	"unprognostic (4.63e-2)"	16.1	0.2	0.4	6.4	0.5	13.2	8.3	0.2	0.7	5.8	3.6	0.3	6.2	0.4	0.8	1.6	26.0	0.4	1.1	1.2	0.8	0.2	1.9	1.8	11.3	0.7	3.3	0.2	1.2	0.2	4.4	0.9	8.2	1.0	8.6	0.0	0.3	9.7	10.7	0.7	17.8	0.7	0.4	0.9	16.5	0.8	2.8	1.1	1.1	0.4	13.5	21.5	3.5	8.3	0.0	0.5	50.9	6.6	0.0	0.0	0.3	1.8	0.1	0.0	0.0	0.4	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	50.7	0.0	3.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.1	0.0	1.6	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	8.3	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.1	0.0	0.0	9.0	0.6	0.6	0.0	1.5	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	50.9	0.0	6.6	0.0	0.0	0.3	0.4	0.5	0.2	0.7	0.8	0.2	3.3	0.2	1.0	1.1
HDAC7	"DKFZP586J0917, HDAC7A"	ENSG00000061273	"Histone deacetylase 7"	Q8WUI4	12	47782722-47833132	"Enzymes, FDA approved drug targets, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 85.8"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 10.5"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA004775			Supported	Cytosol				Cytosol		"HPA004775: "	"unprognostic (3.83e-1)"	"unprognostic (9.49e-3)"	"unprognostic (1.37e-2)"	"unprognostic (4.46e-2)"	"unprognostic (6.56e-3)"	"unprognostic (2.22e-2)"	"unprognostic (2.50e-3)"	"unprognostic (1.26e-1)"	"prognostic unfavourable (5.16e-4)"	"unprognostic (1.28e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.38e-2)"	"prognostic unfavourable (8.25e-4)"	"unprognostic (6.24e-2)"	"unprognostic (4.38e-2)"	"unprognostic (9.69e-2)"	"prognostic favourable (4.65e-4)"	26.0	21.6	8.2	22.7	10.8	17.3	24.4	8.4	10.7	28.2	20.7	8.7	15.4	8.0	27.9	21.5	19.2	25.2	22.1	16.5	10.3	4.3	17.7	5.1	27.6	21.1	8.2	8.0	25.4	8.9	23.7	11.5	17.5	10.0	20.1	4.1	17.6	16.3	18.9	12.5	19.7	13.9	24.9	10.3	23.1	14.9	9.5	11.5	85.8	20.9	12.9	21.0	24.8	25.0	1.4	0.6	10.5	1.9	1.7	1.5	1.8	14.0	9.6	10.0	16.3	7.8	21.9	9.0	13.9	10.8	10.1	6.6	12.8	13.4	28.3	46.2	12.6	13.1	2.3	10.8	3.7	13.2	4.8	9.6	9.4	2.9	8.5	3.0	0.4	14.3	3.8	10.0	5.4	20.8	10.2	11.6	6.4	6.1	27.8	7.5	14.0	10.7	21.4	5.3	10.2	4.3	9.2	2.8	6.8	10.6	4.9	5.0	4.6	4.1	23.5	20.7	22.5	16.8	9.8	26.2	19.0	22.5	8.5	14.3	6.7	0.0	1.9	0.0	1.5	0.8	1.5	1.4	1.3	1.1	0.6	1.1	1.5	1.0	10.5	1.7	0.7	0.5	0.6	1.8	8.2	10.8	8.4	10.7	10.3	4.3	8.2	8.0	10.0	11.5
HIST1H4B	"H4/I, H4FI"	ENSG00000278705	"Histone cluster 1 H4 family member b"	P62805	6	26026815-26027252	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 102.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in some"							"Cell type enriched"	"Detected in many"	6	"neutrophil: 25.8"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 25.8"									HPA042201	Supported					30000000	30000000			"HPA042201: AB_2677898"	"unprognostic (1.16e-1)"	"unprognostic (2.18e-2)"	"unprognostic (2.12e-1)"	"unprognostic (6.31e-3)"	"unprognostic (2.32e-1)"	"unprognostic (1.52e-1)"	"unprognostic (6.07e-2)"	"unprognostic (2.57e-1)"	"unprognostic (1.52e-1)"	"unprognostic (7.87e-2)"	"unprognostic (2.56e-1)"	"unprognostic (6.30e-2)"	"unprognostic (1.69e-3)"	"unprognostic (4.39e-2)"	"unprognostic (3.17e-1)"	"unprognostic (4.50e-2)"	"unprognostic (1.58e-2)"	2.6	1.0	0.3	6.2	0.4	11.3	2.3	6.2	1.0	4.0	3.2	0.0	4.2	1.8	5.7	1.8	5.7	3.3	2.0	1.6	0.2		5.0	1.7	3.0	4.7	0.2	0.0	8.6	19.9	1.0	0.5	2.4	0.4	3.6	1.4	6.0	4.0	3.5	2.3	1.6	2.7	2.0	0.0	6.3	2.2	10.5	0.2	102.5	8.0	3.0	8.9	3.5	4.3	4.3	1.3	25.8	1.2	0.2	1.0	0.3	1.7	0.0	0.2	3.7	0.0	0.0	0.0	2.7	0.3	1.7	1.1	0.7	0.5	1.4	0.6	0.5	0.5	0.8	0.0	1.0	0.6	3.8	4.7	1.8	2.0	0.0	0.3	1.5	0.0	0.0	0.0	0.0	0.0	0.8	5.3	0.5	2.8	4.7	3.7	0.8	0.6	3.4	1.7	2.9	0.0	1.3	1.0	0.7	0.4	2.0	0.0	0.5	2.4	0.0	1.1	2.5	2.0	3.6	3.0	2.8	2.2	1.4	1.4	1.9	0.0	0.5	0.7	0.9	0.6	0.9	1.7	1.0	0.8	0.4	4.3	0.8	0.4	25.8	0.2	1.2	1.3	0.7	0.3										
IFIT2	"cig42, G10P2, GARG-39, IFI-54, IFI54, ISG-54K"	ENSG00000119922	"Interferon induced protein with tetratricopeptide repeats 2"	P09913	10	89283694-89309276	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 93.4"	"Group enriched"	"Detected in many"	4	"BJ hTERT+ SV40 Large T+: 49.6;BJ hTERT+ SV40 Large T+ RasG12V: 39.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 93.4"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 93.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA003408	Approved		Approved	Vesicles				Vesicles		"HPA003408: AB_1079100"	"unprognostic (1.77e-1)"	"unprognostic (2.10e-1)"	"unprognostic (2.42e-2)"	"unprognostic (2.25e-3)"	"unprognostic (1.75e-2)"	"unprognostic (9.28e-2)"	"unprognostic (6.71e-3)"	"unprognostic (2.22e-1)"	"unprognostic (5.40e-1)"	"unprognostic (1.36e-1)"	"unprognostic (7.03e-3)"	"unprognostic (1.27e-1)"	"prognostic unfavourable (6.99e-4)"	"unprognostic (2.92e-2)"	"unprognostic (1.03e-2)"	"unprognostic (5.33e-3)"	"unprognostic (6.46e-2)"	15.5	7.7	10.2	8.9	11.9	31.9	5.5	8.1	10.5	4.5	3.7	15.6	2.1	4.7	3.5	7.4	2.3	6.7	9.7	4.8	10.4	9.2	10.5	14.9	14.4	6.5	23.7	6.7	6.9	2.4	4.5	3.3	11.3	20.4	3.9	3.1	5.2	5.8	4.7	1.8	2.5	4.1	4.6	29.4	18.0	2.6	1.3	17.9	3.9	4.2	0.4	3.7	7.3	3.5	4.0	2.9	93.4	17.0	1.7	2.2	3.4	9.8	0.3	0.1	4.6	4.7	5.2	1.4	3.7	10.4	49.6	39.4	0.0	7.2	1.1	2.1	2.6	10.4	0.2	0.5	5.3	4.1	0.0	1.8	5.3	0.0	8.1	0.2	0.8	2.9	0.2	3.7	0.5	0.2	0.0	0.2	0.7	0.0	1.2	2.3	0.1	2.0	0.7	1.2	0.2	1.6	2.0	0.0	0.0	1.1	0.2	8.9	0.2	0.5	0.3	0.5	0.1	1.4	0.3	0.3	1.7	0.1	0.8	0.8	1.0	17.9	7.0	21.8	2.2	15.1	1.2	4.0	1.7	1.5	2.3	3.5	1.8	1.6	93.4	1.7	17.0	2.9	0.9	3.4	10.2	11.9	8.1	10.5	10.4	9.2	23.7	6.7	20.4	17.9
IFITM2	1-8D	ENSG00000185201	"Interferon induced transmembrane protein 2"	Q01629	11	307631-315272	"Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 875.3"	"Cell line enhanced"	"Detected in many"		"HHSteC: 98.0;HMC-1: 111.9;HSkMC: 121.1;U-937: 86.9"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 875.3"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 875.3"									HPA004337	Uncertain									"HPA004337: AB_1851427"	"unprognostic (2.39e-2)"	"unprognostic (2.69e-2)"	"unprognostic (4.54e-1)"	"unprognostic (1.65e-2)"	"unprognostic (3.41e-2)"	"unprognostic (1.86e-1)"	"unprognostic (3.56e-2)"	"unprognostic (3.87e-2)"	"unprognostic (3.87e-1)"	"unprognostic (2.36e-1)"	"unprognostic (2.46e-3)"	"unprognostic (1.64e-2)"	"prognostic unfavourable (2.37e-9)"	"unprognostic (2.79e-1)"	"unprognostic (3.28e-2)"	"unprognostic (1.51e-1)"	"unprognostic (1.16e-2)"	101.0	25.2	14.3	95.5	20.9	56.3	143.6	8.2	16.6	70.8	40.2	10.9	14.3	9.5	63.6	46.1	56.0	70.8	28.5	91.1	13.3	10.8	83.0	326.2	141.9	255.5	29.3	3.3	106.5	31.1	68.6	18.9	48.0	21.1	54.3	17.7	39.1	20.1	37.7	72.7	20.1	24.0	63.2	21.7	233.4	28.4	38.5	15.6	12.5	83.4	26.2	35.4	98.0	119.7	27.5	21.6	875.3	74.9	52.8	33.3	47.1	4.1	12.8	35.3	0.2	23.0	66.8	0.1	13.0	25.1	7.4	17.2	0.4	38.1	0.0	31.6	66.2	8.5	0.1	2.2	3.1	0.0	5.3	12.7	14.5	14.1	98.0	20.4	111.9	121.1	0.4	2.1	1.1	24.3	0.5	42.0	5.3	28.4	0.1	74.8	4.3	29.9	14.0	3.7	0.2	68.6	0.0	0.1	0.8	9.6	11.1	3.9	16.1	7.3	63.7	1.1	4.0	5.8	0.2	0.1	0.6	0.6	2.1	86.9	3.9	77.9	19.8	138.8	33.3	53.2	24.6	27.5	30.0	29.4	21.6	24.5	26.0	28.1	875.3	52.8	74.9	9.1	15.8	47.1	14.3	20.9	8.2	16.6	13.3	10.8	29.3	3.3	21.1	15.6
IL1R2	"CD121b, IL1RB"	ENSG00000115590	"Interleukin 1 receptor type 2"	P27930	2	101991844-102028544	"Cancer-related genes, CD markers, Plasma proteins, Predicted membrane proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 73.2;lymphoid tissue: 74.1"	"Cell line enriched"	"Detected in some"	19	"HDLM-2: 100.0"	"Low cancer specificity"	"Detected in many"			"Region enriched"	"Detected in many"	4	"midbrain: 9.2"	"Cell type enriched"	"Detected in some"	25	"neutrophil: 73.2"	"Lineage enriched"	"Detected in many"	25	"granulocytes: 73.2"	"Low region specificity"	"Detected in many"			"Not detected"	"Not detected"			"HPA027597, HPA027598"	Uncertain				"Secreted to blood"	21000000	21000000			"HPA027597: AB_10600768, HPA027598: AB_10601229"	"unprognostic (3.54e-2)"	"unprognostic (1.87e-1)"	"unprognostic (1.21e-1)"	"unprognostic (3.83e-2)"	"unprognostic (6.59e-2)"	"unprognostic (1.42e-1)"	"unprognostic (6.36e-2)"	"unprognostic (4.82e-3)"	"unprognostic (1.62e-2)"	"unprognostic (7.15e-2)"	"unprognostic (8.20e-3)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (5.58e-12)"	"unprognostic (1.92e-1)"	"unprognostic (7.51e-2)"	"unprognostic (1.77e-1)"	"unprognostic (6.62e-2)"	9.1	3.2	1.2	16.4	1.9	22.3	1.6	1.2	1.9	6.4	13.4	0.4	0.1	0.1	1.3	1.3	20.4	9.7	3.4	15.1	1.2	0.5	5.8	8.2	25.5	74.1	9.2	0.2	2.5	1.4	0.0	2.4	24.9	2.2	1.1	20.0	1.8	4.3	0.8	2.8	14.1	2.2	1.3	4.4	47.5	14.6	1.6	1.1	1.6	1.8	8.5	25.1	3.2	9.1	0.0	2.8	73.2	0.8	0.0	1.1	0.2	1.5	0.1	0.0	0.0	0.2	0.2	0.1	0.0	0.0	0.0	0.0	1.6	0.0	0.0	3.3	0.0	0.6	0.0	0.1	0.0	100.0	0.1	0.0	0.0	0.8	0.5	0.0	0.0	2.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.2	0.3	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.2	0.0	1.6	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.8	0.0	0.0	0.4	0.0	0.0	0.1	0.0	2.8	0.0	0.0	0.0	73.2	0.0	0.0	0.0	1.1	0.2	1.2	1.9	1.2	1.9	1.2	0.5	9.2	0.2	2.2	1.1
KAZN	"FLJ43806, KAZRIN, KIAA1026"	ENSG00000189337	"Kazrin, periplakin interacting protein"	Q674X7	1	13892792-15118043	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 64.9"	"Cell line enhanced"	"Detected in many"		"AN3-CA: 39.7;SK-BR-3: 21.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	21	"neutrophil: 6.9"	"Lineage enriched"	"Detected in single"	21	"granulocytes: 6.9"									"HPA032095, HPA032096"	Approved		Supported	"Nucleoplasm,Nuclear speckles,Cytosol"				Nucleoplasm	"Nuclear speckles, Cytosol"	"HPA032095: , HPA032096: AB_10670826"	"unprognostic (2.81e-1)"	"unprognostic (5.82e-2)"	"unprognostic (1.12e-1)"	"unprognostic (2.42e-3)"	"unprognostic (5.34e-2)"	"unprognostic (2.15e-3)"	"unprognostic (6.57e-3)"	"unprognostic (7.88e-3)"	"unprognostic (3.21e-1)"	"unprognostic (4.96e-3)"	"unprognostic (1.10e-1)"	"unprognostic (5.55e-2)"	"prognostic favourable (1.20e-6)"	"unprognostic (3.61e-2)"	"unprognostic (7.93e-2)"	"unprognostic (3.21e-1)"	"unprognostic (1.06e-2)"	8.0	11.0	13.4	3.0	17.4	1.2	7.6	41.1	21.9	8.0	3.8	27.5	5.7	4.6	3.1	11.1	18.8	11.0	7.0	4.1	12.4	12.4	13.2	5.2	8.5	1.5	25.1	12.1	10.4	8.0	22.9	2.7	11.0	15.0	4.1	4.0	10.5	16.8	7.2	1.7	14.2	4.9	3.7	25.0	64.9	4.9	4.1	18.9	0.0	6.6	7.0	6.3	7.9	9.4	0.3	0.0	6.9	0.0	0.0	0.0	0.0	7.8	1.4	8.6	39.7	3.8	3.9	2.9	3.8	3.2	7.1	5.1	1.8	4.2	0.0	9.9	8.1	2.8	1.9	6.2	3.5	0.2	3.9	4.5	4.7	11.8	2.8	0.0	2.3	5.5	8.3	1.6	1.1	0.0	1.8	9.2	5.6	5.7	0.0	0.4	2.4	1.2	2.7	0.2	4.8	11.9	2.4	4.6	3.3	0.6	21.6	14.8	1.2	3.0	0.0	5.8	5.5	9.2	4.5	1.5	1.3	0.0	5.4	7.9	2.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	6.9	0.0	0.0	0.0	0.0	0.0	13.4	17.4	41.1	21.4	12.4	12.4	25.1	12.1	15.0	18.9
KIAA1551	"C12orf35, FLJ10652, FLJ20696, GET, UTA2-1"	ENSG00000174718	KIAA1551	Q9HCM1	12	31959370-31993107	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 58.8;lymphoid tissue: 56.3"	"Low cell line specificity"	"Detected in all"			"Cancer enhanced"	"Detected in all"		"testis cancer: 65.6"	"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 58.8"	"Lineage enriched"	"Detected in all"	4	"granulocytes: 58.8"					"Low region specificity"	"Detected in all"			"HPA013816, HPA015622"	Approved		Supported	"Nucleoli,Intermediate filaments,Cytosol"				Nucleoli	"Intermediate filaments, Cytosol"	"HPA013816: AB_1848661, HPA015622: AB_1848663"	"unprognostic (7.97e-3)"	"unprognostic (1.69e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.49e-2)"	"unprognostic (3.21e-1)"	"unprognostic (3.09e-3)"	"unprognostic (2.24e-1)"	"unprognostic (2.19e-1)"	"unprognostic (8.87e-2)"	"unprognostic (1.09e-1)"	"unprognostic (1.13e-1)"	"unprognostic (2.90e-2)"	"prognostic unfavourable (5.04e-9)"	"unprognostic (3.83e-1)"	"unprognostic (1.09e-1)"	"unprognostic (2.61e-1)"	"unprognostic (7.26e-3)"	12.4	5.8	4.7	28.8	6.1	9.0	10.3	8.7	7.0	15.7	17.5	2.7	7.1	10.7	11.2	10.3	12.3	19.0	8.9	6.2	4.8	3.5	8.1	14.2	17.0	56.3	7.5	4.1	38.3	7.0	3.6	8.0	17.5	5.4	11.6	6.5	3.5	8.6	5.5	5.4	6.7	30.0	8.5	8.1	39.1	8.8	8.7	5.9	48.5	10.0	7.6	27.6	17.3	13.9	9.6	3.3	58.8	4.5	8.0	13.2	5.0	2.9	5.3	9.2	3.5	4.2	5.0	13.7	3.6	3.6	2.6	2.8	20.0	19.6	14.3	9.0	3.0	4.0	12.6	2.4	3.7	10.5	1.7	20.0	2.6	2.6	8.2	14.4	32.4	2.7	3.7	2.9	4.8	20.2	11.4	22.8	2.7	1.4	20.2	6.0	19.6	2.2	9.4	8.8	6.2	2.6	5.5	3.7	3.3	4.7	2.4	2.5	8.4	16.0	12.7	2.7	4.4	4.7	3.8	13.9	14.7	17.6	1.5	8.1	3.0	12.5	3.9	3.9	12.5	4.4	11.8	9.6	11.2	11.6	3.3	7.5	13.2	12.6	58.8	8.0	4.5	2.0	10.2	5.0	4.7	6.1	8.7	7.0	4.8	3.5	7.5	4.1	5.4	5.9
LITAF	"FLJ38636, PIG7, SIMPLE, TP53I7"	ENSG00000189067	"Lipopolysaccharide induced TNF factor"	Q99732	16	11547722-11636381	"Disease related genes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 202.5"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 202.5"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 202.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA006960	Approved		Supported	Nucleoplasm,Vesicles,Cytosol				"Nucleoplasm, Vesicles"	Cytosol	"HPA006960: AB_1079254"	"unprognostic (2.26e-1)"	"unprognostic (4.96e-2)"	"unprognostic (2.32e-3)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (2.02e-4)"	"unprognostic (4.07e-2)"	"unprognostic (8.75e-3)"	"unprognostic (3.60e-1)"	"unprognostic (6.15e-3)"	"unprognostic (1.04e-1)"	"unprognostic (4.61e-2)"	"unprognostic (5.01e-1)"	"unprognostic (1.85e-2)"	"unprognostic (9.49e-2)"	"prognostic unfavourable (6.25e-4)"	"unprognostic (3.57e-2)"	"unprognostic (1.60e-1)"	55.0	14.1	18.0	49.2	42.4	53.3	65.7	5.0	18.5	50.4	36.4	45.2	20.2	13.9	42.7	28.8	19.6	34.0	35.3	31.5	20.7	15.7	48.9	66.3	73.0	80.6	28.6	13.2	43.1	26.3	15.9	17.1	46.2	42.8	36.2	36.7	26.0	57.3	32.2	18.6	28.5	24.1	41.6	52.1	57.9	26.3	11.0	19.0	18.7	53.3	18.8	36.4	47.4	41.6	14.1	16.9	202.5	10.3	20.2	37.6	35.6	13.7	25.6	16.2	7.8	2.5	1.9	16.4	17.9	55.1	17.0	25.4	10.6	37.1	6.9	22.9	15.1	17.0	6.8	30.0	16.3	52.7	7.1	0.5	22.3	53.7	38.0	2.1	2.3	5.7	58.3	13.9	38.2	0.0	4.2	26.8	0.2	13.1	0.3	31.8	26.4	0.1	2.1	3.5	39.6	14.3	19.4	4.0	12.2	30.9	39.5	31.8	22.1	11.7	0.1	7.1	12.0	4.1	4.1	10.5	23.1	17.7	8.1	16.8	40.5	32.2	10.3	20.8	37.6	9.8	22.8	14.1	23.5	33.5	13.6	13.9	26.8	31.7	202.5	20.2	5.7	16.9	26.2	35.6	18.0	42.4	5.0	18.5	20.7	15.7	28.6	13.2	42.8	19.0
LY6G6F	"C6orf21, G6f, LY6G6D, NG32"	ENSG00000204424	"Lymphocyte antigen 6 family member G6F"	Q5SQ64	6	31706885-31710595	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"blood: 6.0;bone marrow: 4.0;lung: 3.3;lymphoid tissue: 4.3"	"Cell line enriched"	"Detected in single"	138	"HEL: 13.7"	"Not detected"	"Not detected"			"Not detected"	"Not detected"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.3"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.3"									HPA008053	Uncertain					12000000	12000000			"HPA008053: AB_1840160"			"unprognostic (3.77e-1)"							"unprognostic (7.01e-2)"						"unprognostic (2.66e-3)"		0.0	0.0	0.0	0.0	0.0	4.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	2.6	0.0	0.0	1.1	0.1	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.6	0.0	0.0	0.0	0.0	0.0	0.0	1.2	0.0	0.0	0.0	4.3	0.0	0.7	0.0	0.0	0.4	0.0	0.0	0.0	0.0	0.0	0.2	1.3	0.1	0.0	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	13.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.2	0.0	6.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0
LY96	MD-2	ENSG00000154589	"Lymphocyte antigen 96"	Q9Y6Y9	8	73991352-74029087	"Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 92.6"	"Cell line enhanced"	"Detected in many"		"ASC TERT1: 20.9;Karpas-707: 52.0;RPMI-8226: 25.1;U-87 MG: 26.8"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 92.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 92.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA053060			Approved	Vesicles	"Secreted to blood"	95000	95000	Vesicles		"HPA053060: AB_2682029"	"unprognostic (2.96e-1)"	"unprognostic (2.64e-2)"	"unprognostic (2.11e-1)"	"unprognostic (1.85e-1)"	"unprognostic (1.64e-2)"	"unprognostic (2.87e-1)"	"unprognostic (2.12e-3)"	"unprognostic (1.42e-1)"	"unprognostic (8.29e-2)"	"unprognostic (1.06e-1)"	"unprognostic (1.24e-1)"	"unprognostic (2.43e-1)"	"prognostic unfavourable (6.38e-11)"	"unprognostic (2.87e-2)"	"unprognostic (1.29e-2)"	"unprognostic (1.60e-2)"	"unprognostic (5.90e-2)"	23.4	9.6	5.7	20.9	9.6	7.3	12.6	1.6	7.8	7.5	10.3	2.5	2.7	6.0	6.2	12.3	9.6	7.6	17.1	18.8	11.2	5.8	7.4	10.9	17.3	36.3	11.6	1.9	12.7	3.2	0.7	7.2	21.8	9.2	9.6	7.4	3.9	9.0	3.4	6.0	3.5	7.0	10.0	19.6	47.3	4.9	7.2	6.6	5.3	6.5	5.2	18.4	15.3	16.1	4.0	6.8	92.6	14.2	0.0	3.1	4.6	0.4	0.0	0.1	0.0	10.0	20.9	0.0	13.9	16.9	3.7	8.7	0.0	0.1	4.3	4.8	8.9	0.1	0.0	0.2	9.7	4.6	0.1	0.1	0.0	0.4	5.0	0.7	0.2	6.1	0.1	6.1	1.2	18.5	0.0	52.0	13.4	0.0	1.7	0.5	0.0	0.3	1.7	0.0	25.1	0.7	0.0	0.1	0.0	0.0	0.0	1.7	0.0	0.9	14.3	9.7	0.7	5.1	3.3	13.7	6.3	2.6	26.8	0.2	4.1	1.6	14.2	0.0	0.0	12.3	0.2	4.0	2.0	0.3	6.8	1.8	1.3	0.4	92.6	0.0	9.8	5.6	3.1	4.6	5.7	9.6	1.6	7.8	11.2	5.8	11.6	1.9	9.2	6.6
MADCAM1	MACAM1	ENSG00000099866	"Mucosal vascular addressin cell adhesion molecule 1"	Q13477	19	489176-505342	"Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"gallbladder: 19.9;lymphoid tissue: 27.2"	"Cell line enhanced"	"Detected in some"		"HEK 293: 3.6;Hep G2: 4.3;U-266/70: 4.8"	"Low cancer specificity"	"Detected in some"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 10.3"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 10.3"									CAB075699	Enhanced					41000000	41000000			"CAB075699: "	"unprognostic (2.30e-1)"	"unprognostic (7.81e-2)"	"unprognostic (5.52e-2)"	"unprognostic (1.56e-1)"	"unprognostic (7.56e-2)"	"unprognostic (6.26e-4)"	"unprognostic (1.68e-2)"	"unprognostic (2.17e-4)"	"unprognostic (2.00e-1)"	"unprognostic (1.12e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.09e-1)"	"unprognostic (2.54e-4)"	"unprognostic (2.42e-1)"	"unprognostic (4.95e-3)"	"unprognostic (9.80e-2)"	"unprognostic (2.07e-2)"	1.4	0.9	4.6	27.2	5.2	0.9	1.1	6.8	6.3	0.7	5.6	0.9	1.2	5.1	0.9	3.3	1.6	0.6	19.9	0.7	3.6	2.9	0.7	0.9	0.8	3.2	2.4	3.1	0.7	3.3	2.9	2.9	0.9	2.7	0.9	5.0	0.5	1.3	0.7	1.5	0.9	12.1	0.8	2.4	13.7	5.0	1.6	3.2	1.0	2.3	0.0	0.8	0.7	1.5	1.0	0.4	10.3	0.4	0.4	1.2	0.1	0.8	0.1	0.3	1.2	1.1	0.1	1.4	0.3	0.2	0.4	0.1	0.8	0.5	0.5	2.4	0.2	1.3	0.2	0.0	0.1	2.8	3.6	0.0	2.2	4.3	0.1	0.1	2.7	1.2	0.2	0.3	0.0	0.0	0.7	1.9	0.4	2.6	0.2	1.3	0.4	2.0	0.7	0.0	0.2	0.0	0.6	1.7	0.4	0.2	0.3	0.1	0.1	0.0	0.0	1.4	0.3	1.0	0.2	4.8	1.7	0.9	0.2	1.2	0.1	0.0	0.4	1.0	0.5	0.4	0.6	0.6	0.4	0.3	0.1	1.0	1.2	1.2	10.3	0.4	0.3	0.4	0.0	0.1	4.6	5.2	6.8	6.3	3.6	2.9	2.4	3.1	2.7	3.2
MNDA	PYHIN3	ENSG00000163563	"Myeloid cell nuclear differentiation antigen"	P41218	1	158831317-158849506	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 289.8;bone marrow: 83.3"	"Group enriched"	"Detected in some"	15	"NB-4: 35.9;THP-1: 67.7;U-937: 44.4"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 289.8"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 289.8"					"Low region specificity"	"Detected in all"			"HPA034532, HPA073215"	Enhanced		Supported	Nucleoplasm,Nucleoli		110000	110000	"Nucleoplasm, Nucleoli"		"HPA034532: AB_10669677, HPA073215: "	"unprognostic (1.53e-2)"	"unprognostic (7.84e-3)"	"unprognostic (2.45e-2)"	"unprognostic (1.03e-1)"	"unprognostic (1.42e-1)"	"unprognostic (1.41e-2)"	"unprognostic (2.02e-2)"	"unprognostic (7.99e-3)"	"unprognostic (1.58e-2)"	"unprognostic (1.46e-1)"	"unprognostic (1.65e-1)"	"unprognostic (9.89e-2)"	"unprognostic (1.96e-2)"	"unprognostic (1.07e-1)"	"unprognostic (4.95e-2)"	"unprognostic (2.81e-2)"	"unprognostic (1.02e-1)"	17.6	6.3	5.4	24.4	7.9	83.3	3.0	1.4	5.8	2.1	2.1	3.2	0.2	1.1	1.7	3.4	2.3	4.7	8.4	6.3	4.9	3.2	3.9	4.2	31.3	32.2	10.7	2.6	3.4	2.4	1.1	2.2	9.9	6.8	2.6	2.5	5.0	3.6	1.2	2.0	1.9	3.6	6.2	18.6	57.3	2.6	4.0	6.3	5.5	2.1	1.4	4.2	9.1	4.9	1.6	29.7	289.8	60.9	0.1	0.1	40.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	3.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	35.9	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	67.7	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	44.4	0.0	7.1	60.9	11.1	0.1	25.4	0.1	1.6	0.0	0.1	29.7	0.6	0.0	0.0	289.8	0.1	12.0	0.4	0.0	40.2	5.4	7.9	1.4	5.8	4.9	3.2	10.7	2.6	6.8	6.3
MPL	"CD110, TPOR"	ENSG00000117400	"MPL proto-oncogene, thrombopoietin receptor"	P40238	1	43337849-43352772	"Cancer-related genes, CD markers, Disease related genes, FDA approved drug targets, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"lymphoid tissue: 8.6"	"Cell line enriched"	"Detected in single"	78	"HEL: 40.7"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in single"			"Cell type enriched"	"Detected in single"	5	"neutrophil: 1.6"	"Lineage enriched"	"Detected in single"	5	"granulocytes: 1.6"	"Region enhanced"	"Detected in single"		"cerebral cortex: 1.4"	"Low region specificity"	"Detected in all"			HPA007619			Supported	"Nuclear membrane,Plasma membrane"				"Plasma membrane"	"Nuclear membrane"	"HPA007619: "	"unprognostic (2.74e-1)"	"unprognostic (6.56e-2)"	"unprognostic (2.95e-1)"	"unprognostic (8.71e-2)"	"unprognostic (1.37e-2)"	"unprognostic (1.06e-3)"	"unprognostic (1.19e-1)"	"unprognostic (1.22e-2)"	"unprognostic (5.83e-2)"	"unprognostic (1.03e-1)"	"unprognostic (5.94e-4)"	"unprognostic (1.51e-1)"	"unprognostic (1.19e-4)"	"unprognostic (2.39e-1)"	"unprognostic (3.26e-1)"	"unprognostic (1.03e-4)"	"unprognostic (1.42e-1)"	1.1	0.3	0.9	0.5	0.8	2.0	0.9	0.5	2.2	0.6	0.6	0.5	0.5	0.3	0.9	1.7	0.9	2.1	0.5	3.9	0.8	0.6	0.5	0.5	2.0	0.5	0.9	0.5	6.6	1.1	0.6	0.6	2.2	0.5	1.5	0.7	0.5	0.5	0.7	0.6	0.4	1.2	2.1	2.5	8.6	0.5	2.1	0.5	0.5	2.2	2.4	0.5	0.9	0.5	0.0	0.0	1.6	0.3	0.0	0.0	4.0	0.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.5	0.0	0.1	0.0	0.1	0.0	0.1	0.0	0.2	0.0	40.7	0.4	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.3	0.1	0.0	0.0	0.1	0.4	0.2	0.2	0.0	0.3	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.6	0.0	0.0	0.0	0.0	4.0	0.9	0.8	0.5	2.2	0.8	0.6	0.9	0.5	0.5	0.5
MX2	MXB	ENSG00000183486	"MX dynamin like GTPase 2"	P20592	21	41361943-41409390	"Plasma proteins, Predicted intracellular proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 61.2;lymphoid tissue: 35.9"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+ SV40 Large T+: 42.2;BJ hTERT+ SV40 Large T+ RasG12V: 41.2;MOLT-4: 26.3;U-266/84: 43.8;U-937: 45.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in all"	5	"neutrophil: 61.2"	"Lineage enriched"	"Detected in all"	5	"granulocytes: 61.2"					"Low region specificity"	"Detected in all"			HPA030235	Uncertain									"HPA030235: AB_10601970"	"unprognostic (1.88e-1)"	"unprognostic (2.26e-1)"	"unprognostic (7.90e-3)"	"prognostic unfavourable (3.71e-5)"	"unprognostic (2.50e-1)"	"unprognostic (2.30e-1)"	"unprognostic (7.77e-2)"	"unprognostic (3.36e-1)"	"unprognostic (2.63e-1)"	"unprognostic (6.64e-2)"	"unprognostic (2.01e-2)"	"unprognostic (9.48e-2)"	"unprognostic (3.38e-14)"	"unprognostic (6.31e-2)"	"unprognostic (1.59e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.16e-2)"	21.6	1.4	1.6	14.3	7.6	12.5	11.5	0.7	2.3	9.2	4.7	3.0	2.5	5.5	9.2	7.4	5.7	5.6	12.4	7.1	2.3	2.2	4.9	3.0	6.1	34.7	2.2	2.8	3.9	2.8	0.2	1.7	5.7	6.1	4.4	2.8	5.7	6.7	1.8	4.5	4.8	8.9	4.9	5.5	24.3	11.2	3.9	2.1	35.9	4.6	2.4	14.9	12.3	6.7	5.2	7.4	61.2	11.7	2.5	8.3	6.3	0.2	0.0	0.0	0.0	0.9	2.3	0.0	0.0	5.8	42.2	41.2	0.0	14.3	0.0	0.0	0.7	0.0	0.0	0.0	1.4	0.5	0.0	17.4	0.0	7.5	0.3	0.3	0.0	3.4	0.0	0.8	0.0	0.0	0.7	8.9	0.0	0.0	26.3	10.5	16.5	0.2	3.8	0.0	1.3	0.0	1.1	0.0	0.0	0.9	0.0	1.1	0.0	10.1	0.0	0.0	0.0	0.0	0.0	0.0	43.8	0.6	1.3	45.2	4.5	2.3	10.5	9.0	4.4	11.7	5.7	5.2	7.1	5.2	7.4	4.7	8.3	5.4	61.2	2.5	10.3	4.2	4.8	6.3	1.6	7.6	0.7	2.3	2.3	2.2	2.2	2.8	6.1	2.1
MXD1	"bHLHc58, MAD, MAD1"	ENSG00000059728	"MAX dimerization protein 1"	Q05195	2	69897688-69942945	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 81.1;bone marrow: 72.8;esophagus: 64.8"	"Cell line enhanced"	"Detected in many"		"hTERT-HME1: 20.0"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 81.1"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 81.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001599	Enhanced		Uncertain	Nucleoplasm,Mitochondria,Cytosol				"Nucleoplasm, Mitochondria"	Cytosol	"HPA001599: AB_1079434"	"unprognostic (1.59e-1)"	"unprognostic (5.11e-2)"	"unprognostic (1.63e-2)"	"prognostic unfavourable (8.14e-6)"	"unprognostic (1.49e-1)"	"unprognostic (1.76e-1)"	"unprognostic (4.36e-2)"	"unprognostic (8.73e-3)"	"unprognostic (3.39e-2)"	"unprognostic (1.18e-1)"	"prognostic unfavourable (8.50e-4)"	"unprognostic (8.72e-2)"	"unprognostic (3.24e-2)"	"unprognostic (1.59e-1)"	"unprognostic (1.61e-1)"	"unprognostic (1.56e-3)"	"unprognostic (1.77e-2)"	6.9	2.2	2.7	18.7	3.8	72.8	3.7	5.7	4.1	15.8	19.6	4.7	0.9	13.6	2.9	2.6	64.8	3.8	4.9	10.8	3.0	2.9	3.0	5.5	17.0	14.3	5.9	2.4	3.3	2.5	3.6	4.0	15.8	3.1	3.3	14.0	5.1	8.8	1.4	3.1	5.9	50.2	4.6	4.3	15.8	8.2	3.6	3.7	9.4	4.0	20.8	34.0	6.3	21.6	0.2	0.8	81.1	1.6	0.4	0.4	0.6	3.4	1.5	2.2	1.6	4.9	2.4	8.2	3.8	2.2	1.9	1.3	4.9	2.7	2.0	2.0	1.5	12.3	4.2	7.7	2.0	1.1	5.0	4.1	4.4	4.8	16.4	4.9	4.1	2.8	13.0	4.3	20.0	2.4	7.1	7.9	1.2	2.8	2.4	9.9	0.6	2.5	1.1	2.2	4.9	2.5	4.1	7.1	3.0	5.1	6.8	2.7	1.0	2.9	9.4	2.7	0.7	2.9	3.6	5.4	9.1	0.7	2.8	8.7	1.0	17.0	1.6	16.8	0.3	1.0	0.4	0.1	0.2	0.2	0.8	0.2	0.2	0.3	81.1	0.4	0.8	0.2	0.2	0.6	2.7	3.8	5.7	4.1	3.0	2.9	5.9	2.4	3.1	3.7
NAMPT	"PBEF, PBEF1"	ENSG00000105835	"Nicotinamide phosphoribosyltransferase"	P43490	7	106248285-106286326	"Cancer-related genes, Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"U-87 MG: 108.1"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	18	"neutrophil: 143.5"	"Lineage enriched"	"Detected in many"	20	"granulocytes: 143.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB034349, HPA047776, HPA057722"	Approved		Approved	"Nuclear speckles,Cell Junctions"	"Secreted to blood"	410000	410000	"Nuclear speckles"	"Cell Junctions"	"CAB034349: AB_2251220, HPA047776: , HPA057722: "	"unprognostic (2.87e-1)"	"prognostic unfavourable (4.78e-4)"	"unprognostic (5.90e-3)"	"unprognostic (1.63e-2)"	"unprognostic (1.50e-2)"	"prognostic unfavourable (8.81e-4)"	"unprognostic (2.15e-1)"	"unprognostic (2.74e-2)"	"unprognostic (2.74e-1)"	"unprognostic (3.30e-1)"	"prognostic unfavourable (1.51e-4)"	"unprognostic (3.02e-1)"	"prognostic unfavourable (2.49e-6)"	"unprognostic (6.83e-2)"	"unprognostic (6.96e-2)"	"unprognostic (7.76e-2)"	"unprognostic (6.44e-3)"	67.3	22.2	8.1	113.6	18.1	110.4	52.6	7.8	12.9	11.6	18.2	2.9	9.5	9.3	9.9	13.5	53.4	27.8	28.1	84.4	13.4	6.3	13.5	92.9	48.9	117.5	10.3	5.2	27.3	18.3	5.5	10.0	23.9	29.2	17.4	10.5	8.2	32.9	14.3	41.0	12.9	14.1	44.9	59.1	41.1	26.4	11.9	7.1	6.2	13.5	40.7	13.2	48.8	26.4	0.8	2.0	143.5	7.3	1.0	1.5	1.3	18.9	12.6	4.6	7.6	19.4	22.6	7.5	6.0	34.0	12.2	21.6	7.4	11.5	15.9	14.4	6.7	15.0	8.4	18.1	26.8	9.4	9.1	6.4	5.4	5.8	72.5	12.4	11.9	21.6	20.7	21.8	25.5	38.8	13.4	60.9	14.5	9.9	12.3	5.2	8.8	10.2	5.9	6.5	34.9	11.6	17.8	9.3	5.1	8.4	18.5	21.4	5.9	3.6	33.0	18.2	14.1	26.1	11.0	42.0	23.8	22.8	108.1	14.1	26.9	8.1	2.3	3.5	0.4	5.6	0.7	0.8	0.5	0.6	2.0	0.7	0.8	0.4	143.5	1.0	7.3	0.8	1.5	1.3	8.1	18.1	7.8	12.9	13.4	6.3	10.3	5.2	29.2	7.1
NRBF2	"COPR1, COPR2, DKFZp564C1664, FLJ30395"	ENSG00000148572	"Nuclear receptor binding factor 2"	Q96F24	10	63133247-63155031	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 100.9"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	4	"neutrophil: 100.9"	"Lineage enriched"	"Detected in all"	8	"granulocytes: 100.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021670, HPA059477"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA021670: AB_2670803, HPA059477: AB_2684032"	"unprognostic (7.71e-2)"	"unprognostic (2.74e-1)"	"unprognostic (1.71e-1)"	"unprognostic (2.05e-2)"	"unprognostic (1.47e-2)"	"unprognostic (1.04e-1)"	"unprognostic (1.21e-1)"	"unprognostic (1.32e-2)"	"unprognostic (2.33e-1)"	"unprognostic (9.57e-2)"	"unprognostic (2.42e-3)"	"unprognostic (1.31e-2)"	"prognostic unfavourable (2.36e-4)"	"unprognostic (2.38e-1)"	"unprognostic (3.21e-2)"	"unprognostic (2.44e-2)"	"unprognostic (1.59e-2)"	15.1	10.0	10.7	16.1	10.2	22.1	21.6	10.9	13.9	12.3	12.3	7.0	9.0	12.4	13.9	9.9	13.9	10.0	13.2	13.6	10.9	9.5	10.6	50.2	19.1	29.4	13.1	8.9	9.2	10.3	6.9	11.5	21.3	11.7	8.7	12.8	6.0	14.8	11.0	46.2	14.6	15.0	10.8	11.7	22.9	10.5	10.0	8.9	16.4	14.2	13.9	14.6	14.6	13.5	7.0	10.0	100.9	13.3	4.3	5.7	7.2	8.7	8.0	8.0	7.3	19.2	29.6	8.0	12.6	21.6	10.1	14.4	16.9	9.4	11.4	6.2	14.1	6.9	7.7	10.6	13.8	10.2	7.8	8.4	4.2	13.5	24.6	11.1	9.9	27.4	22.9	16.4	40.4	10.3	8.5	13.3	12.8	6.5	9.4	19.8	9.3	33.3	9.2	7.2	6.6	11.6	5.0	4.6	7.9	7.5	14.6	21.9	9.1	11.1	10.5	7.0	10.4	10.9	13.3	16.8	12.8	13.8	19.6	17.9	5.6	13.8	11.8	22.8	4.5	13.3	4.7	7.0	4.6	4.9	10.0	5.9	5.7	5.3	100.9	4.3	12.5	4.9	5.1	7.2	10.7	10.2	10.9	13.9	10.9	9.5	13.1	8.9	11.7	8.9
OR52M1	OR52M1P	ENSG00000197790	"Olfactory receptor family 52 subfamily M member 1"	Q8NGK5	11	4545191-4546144	"G-protein coupled receptors, Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in single"		"blood: 1.1"	"Not detected"	"Not detected"			"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	11	"neutrophil: 1.1"	"Lineage enriched"	"Detected in single"	11	"granulocytes: 1.1"	"Not detected"	"Not detected"																																			0.4	0.0	0.0	0.0	0.0	0.7	0.0	0.0	0.0	0.2	0.0			0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0		0.3	0.0	0.0	0.0	0.0		0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2			0.0		0.0	0.4	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.1	0.0	0.0	0.0	0.0	0.0										
PIP4P2	"DKFZp762O076, TMEM55A"	ENSG00000155099	"Phosphatidylinositol-4,5-bisphosphate 4-phosphatase 2"	Q8N4L2	8	90993796-91041064	"Enzymes, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 36.2"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 36.2"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA014591	Approved					57000	57000			"HPA014591: AB_1858124"	"unprognostic (6.09e-2)"	"prognostic unfavourable (1.01e-4)"	"unprognostic (8.45e-2)"	"unprognostic (1.23e-3)"	"unprognostic (1.19e-1)"	"prognostic unfavourable (1.54e-4)"	"prognostic unfavourable (3.76e-5)"	"unprognostic (3.76e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.58e-2)"	"unprognostic (4.42e-1)"	"unprognostic (6.95e-2)"	"unprognostic (7.25e-2)"	"prognostic unfavourable (8.01e-4)"	"unprognostic (1.59e-1)"	"unprognostic (9.05e-2)"	"unprognostic (7.99e-2)"	15.8	18.6	18.7	9.1	19.5	35.2	11.7	21.4	31.7	14.2	16.5	11.1	7.3	4.4	15.0	7.1	8.5	8.6	15.5	26.0	18.2	23.5	13.7	5.7	8.1	11.8	22.8	20.0	16.1	4.8	14.6	13.4	12.2	25.5	12.3	7.2	17.4	10.1	18.6	16.7	8.0	6.6	18.6	25.4	11.2	9.6	9.7	21.1	7.1	9.4	6.9	7.7	13.3	10.5	1.5	5.3	36.2	5.6	1.2	2.4	2.9	2.6	1.6	9.4	5.9	15.3	18.1	1.9	11.4	13.5	5.8	8.6	1.0	4.4	5.1	1.5	10.9	0.6	2.2	3.7	7.6	4.7	4.6	8.1	1.7	0.8	13.8	1.9	7.3	10.0	2.4	7.3	5.4	5.5	4.0	17.0	20.1	1.8	5.4	4.8	4.9	5.9	2.2	3.8	6.1	8.1	1.6	1.0	5.3	0.7	3.6	13.9	0.1	3.3	8.3	10.4	4.3	6.0	4.8	6.8	4.1	3.1	18.0	3.4	13.9	0.3	5.6	5.3	0.8	2.6	1.3	1.5	1.8	0.9	5.3	1.1	2.4	1.0	36.2	1.2	1.0	3.1	1.5	2.9	18.7	19.5	21.4	31.7	18.2	23.5	22.8	20.0	25.5	21.1
PITPNM3	"ACKR6, CORD5, NIR1, RDGBA3"	ENSG00000091622	"PITPNM family member 3"	Q9BZ71	17	6451264-6556494	"Disease related genes, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"brain: 23.0;lymphoid tissue: 43.3;ovary: 24.2"	"Cell line enhanced"	"Detected in some"		"HaCaT: 11.1;HeLa: 8.6;hTCEpi: 32.3"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in single"	58	"neutrophil: 5.8"	"Lineage enriched"	"Detected in single"	58	"granulocytes: 5.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA022432, HPA059005"	Enhanced		Approved	"Plasma membrane"				"Plasma membrane"		"HPA022432: AB_2670936, HPA059005: AB_2683876"	"unprognostic (2.97e-2)"	"unprognostic (8.60e-3)"	"unprognostic (1.45e-2)"	"unprognostic (1.52e-1)"	"unprognostic (2.69e-2)"	"prognostic favourable (3.67e-6)"	"unprognostic (1.25e-2)"	"unprognostic (6.86e-2)"	"unprognostic (3.66e-2)"	"unprognostic (3.01e-2)"	"unprognostic (2.99e-3)"	"unprognostic (3.58e-2)"	"unprognostic (2.41e-1)"	"unprognostic (9.60e-2)"	"unprognostic (1.61e-1)"	"unprognostic (3.55e-1)"	"unprognostic (2.63e-1)"	1.1	2.4	17.9	1.2	18.8	0.5	1.7	18.7	23.0	2.4	4.5	0.7	3.4	1.5	1.9	3.4	9.4	4.3	3.8	0.8	7.2	5.2	1.5	1.6	3.1	0.6	2.9	11.9	24.2	0.9	1.9	0.7	0.6	2.5	2.7	3.6	2.3	1.9	8.3	1.1	14.3	1.4	3.8	0.9	43.3	3.2	2.4	1.5	0.0	2.4	0.7	2.1	1.3	2.5	0.0	0.0	5.8	0.0	0.0	0.0	0.0	5.4	0.5	0.4	0.2	0.0	0.1	0.4	0.4	0.1	0.5	0.3	0.3	3.9	0.1	2.1	0.1	11.1	0.2	2.3	0.2	0.2	0.4	0.1	8.6	0.1	0.6	0.2	0.3	0.1	32.3	0.6	1.8	0.3	0.1	0.0	0.3	0.5	0.0	0.1	0.6	1.6	0.1	1.2	0.0	0.8	0.1	0.3	0.3	5.0	2.4	0.1	0.8	0.0	0.2	0.3	2.1	0.4	1.3	0.3	0.1	0.0	0.4	0.1	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	5.8	0.0	0.0	0.0	0.0	0.0	17.9	18.8	18.7	23.0	7.2	5.2	2.9	11.9	2.5	1.5
PROK2	"BV8, KAL4, MIT1, PK2"	ENSG00000163421	"Prokineticin 2"	Q9HC23	3	71771656-71785206	"Disease related genes, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"		"Tissue enhanced"	"Detected in many"		"blood: 82.6;bone marrow: 42.8"	"Cell line enhanced"	"Detected in some"		"HL-60: 8.8;NB-4: 7.6;NTERA-2: 5.4;U-266/70: 12.1;U-266/84: 19.7;U-937: 8.1"	"Cancer enhanced"	"Detected in some"		"ovarian cancer: 2.1"	"Low region specificity"	"Detected in some"			"Cell type enriched"	"Detected in some"	49	"neutrophil: 82.6"	"Lineage enriched"	"Detected in many"	49	"granulocytes: 82.6"	"Group enriched"	"Detected in some"	6	"basal ganglia: 2.7;hypothalamus: 1.3;olfactory region: 4.3"	"Region enhanced"	"Detected in many"		"olfactory region: 11.4"	HPA041408	Approved				"Secreted to blood"					"HPA041408: AB_10964057"	"unprognostic (5.24e-2)"	"unprognostic (3.13e-3)"	"unprognostic (3.51e-3)"	"unprognostic (3.59e-2)"	"unprognostic (1.89e-1)"	"unprognostic (2.94e-1)"	"unprognostic (2.97e-2)"	"unprognostic (9.52e-2)"	"unprognostic (4.29e-2)"	"unprognostic (9.91e-3)"	"unprognostic (6.89e-2)"	"unprognostic (5.73e-1)"	"unprognostic (1.59e-4)"	"unprognostic (2.02e-2)"	"unprognostic (1.48e-1)"	"unprognostic (1.40e-2)"	"unprognostic (2.16e-2)"	5.7	0.2	0.8	12.6	0.9	42.8	0.3	0.5	2.1	0.3	0.4	0.6	0.0	0.2	0.2	0.1	0.5	2.7	0.9	9.0	0.8	0.8	0.5	2.0	10.7	21.9	3.7	0.0	0.7	0.7	0.0	0.5	2.2	0.8	0.8	0.1	0.9	0.2	0.0	0.6	0.2	0.7	1.0	1.3	20.8	0.6	22.1	1.1	0.4	1.4	0.1	0.3	2.0	4.3	0.0	0.1	82.6	1.6	0.0	1.1	0.5	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	8.8	0.2	0.0	0.0	0.0	0.0	0.0	1.5	0.0	0.0	0.0	0.2	7.6	5.4	0.0	0.0	0.0	0.0	0.0	0.2	1.1	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	12.1	19.7	0.0	0.0	8.1	0.0	0.0	1.6	0.6	0.7	0.1	0.0	0.0	0.6	0.6	0.1	0.0	0.2	1.1	82.6	0.0	0.0	0.0	0.3	0.5	0.8	0.9	0.5	2.1	0.8	0.8	3.7	0.0	0.8	1.1
QPCT	"GCT, QC"	ENSG00000115828	"Glutaminyl-peptide cyclotransferase"	Q16769	2	37344574-37373322	"Enzymes, Plasma proteins, Predicted intracellular proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"adrenal gland: 77.6;blood: 137.6"	"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 17.5;SCLC-21H: 23.8;SK-MEL-30: 80.0;U-266/84: 62.5"	"Cancer enhanced"	"Detected in all"		"melanoma: 97.4"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 137.6"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 137.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA008406	Enhanced		Approved	Cytosol	"Secreted to blood"			Cytosol		"HPA008406: AB_1855981"	"unprognostic (6.25e-3)"	"unprognostic (6.69e-2)"	"unprognostic (4.95e-2)"	"unprognostic (1.44e-1)"	"unprognostic (1.44e-2)"	"unprognostic (9.32e-2)"	"unprognostic (1.13e-3)"	"unprognostic (9.73e-2)"	"unprognostic (2.71e-3)"	"unprognostic (7.86e-2)"	"unprognostic (3.67e-2)"	"unprognostic (1.17e-1)"	"unprognostic (6.78e-2)"	"unprognostic (7.76e-3)"	"unprognostic (1.21e-1)"	"unprognostic (9.48e-3)"	"unprognostic (3.62e-3)"	3.2	77.6	4.3	5.4	5.8	17.0	6.4	1.2	11.6	9.2	11.3	2.2	1.5	2.2	6.2	43.7	2.4	1.9	5.5	2.9	6.7	17.9	12.4	1.3	6.1	7.4	3.9	5.0	1.4	5.5	9.6	31.6	7.8	5.9	3.5	4.2	21.2	14.7	2.8	4.0	14.2	2.3	3.4	3.0	8.5	3.4	2.6	0.5	2.3	1.8	4.4	4.8	7.0	2.9	0.2	10.7	137.6	29.7	0.0	0.0	12.1	0.1	7.9	0.0	0.0	1.0	2.6	0.0	1.0	17.5	1.3	2.1	0.5	1.4	0.0	0.6	5.9	0.0	0.5	0.0	2.1	0.1	15.3	3.5	0.0	1.5	0.1	0.5	0.0	1.5	0.0	9.7	0.0	5.2	0.0	0.0	0.0	0.8	0.0	0.3	0.1	0.0	0.0	0.0	0.1	8.6	2.1	23.8	0.0	1.3	0.0	80.0	0.1	0.5	3.7	0.0	0.0	0.0	0.1	3.0	62.5	0.0	5.3	0.0	0.0	0.6	29.7	0.2	0.0	3.4	0.0	0.2	0.0	0.0	10.7	0.1	0.0	0.0	137.6	0.0	0.3	0.2	0.0	12.1	4.3	5.8	1.2	11.6	6.7	17.9	3.9	5.0	5.9	0.5
R3HDM4	"C19orf22, MGC16353"	ENSG00000198858	"R3H domain containing 4"	Q96D70	19	896503-913245	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 93.1"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 93.1"	"Lineage enriched"	"Detected in all"	12	"granulocytes: 93.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA043025, HPA048638"	Uncertain		Approved	Nucleoplasm,Cytosol				Nucleoplasm	Cytosol	"HPA043025: AB_2678275, HPA048638: AB_2680472"	"unprognostic (9.22e-2)"	"unprognostic (2.32e-2)"	"unprognostic (1.28e-2)"	"prognostic favourable (7.33e-6)"	"unprognostic (4.30e-2)"	"unprognostic (2.02e-2)"	"unprognostic (3.94e-3)"	"unprognostic (1.06e-1)"	"unprognostic (3.67e-1)"	"unprognostic (1.17e-1)"	"unprognostic (2.02e-1)"	"unprognostic (4.28e-1)"	"unprognostic (1.46e-3)"	"unprognostic (7.44e-2)"	"unprognostic (4.52e-1)"	"unprognostic (2.08e-1)"	"unprognostic (6.74e-2)"	15.4	11.7	23.3	33.2	19.5	57.7	15.4	12.7	26.6	15.9	16.5	16.3	10.0	17.1	15.3	13.2	33.0	15.7	20.1	12.5	20.2	11.9	18.8	24.1	22.7	43.3	14.8	11.9	19.2	34.9	10.0	16.2	18.5	12.8	17.7	12.6	15.5	24.2	14.5	21.6	22.4	18.0	13.4	10.3	41.1	24.1	8.1	12.5	31.9	14.6	19.6	43.0	20.6	19.0	6.4	2.2	93.1	2.0	1.2	7.7	3.8	17.9	10.5	11.3	15.2	7.2	12.7	18.5	12.2	9.7	12.3	10.9	11.1	15.4	13.0	10.2	13.8	16.4	6.5	14.5	5.6	19.9	13.8	17.9	9.2	19.5	21.6	9.7	31.7	16.9	28.0	8.0	16.8	14.1	33.0	26.6	11.4	32.1	13.9	18.8	14.5	17.3	13.8	5.4	24.7	20.3	18.9	19.9	19.3	10.7	23.8	19.9	20.9	23.6	14.2	22.5	12.5	26.2	12.1	29.6	15.4	19.0	14.4	14.1	19.6	14.6	2.0	16.2	2.5	1.5	3.9	6.4	5.0	3.4	2.2	3.8	4.8	3.3	93.1	1.2	2.0	0.9	7.7	3.8	23.3	19.5	12.7	26.6	20.2	11.9	14.8	11.9	12.8	12.5
RALBP1	"RIP, RIP1, RLIP76"	ENSG00000017797	"RalA binding protein 1"	Q15311	18	9475009-9538116	"Predicted intracellular proteins, RAS pathway related proteins, Transporters"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	10	"neutrophil: 55.1"	"Lineage enriched"	"Detected in all"	10	"granulocytes: 55.1"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"CAB046010, HPA046651"	Approved		Approved	"Nuclear membrane,Vesicles,Cytosol"				Cytosol	"Nuclear membrane, Vesicles"	"CAB046010: AB_11126824, HPA046651: "	"unprognostic (1.23e-1)"	"unprognostic (5.84e-3)"	"unprognostic (1.58e-1)"	"unprognostic (1.74e-2)"	"unprognostic (8.24e-2)"	"unprognostic (1.12e-1)"	"unprognostic (5.72e-2)"	"unprognostic (9.90e-2)"	"unprognostic (1.53e-1)"	"prognostic favourable (8.47e-4)"	"unprognostic (4.03e-3)"	"unprognostic (1.76e-1)"	"prognostic favourable (5.39e-6)"	"unprognostic (1.28e-1)"	"unprognostic (3.16e-2)"	"unprognostic (2.47e-1)"	"unprognostic (1.26e-1)"	19.7	14.6	23.2	14.8	24.3	17.9	19.1	27.1	27.2	17.1	20.7	14.0	54.7	12.5	15.9	16.7	33.7	17.5	13.7	21.4	24.7	19.6	30.6	14.2	15.1	14.6	23.1	13.7	18.8	10.4	19.8	15.3	28.8	19.6	24.3	17.4	9.8	17.6	44.8	24.3	47.5	13.4	22.7	20.6	19.3	17.4	8.5	23.1	15.4	15.7	23.4	16.4	24.3	26.3	2.5	5.5	55.1	4.5	4.3	3.2	1.2	22.7	15.4	13.7	15.5	15.8	24.9	18.1	27.6	15.0	14.2	15.3	17.0	22.6	29.0	20.2	25.2	13.1	18.9	20.7	17.8	28.8	18.3	15.4	14.2	12.7	12.9	45.0	17.8	17.3	20.8	19.8	19.8	23.9	21.9	26.8	22.3	18.0	27.0	19.8	10.6	15.7	36.4	24.5	21.3	19.6	31.7	18.5	15.1	23.9	20.9	12.2	12.9	20.9	28.5	42.1	32.4	29.1	32.7	16.6	16.5	31.4	18.3	21.4	15.9	3.1	2.8	4.3	3.2	2.9	2.7	2.5	2.7	2.6	2.4	2.4	2.3	2.9	55.1	4.3	4.5	5.5	1.7	1.2	23.2	24.3	27.1	27.2	24.7	19.6	23.1	13.7	19.6	23.1
RNF149	FLJ90504	ENSG00000163162	"Ring finger protein 149"	Q8NC42	2	101271219-101308701	"Enzymes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 123.7"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 123.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 123.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA011424	Approved		Approved	"Vesicles,Plasma membrane"				"Vesicles, Plasma membrane"		"HPA011424: AB_1079825"	"unprognostic (2.56e-2)"	"unprognostic (4.70e-2)"	"unprognostic (1.96e-1)"	"unprognostic (3.49e-2)"	"unprognostic (3.17e-2)"	"unprognostic (5.17e-3)"	"unprognostic (4.16e-2)"	"unprognostic (4.77e-3)"	"unprognostic (5.61e-2)"	"unprognostic (1.43e-2)"	"unprognostic (5.69e-3)"	"unprognostic (1.51e-1)"	"prognostic unfavourable (2.04e-8)"	"unprognostic (1.39e-1)"	"unprognostic (6.16e-2)"	"unprognostic (2.70e-1)"	"prognostic favourable (2.91e-4)"	20.3	13.4	7.9	29.0	10.9	32.9	13.5	7.9	10.8	12.5	16.6	10.8	11.4	12.3	11.3	12.8	28.9	14.3	14.5	12.1	9.5	9.4	15.1	19.6	24.5	47.4	13.7	6.2	14.3	21.1	14.3	10.6	19.4	11.2	11.1	12.0	12.8	15.8	8.1	8.8	20.2	16.8	9.6	13.9	65.0	13.8	15.2	9.7	17.0	12.7	13.1	24.4	14.9	17.2	2.1	9.3	123.7	21.3	2.3	9.0	9.9	9.6	5.7	4.3	5.5	16.3	16.4	25.5	12.0	15.8	16.2	18.3	14.4	25.6	2.8	14.5	11.8	19.7	6.1	12.2	15.1	8.4	8.4	6.0	5.1	24.3	21.8	6.4	9.7	15.0	20.1	19.2	12.7	29.5	5.2	9.0	16.2	8.2	8.6	6.5	3.0	10.4	5.6	7.2	11.1	19.1	23.7	5.7	4.2	7.2	17.9	17.3	4.8	8.7	19.5	8.2	4.7	12.2	2.6	18.3	10.7	0.1	2.6	9.0	6.0	5.8	13.0	14.8	8.2	20.4	7.4	2.1	7.3	8.1	4.8	1.5	5.1	5.3	123.7	2.3	21.3	9.3	9.0	9.9	7.9	10.9	7.9	10.8	9.5	9.4	13.7	6.2	11.2	9.7
RPS4Y2	RPS4Y2P	ENSG00000280969	"Ribosomal protein S4, Y-linked 2"	Q8TD47	Y	20756164-20781032	"Predicted intracellular proteins, Ribosomal proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"		"Tissue enhanced"	"Detected in some"		"blood: 10.7;prostate: 6.8;salivary gland: 3.8;testis: 3.3"	"Cell line enriched"	"Detected in single"	7	"U-266/84: 6.3"	"Cancer enriched"	"Detected in single"	9	"prostate cancer: 1.8"					"Cell type enriched"	"Detected in some"	5	"neutrophil: 10.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 10.7"									HPA000857	Uncertain									"HPA000857: AB_1079849"					"unprognostic (1.50e-2)"							"unprognostic (3.63e-1)"		"unprognostic (6.39e-6)"	"unprognostic (5.92e-2)"			0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.8	0.0	0.0	0.0	0.0	1.6	0.0	0.0	2.0	0.0	0.0		0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	6.8	0.0	0.0	3.8	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	3.3	0.0	0.0	0.0	0.0	0.6	0.0	0.0	2.2	0.0	10.7	0.0	0.0	0.1	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.0	0.7	0.0	0.8	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	6.3	0.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	1.0	0.1	0.0	0.0	2.2	0.1	0.0	10.7	0.0	0.0	0.0	0.0	0.0										
SCARF1	"KIAA0149, SREC, SREC1"	ENSG00000074660	"Scavenger receptor class F member 1"	Q14162	17	1633858-1645747	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"lymphoid tissue: 28.9"	"Cell line enhanced"	"Detected in some"		"HEL: 4.6;HUVEC TERT2: 15.5;REH: 7.9;TIME: 19.5"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	5	"neutrophil: 8.3"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 8.3"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA072936	Enhanced				"Intracellular and membrane"	940000	940000			"HPA072936: AB_2686559"	"unprognostic (1.94e-1)"	"unprognostic (2.84e-1)"	"unprognostic (2.53e-3)"	"unprognostic (2.88e-1)"	"unprognostic (3.28e-1)"	"unprognostic (2.15e-2)"	"unprognostic (2.04e-1)"	"unprognostic (2.18e-2)"	"unprognostic (1.31e-1)"	"unprognostic (1.91e-1)"	"unprognostic (1.62e-2)"	"unprognostic (3.76e-1)"	"unprognostic (1.32e-1)"	"unprognostic (2.13e-2)"	"unprognostic (3.22e-2)"	"unprognostic (1.38e-1)"	"unprognostic (6.39e-2)"	15.3	3.4	2.3	6.8	2.8	3.7	15.6	3.5	2.4	6.7	3.8	2.4	2.3	3.9	8.7	5.7	2.9	4.1	4.8	10.1	2.1	2.2	5.4	6.1	12.6	8.5	2.9	3.1	4.5	3.1	2.5	2.8	7.6	3.4	5.0	1.8	5.3	2.7	3.4	5.7	2.4	3.8	3.6	2.4	28.9	3.4	3.4	1.3	1.5	13.5	4.6	2.5	4.7	12.4	0.0	1.1	8.3	1.7	0.0	0.1	0.5	0.0	0.0	0.1	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	1.7	0.0	0.1	0.0	0.0	0.0	0.1	0.0	4.6	0.0	0.0	0.1	0.0	0.9	0.0	0.0	0.0	0.0	15.5	0.1	0.0	0.0	0.0	0.0	0.1	0.0	0.0	7.9	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.1	19.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	2.9	0.0	0.0	1.7	0.0	0.0	0.5	0.0	0.0	0.1	0.0	1.1	0.0	0.0	0.0	8.3	0.0	0.0	0.0	0.0	0.5	2.3	2.8	3.5	2.4	2.1	2.2	2.9	3.1	3.4	1.3
SDR42E2		ENSG00000183921	"Short chain dehydrogenase/reductase family 42E, member 2"	A6NKP2	16	22165583-22191754	"Predicted membrane proteins"	"Evidence at transcript level"	"Evidence at transcript level"	"No human protein/transcript evidence"	"No human protein/transcript evidence"		"Tissue enhanced"	"Detected in some"		"blood: 6.0;fallopian tube: 5.0;testis: 3.3"	"Cell line enriched"	"Detected in single"	5	"RPMI-8226: 3.8"	"Not detected"	"Not detected"							"Cell type enriched"	"Detected in single"	7	"neutrophil: 6.0"	"Lineage enriched"	"Detected in single"	7	"granulocytes: 6.0"	"Not detected"	"Not detected"			"Low region specificity"	"Detected in all"														"unprognostic (8.03e-3)"	"unprognostic (2.80e-1)"	"unprognostic (2.06e-1)"	"unprognostic (1.72e-4)"	"unprognostic (1.85e-1)"	"unprognostic (7.07e-2)"	"unprognostic (8.77e-2)"	"unprognostic (3.72e-1)"	"unprognostic (4.25e-1)"	"unprognostic (1.27e-1)"	"unprognostic (6.32e-3)"	"unprognostic (2.01e-1)"	"unprognostic (7.09e-2)"	"unprognostic (4.76e-2)"	"unprognostic (8.78e-2)"	"unprognostic (1.09e-1)"	"unprognostic (6.61e-2)"	0.1	0.1	1.0	0.2	2.1	0.1	0.0	0.0	1.1	0.5	0.0			0.6	0.1	0.1	0.0	5.0	0.2	0.0	1.7	2.4	0.2	0.0	0.4	0.3	0.0		0.3	0.5	0.1	2.2	0.2		0.2	0.1		0.2	0.0	1.5	0.6	0.2	0.0	0.3	0.5	0.1	3.3			0.1		0.0	0.1	0.0	0.8	0.3	6.0	0.8	0.3	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	3.8	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.5	0.8	0.0	0.0	0.0	0.0	0.1	0.8	0.2	0.3	0.3	0.4	0.5	0.3	0.4	0.1	0.8	0.3	0.4	6.0	0.3	0.1	0.3	0.3	0.2										
SEC14L1	"PRELID4A, SEC14L"	ENSG00000129657	"SEC14 like lipid binding 1"	Q92503	17	77086716-77217101	"Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in all"		"HUVEC TERT2: 90.8;TIME: 56.7"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	8	"neutrophil: 71.8"	"Lineage enriched"	"Detected in all"	11	"granulocytes: 71.8"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA021463, HPA028703"	Approved		Supported	Nucleoplasm,Cytosol				"Nucleoplasm, Cytosol"		"HPA021463: AB_2670712, HPA028703: AB_10602300"	"unprognostic (1.19e-1)"	"unprognostic (8.61e-2)"	"unprognostic (1.51e-2)"	"unprognostic (4.64e-3)"	"unprognostic (1.26e-1)"	"unprognostic (1.24e-1)"	"unprognostic (1.03e-1)"	"unprognostic (1.61e-1)"	"unprognostic (7.37e-2)"	"unprognostic (1.21e-1)"	"unprognostic (7.40e-3)"	"unprognostic (1.39e-1)"	"unprognostic (1.32e-1)"	"unprognostic (1.37e-1)"	"unprognostic (1.33e-3)"	"unprognostic (3.09e-1)"	"unprognostic (4.30e-2)"	40.8	34.0	25.4	25.3	39.1	33.4	40.6	42.3	33.2	27.7	11.1	21.9	12.2	13.3	15.8	18.9	18.8	15.9	21.2	18.2	27.0	19.5	25.1	15.8	38.4	25.8	31.6	20.6	12.6	18.3	17.3	18.6	49.3	22.5	10.8	10.5	24.2	21.4	12.9	51.0	11.9	12.2	16.2	25.8	33.9	18.4	35.4	24.4	10.0	24.0	14.4	26.0	15.7	14.7	2.4	2.3	71.8	6.2	1.5	2.0	1.9	11.7	8.6	15.2	23.3	6.4	7.9	5.4	10.7	9.2	12.6	10.9	11.4	7.7	31.4	21.5	14.7	4.5	6.7	10.4	16.4	5.8	6.1	16.4	6.6	14.8	10.8	3.3	7.7	11.1	4.2	10.5	11.0	90.8	10.0	26.5	17.7	5.9	5.7	4.4	5.5	7.8	4.4	24.4	23.3	21.4	4.7	11.7	9.1	11.8	6.2	6.6	5.2	3.6	56.7	14.3	13.5	7.8	7.6	15.2	11.9	16.5	6.2	3.4	4.2	4.2	3.2	9.2	0.7	5.5	0.6	2.4	0.7	0.5	2.3	1.2	0.8	0.5	71.8	1.5	6.2	0.8	2.0	1.9	25.4	39.1	42.3	33.2	27.0	19.5	31.6	20.6	22.5	24.4
SLC19A1	"FOLT, RFC1"	ENSG00000173638	"Solute carrier family 19 member 1"	P41440	21	45493572-45544411	"Cancer-related genes, Predicted membrane proteins, Transporters"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 37.6"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 37.6"	"Lineage enriched"	"Detected in many"	6	"granulocytes: 37.6"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA024802	Approved		Approved	"Plasma membrane"				"Plasma membrane"		"HPA024802: AB_10602892"	"unprognostic (4.31e-3)"	"prognostic unfavourable (4.15e-4)"	"unprognostic (5.23e-2)"	"unprognostic (2.02e-1)"	"unprognostic (3.11e-1)"	"unprognostic (3.04e-2)"	"unprognostic (7.34e-2)"	"unprognostic (2.87e-3)"	"unprognostic (4.04e-2)"	"unprognostic (4.09e-2)"	"unprognostic (2.85e-1)"	"unprognostic (2.39e-1)"	"prognostic unfavourable (1.07e-10)"	"unprognostic (1.44e-1)"	"unprognostic (2.31e-1)"	"unprognostic (7.97e-5)"	"unprognostic (3.10e-1)"	9.0	7.8	7.1	8.2	13.5	10.5	12.5	9.6	8.9	5.0	9.7	6.0	9.4	31.2	4.3	4.6	2.3	4.6	3.5	3.2	7.1	6.1	4.7	14.1	13.9	14.1	8.7	4.4	8.1	5.4	1.8	3.5	32.9	11.5	4.7	2.0	17.8	6.0	3.5	3.5	6.1	16.5	2.3	5.9	11.7	5.7	3.4	3.4	11.8	9.6	2.8	4.1	3.1	3.1	0.9	4.9	37.6	6.4	0.4	1.1	2.4	10.4	9.5	1.9	7.8	0.6	0.8	15.6	4.9	0.8	4.5	2.9	22.0	9.7	9.7	9.8	1.2	5.4	3.9	3.6	1.1	8.9	19.0	20.5	5.2	15.3	2.7	13.3	3.2	1.0	2.7	4.9	1.6	3.7	24.4	4.3	1.6	11.7	18.1	12.4	11.2	11.2	24.6	2.2	28.3	2.0	6.3	11.7	10.3	5.5	9.1	4.2	6.9	15.8	4.5	5.9	7.4	1.6	8.0	1.8	6.5	8.8	2.6	21.8	4.7	0.6	6.4	8.5	0.3	6.0	1.1	0.9	0.5	0.7	4.9	0.3	0.8	0.5	37.6	0.4	3.7	1.5	1.0	2.4	7.1	13.5	9.6	8.9	7.1	6.1	8.7	4.4	11.5	3.4
SLC22A4	"DFNB60, MGC34546, OCTN1"	ENSG00000197208	"Solute carrier family 22 member 4"	Q9H015	5	132294443-132344206	"Disease related genes, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in many"			"Cell line enhanced"	"Detected in many"		"BJ hTERT+: 34.4;U-138 MG: 14.6"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in some"	7	"neutrophil: 23.0"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 23.0"	"Region enhanced"	"Detected in all"		"cerebellum: 72.4"	"Low region specificity"	"Detected in all"			"CAB015468, HPA036974"	Approved		Approved	Mitochondria				Mitochondria		"CAB015468: , HPA036974: "	"unprognostic (1.33e-1)"	"unprognostic (2.20e-1)"	"unprognostic (3.91e-2)"	"unprognostic (8.42e-3)"	"unprognostic (6.17e-2)"	"unprognostic (6.22e-3)"	"unprognostic (4.17e-3)"	"unprognostic (3.33e-1)"	"unprognostic (1.30e-1)"	"unprognostic (9.79e-2)"	"unprognostic (1.95e-3)"	"unprognostic (7.82e-2)"	"unprognostic (1.74e-2)"	"unprognostic (2.31e-3)"	"unprognostic (1.20e-1)"	"unprognostic (1.95e-2)"	"unprognostic (4.06e-2)"	2.7	4.1	3.5	3.8	5.0	22.4	3.1	3.1	4.7	2.4	5.9	4.4	1.8	4.6	2.1	3.2	0.8	14.7	2.6	3.0	3.9	4.9	15.4	1.6	7.2	3.8	3.2	2.0	5.0	1.0	7.7	6.9	6.8	12.6	5.4	3.1	13.8	2.6	4.1	9.2	1.7	18.1	1.5	9.9	7.7	2.2	0.9	2.7	0.5	1.0	2.7	0.8	2.5	2.2	0.0	1.7	23.0	3.5	0.0	0.0	0.6	1.1	1.7	0.1	0.4	0.7	0.6	0.5	7.4	34.4	5.7	6.0	0.6	1.9	0.3	2.1	4.3	1.8	0.0	1.2	4.0	1.4	0.2	0.1	3.2	0.1	0.6	2.3	0.0	1.4	0.2	3.1	2.9	2.5	2.9	3.9	4.4	0.6	0.0	5.3	0.2	1.9	0.0	0.4	0.2	0.9	0.1	0.4	0.2	8.1	0.5	0.2	0.3	1.4	3.0	14.6	1.4	5.7	1.9	0.0	1.5	0.0	4.3	2.7	1.7	0.0	3.5	3.5	0.0	0.8	0.0	0.0	0.0	0.0	1.7	0.0	0.0	0.0	23.0	0.0	0.2	0.2	0.0	0.6	3.5	5.0	3.1	4.7	3.9	4.9	3.2	2.0	12.6	2.7
TLR6	CD286	ENSG00000174130	"Toll like receptor 6"	Q9Y2C9	4	38823715-38856817	"CD markers, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 14.2;brain: 16.0;lymphoid tissue: 16.2"	"Cell line enhanced"	"Detected in many"		"CAPAN-2: 13.0;RPMI-8226: 10.2"	"Low cancer specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 14.2"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 14.2"	"Low region specificity"	"Detected in many"			"Low region specificity"	"Detected in all"			HPA062733			Approved	"Endoplasmic reticulum"				"Endoplasmic reticulum"		"HPA062733: AB_2684853"	"unprognostic (9.82e-2)"	"unprognostic (4.76e-2)"	"unprognostic (3.30e-2)"	"unprognostic (3.05e-2)"	"unprognostic (1.91e-1)"	"unprognostic (1.87e-2)"	"unprognostic (1.83e-1)"	"unprognostic (4.45e-2)"	"unprognostic (9.26e-2)"	"unprognostic (1.30e-1)"	"unprognostic (1.05e-2)"	"unprognostic (2.69e-1)"	"unprognostic (7.62e-7)"	"unprognostic (4.89e-2)"	"unprognostic (1.02e-2)"	"unprognostic (7.78e-2)"	"unprognostic (2.12e-2)"	2.9	2.7	6.1	10.7	7.9	6.4	2.1	2.0	3.9	1.8	1.6	2.6	0.2	1.7	1.4	2.0	1.8	1.9	3.9	1.5	4.5	1.7	1.7	2.1	5.0	11.2	10.6	1.9	1.6	1.2	0.7	1.9	2.8	7.2	1.6	2.4	0.9	4.3	0.5	0.9	1.7	7.8	2.1	16.0	16.2	2.1	0.8	6.8	1.8	1.5	1.1	14.8	5.8	1.9	1.8	1.8	14.2	2.6	0.3	0.4	0.6	1.5	6.0	0.2	0.1	0.3	6.9	0.0	1.6	7.1	0.7	2.4	0.0	13.0	7.1	2.8	0.3	0.7	0.1	1.3	1.1	0.0	0.5	3.3	7.2	0.2	0.5	3.6	5.4	2.9	1.3	2.9	1.6	1.4	3.6	2.3	3.3	0.0	0.0	6.3	0.2	1.0	3.5	3.2	10.2	0.4	0.1	0.0	0.1	0.2	0.0	1.0	0.3	1.9	2.0	2.3	7.8	0.9	2.5	0.1	0.0	6.0	5.3	4.3	1.7	0.0	2.6	0.7	0.2	2.4	0.0	1.8	0.1	0.1	1.8	1.2	0.3	0.2	14.2	0.3	1.2	1.3	0.4	0.6	6.1	7.9	2.0	3.9	4.5	1.7	10.6	1.9	7.2	6.8
TMEM91	"FLJ27310, IFITMD6"	ENSG00000142046	"Transmembrane protein 91"	Q6ZNR0	19	41350911-41384083	"Predicted intracellular proteins, Predicted membrane proteins, Transporters"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at transcript level"		"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"HEL: 15.1;HSkMC: 16.2;TIME: 15.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	4	"neutrophil: 51.9"	"Lineage enriched"	"Detected in many"	4	"granulocytes: 51.9"	"Low region specificity"	"Detected in all"							HPA053240	Uncertain									"HPA053240: AB_2682085"	"unprognostic (3.02e-3)"	"unprognostic (1.92e-2)"	"unprognostic (5.13e-3)"	"unprognostic (2.97e-2)"	"unprognostic (1.29e-1)"	"unprognostic (9.90e-2)"	"unprognostic (4.70e-2)"	"unprognostic (2.83e-1)"	"unprognostic (1.03e-1)"	"unprognostic (5.69e-3)"	"prognostic favourable (3.54e-5)"	"unprognostic (1.07e-1)"	"prognostic unfavourable (3.52e-7)"	"unprognostic (1.14e-2)"	"unprognostic (1.24e-1)"	"unprognostic (1.63e-1)"	"unprognostic (3.06e-2)"	10.5	6.2	12.1	9.2	42.0	35.5	22.0	5.2	13.0	12.1	9.8	9.5	12.9	4.3	17.3	12.8	11.2	15.8	9.7	7.2	11.3	22.9	8.3	4.2	13.9	6.8	9.3	13.7	9.7	12.9	4.3	19.2	10.8	11.6	12.3	5.1	12.3	8.6	13.5	4.0	29.7	5.4	10.9	8.1	15.7	6.0	15.2	14.7	6.0	10.7	3.8	8.6	14.4	12.1	0.4	3.4	51.9	12.5	0.3	2.0	11.0	2.2	5.5	4.1	1.9	5.1	11.0	3.7	1.7	2.5	0.9	1.7	0.4	2.0	1.1	1.6	2.2	0.7	1.1	1.9	2.3	1.6	2.5	15.1	3.6	8.1	9.3	2.5	4.1	16.2	9.6	3.1	7.0	6.9	2.8	4.5	1.6	5.0	1.4	4.5	1.7	3.3	3.0	1.1	1.0	2.6	1.3	1.2	2.3	3.9	0.8	2.5	0.7	7.0	15.2	2.6	2.3	2.3	2.1	3.0	0.4	0.9	5.0	3.1	0.9	7.1	12.5	0.9	1.5	2.6	1.8	0.1	0.8	0.7	2.1	0.4	2.0	0.9	51.9	0.3	1.8	3.4	1.0	11.0	12.1	42.0	5.2	13.0	11.3	22.9	9.3	13.7	11.6	14.7
TNFAIP6	"TSG-6, TSG6"	ENSG00000123610	"TNF alpha induced protein 6"	P98066	2	151357592-151380048	"Plasma proteins, Predicted secreted proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 50.9"	"Cell line enhanced"	"Detected in some"		"BJ hTERT+: 30.4;HHSteC: 18.9;hTEC/SVTERT24-B: 25.1;SH-SY5Y: 9.9;U-2197: 20.2"	"Cancer enhanced"	"Detected in many"		"renal cancer: 27.2"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	22	"neutrophil: 50.9"	"Lineage enriched"	"Detected in many"	22	"granulocytes: 50.9"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in many"			"CAB032719, HPA050884"	Approved				"Secreted to blood"	15000	15000			"CAB032719: AB_2204650, HPA050884: "	"unprognostic (1.31e-1)"	"prognostic unfavourable (8.18e-5)"	"unprognostic (8.66e-2)"	"unprognostic (2.51e-2)"	"unprognostic (1.15e-3)"	"unprognostic (3.26e-3)"	"unprognostic (3.75e-4)"	"unprognostic (4.49e-3)"	"unprognostic (1.22e-1)"	"unprognostic (1.90e-1)"	"unprognostic (5.87e-3)"	"unprognostic (1.08e-1)"	"prognostic unfavourable (5.59e-4)"	"unprognostic (1.06e-2)"	"unprognostic (1.25e-2)"	"unprognostic (5.46e-2)"	"prognostic unfavourable (9.16e-5)"	14.0	0.6	4.8	23.7	5.6	5.8	10.3	0.3	3.8	9.4	6.8	0.4	0.2	0.7	2.0	4.0	8.2	2.4	17.9	17.3	6.3	1.9	0.8	1.1	17.3	2.2	9.9	1.2	1.4	1.1	0.7	0.6	1.8	5.6	4.3	2.6	2.2	2.8	1.0	4.7	3.2	2.5	7.8	4.3	3.9	3.8	9.7	5.8	0.7	1.9	6.6	0.5	13.5	2.8	0.0	0.0	50.9	2.3	0.0	0.0	0.6	0.0	0.0	0.0	0.0	1.7	7.3	0.0	1.1	30.4	1.1	5.7	0.0	0.0	0.0	0.4	0.4	0.0	0.0	0.0	1.2	0.0	0.0	0.0	0.1	0.0	18.9	0.0	0.0	9.1	0.0	25.1	1.7	0.0	0.0	0.0	2.7	0.0	0.0	0.0	0.1	7.0	0.0	0.5	0.0	0.0	0.0	0.0	9.9	0.2	0.0	0.0	0.0	0.0	0.0	1.0	2.1	20.2	0.3	0.0	0.0	0.0	2.2	0.3	1.5	0.0	2.3	0.0	0.0	0.5	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	50.9	0.0	0.5	0.0	0.0	0.6	4.8	5.6	0.3	3.8	6.3	1.9	9.9	1.2	5.6	5.8
TRANK1	"KIAA0342, LBA1"	ENSG00000168016	"Tetratricopeptide repeat and ankyrin repeat containing 1"	O15050	3	36826820-36945098	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 42.3"	"Cell line enhanced"	"Detected in many"		"Daudi: 38.1;HMC-1: 15.3"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	7	"neutrophil: 42.3"	"Lineage enriched"	"Detected in many"	7	"granulocytes: 42.3"	"Low region specificity"	"Detected in all"							HPA035508	Approved		Approved	Nucleoplasm				Nucleoplasm		"HPA035508: AB_10671105"	"unprognostic (7.11e-3)"	"unprognostic (1.55e-2)"	"unprognostic (3.05e-2)"	"unprognostic (2.34e-1)"	"unprognostic (4.84e-2)"	"unprognostic (2.04e-3)"	"unprognostic (9.13e-2)"	"unprognostic (3.22e-1)"	"unprognostic (1.76e-1)"	"unprognostic (8.59e-2)"	"unprognostic (3.83e-1)"	"unprognostic (2.01e-1)"	"prognostic unfavourable (2.52e-5)"	"unprognostic (1.31e-1)"	"unprognostic (3.69e-1)"	"unprognostic (1.82e-3)"	"unprognostic (1.07e-3)"	4.1	3.6	4.5	10.4	11.2	6.9	4.7	21.5	12.0	8.5	14.2	1.7	3.1	8.6	12.3	4.5	3.1	19.3	7.3	4.1	3.3	3.9	3.2	7.9	6.2	13.9	2.9	6.6	9.0	2.8	5.0	3.8	3.7	6.0	7.9	10.9	4.4	4.9	5.0	2.6	2.9	23.1	10.5	3.2	9.9	6.0	2.9	1.7	15.1	5.8	1.1	16.2	9.8	6.0	5.2	0.5	42.3	1.3	2.8	5.7	0.9	0.7	0.9	0.2	0.0	2.4	9.5	0.0	0.7	5.0	2.3	4.4	0.0	3.9	38.1	1.5	2.8	0.2	0.1	0.5	0.4	1.9	0.0	6.2	2.5	0.0	3.1	1.7	15.3	3.1	1.9	1.7	0.1	2.8	4.9	5.5	1.6	0.0	4.8	0.7	0.2	1.0	1.3	0.1	0.7	0.7	1.7	0.3	0.0	3.8	1.0	0.3	0.6	2.1	1.9	1.8	0.7	0.1	0.6	5.4	1.1	8.4	0.3	1.3	0.2	2.5	0.6	3.9	5.6	0.9	4.2	4.0	4.8	5.7	0.5	5.2	4.4	4.2	42.3	2.8	1.3	0.0	4.0	0.9	4.5	11.2	21.5	12.0	3.3	3.9	2.9	6.6	6.0	1.7
TREM1	"CD354, TREM-1"	ENSG00000124731	"Triggering receptor expressed on myeloid cells 1"	Q9NP99	6	41267926-41286719	"CD markers, Plasma proteins, Predicted intracellular proteins, Predicted membrane proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in many"		"blood: 96.9;bone marrow: 38.5;lung: 34.2"	"Cell line enriched"	"Detected in some"	7	"U-87 MG: 23.6"	"Cancer enhanced"	"Detected in many"		"lung cancer: 9.6"	"Low region specificity"	"Detected in many"			"Cell type enriched"	"Detected in some"	8	"neutrophil: 96.9"	"Lineage enriched"	"Detected in many"	8	"granulocytes: 96.9"									HPA005563	Uncertain				"Intracellular and membrane"					"HPA005563: "	"unprognostic (6.41e-2)"	"unprognostic (1.47e-3)"	"unprognostic (1.22e-1)"	"unprognostic (3.39e-2)"	"unprognostic (6.07e-3)"	"unprognostic (2.97e-2)"	"unprognostic (5.73e-5)"	"unprognostic (1.29e-1)"	"unprognostic (1.24e-2)"	"unprognostic (4.13e-3)"	"unprognostic (2.24e-3)"	"unprognostic (7.65e-2)"	"unprognostic (3.18e-7)"	"unprognostic (6.32e-3)"	"unprognostic (4.95e-2)"	"unprognostic (1.08e-1)"	"unprognostic (7.26e-2)"	10.2	0.6	0.7	21.1	1.5	38.5	1.0	0.6	2.1	0.7	0.9	0.7	0.5	0.1	1.0	1.5	0.6	4.2	5.1	3.7	1.2	0.9	1.1	3.7	34.2	8.0	2.7	0.1	2.1	1.8	0.2	2.7	31.2	2.3	0.9	0.0	2.5	1.3	0.1	2.4	0.4	1.1	3.8	3.9	12.1	1.0	2.6	0.6	0.3	2.2	1.9	1.0	3.9	0.7	0.2	5.0	96.9	12.8	0.0	0.0	4.1	0.0	0.0	0.0	0.0	0.0	0.0	0.4	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.1	0.0	0.0	0.0	0.0	0.0	0.1	0.4	0.3	0.6	0.0	0.0	0.3	0.0	0.0	0.0	3.2	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.6	0.0	0.0	0.0	0.0	0.0	1.3	0.0	0.0	0.0	0.0	0.0	0.0	0.0	0.0	23.6	1.5	0.0	0.0	12.8	0.3	0.0	3.1	0.0	0.0	0.0	0.0	5.0	0.2	0.0	0.0	96.9	0.0	1.4	0.1	0.0	4.1	0.7	1.5	0.6	2.1	1.2	0.9	2.7	0.1	2.3	0.6
USP10	"KIAA0190, UBPO"	ENSG00000103194	"Ubiquitin specific peptidase 10"	Q14694	16	84699978-84779922	"Enzymes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in all"		"blood: 105.5"	"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	6	"neutrophil: 105.5"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 105.5"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"HPA006731, HPA006749"	Enhanced		Enhanced	Nucleoplasm,Cytosol				Cytosol	Nucleoplasm	"HPA006731: AB_1080495, HPA006749: AB_1080492"	"unprognostic (4.14e-2)"	"unprognostic (2.28e-1)"	"unprognostic (2.36e-2)"	"unprognostic (4.85e-2)"	"unprognostic (6.93e-2)"	"unprognostic (1.77e-3)"	"unprognostic (1.03e-3)"	"unprognostic (2.91e-3)"	"unprognostic (1.75e-1)"	"unprognostic (3.84e-2)"	"unprognostic (2.56e-2)"	"unprognostic (1.82e-3)"	"prognostic favourable (1.00e-4)"	"unprognostic (5.91e-2)"	"unprognostic (4.57e-2)"	"unprognostic (8.57e-2)"	"unprognostic (1.38e-1)"	13.9	18.8	16.0	24.2	19.0	13.4	14.4	24.4	20.4	15.9	18.1	15.6	8.4	16.1	20.2	10.4	19.7	18.2	12.0	16.4	19.3	15.1	16.4	20.7	13.7	18.8	19.7	17.4	18.5	17.1	35.8	15.0	23.5	16.2	15.0	15.6	17.9	15.3	17.8	47.0	17.0	17.5	20.2	16.3	16.0	15.0	15.5	16.2	20.4	17.6	15.7	20.9	19.7	15.8	7.2	10.4	105.5	8.6	7.7	17.3	10.0	13.6	18.9	18.4	22.8	6.8	11.6	24.9	13.5	14.3	22.9	12.6	26.6	11.9	23.7	15.7	14.1	15.7	25.5	21.5	30.5	9.6	13.4	13.6	8.9	17.6	9.0	20.2	8.3	7.3	16.6	23.9	27.7	17.5	37.1	5.2	15.8	28.6	20.9	9.8	22.1	12.8	27.2	10.1	11.2	14.4	11.1	17.2	10.1	32.3	10.5	9.1	24.1	12.9	12.8	15.9	12.7	8.0	12.8	8.7	12.1	60.1	10.3	13.0	16.3	2.5	8.6	1.6	5.7	7.0	6.8	7.2	17.3	6.3	10.4	6.7	9.9	6.0	105.5	7.7	6.3	3.5	6.1	10.0	16.0	19.0	24.4	20.4	19.3	15.1	19.7	17.4	16.2	16.2
XPO6	"FLJ22519, KIAA0370, RANBP20"	ENSG00000169180	"Exportin 6"	Q96QU8	16	28097979-28211920	"Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in all"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in all"	7	"neutrophil: 56.4"	"Lineage enriched"	"Detected in all"	9	"granulocytes: 56.4"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA038246	Uncertain		Approved	"Nucleoplasm,Nucleoli,Plasma membrane,Cytosol"				"Nucleoplasm, Nucleoli"	"Plasma membrane, Cytosol"	"HPA038246: AB_10674550"	"unprognostic (1.17e-1)"	"unprognostic (5.43e-2)"	"unprognostic (1.07e-1)"	"unprognostic (3.76e-1)"	"unprognostic (1.38e-1)"	"unprognostic (1.03e-1)"	"prognostic unfavourable (3.68e-4)"	"unprognostic (2.22e-1)"	"unprognostic (1.41e-1)"	"unprognostic (1.31e-2)"	"unprognostic (4.48e-1)"	"unprognostic (1.40e-1)"	"unprognostic (1.01e-3)"	"unprognostic (2.10e-1)"	"unprognostic (5.36e-2)"	"unprognostic (8.50e-2)"	"prognostic unfavourable (8.80e-4)"	18.4	14.1	24.3	32.0	25.0	47.9	17.7	16.0	30.6	12.4	17.7	30.4	9.9	13.4	13.5	12.0	16.8	14.1	14.9	9.6	27.5	23.9	13.3	19.1	20.6	54.6	25.6	16.9	15.3	13.2	22.0	18.0	25.9	21.7	14.1	17.0	16.3	19.4	13.1	8.3	18.8	18.3	16.3	23.8	50.4	14.8	28.9	19.8	37.1	18.0	7.8	31.8	17.2	13.2	5.2	2.6	56.4	4.4	2.7	6.5	2.0	28.4	20.4	18.0	19.3	12.5	19.9	20.7	35.2	31.9	41.3	41.8	28.6	20.4	20.2	30.4	32.0	18.6	42.7	27.0	50.2	45.5	26.5	22.1	28.8	31.8	29.6	30.8	24.9	15.6	20.1	36.6	36.3	23.7	40.2	10.2	27.9	31.9	37.0	36.8	30.5	19.5	34.8	21.4	33.5	15.3	14.5	35.2	19.1	17.4	29.1	15.4	20.9	20.4	25.1	34.9	23.4	29.7	29.3	23.9	30.2	30.0	26.6	32.2	29.4	4.7	2.7	8.4	4.1	3.0	4.4	5.2	4.7	4.4	2.0	3.9	5.2	6.5	56.4	2.7	4.4	2.6	3.8	2.0	24.3	25.0	16.0	30.6	27.5	23.9	25.6	16.9	21.7	19.8
ZFP36L1	"Berg36, BRF1, cMG1, ERF1, RNF162B, TIS11B"	ENSG00000185650	"ZFP36 ring finger protein like 1"	Q07352	14	68787660-68796253	"Cancer-related genes, Plasma proteins, Predicted intracellular proteins"	"Evidence at protein level"	"Evidence at transcript level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	6	"neutrophil: 212.7"	"Lineage enriched"	"Detected in all"	6	"granulocytes: 212.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA001301	Uncertain									"HPA001301: AB_1080644"	"unprognostic (1.18e-2)"	"unprognostic (2.64e-1)"	"unprognostic (1.28e-1)"	"unprognostic (1.58e-1)"	"unprognostic (7.00e-2)"	"unprognostic (1.27e-1)"	"unprognostic (1.64e-2)"	"unprognostic (1.11e-1)"	"unprognostic (2.17e-2)"	"unprognostic (3.81e-3)"	"unprognostic (1.13e-3)"	"unprognostic (1.30e-1)"	"unprognostic (1.11e-2)"	"unprognostic (6.45e-3)"	"unprognostic (5.77e-2)"	"unprognostic (2.97e-1)"	"unprognostic (5.68e-2)"	59.0	22.4	40.2	42.4	35.0	14.2	89.9	16.3	31.0	91.5	60.2	49.6	24.8	26.0	90.6	37.5	66.8	59.9	36.5	36.2	45.1	15.3	34.6	46.0	45.6	39.0	32.7	16.7	121.7	47.1	63.4	14.8	62.7	44.9	65.3	21.9	29.9	60.3	43.7	31.6	90.2	28.5	91.2	47.3	33.9	42.2	26.9	39.4	22.1	43.3	22.7	57.1	81.2	93.2	37.0	8.7	212.7	17.7	10.4	16.1	14.4	38.8	37.3	15.5	22.4	39.3	31.6	34.3	16.5	27.4	9.6	12.1	16.3	25.8	9.4	10.0	28.4	18.0	1.4	51.0	11.8	4.4	2.2	3.4	18.7	11.5	22.4	0.5	4.3	26.6	65.5	11.7	76.7	19.3	9.6	18.5	51.1	9.2	1.4	1.7	12.9	5.4	24.9	20.8	2.8	35.3	28.0	0.1	0.4	18.6	26.8	13.8	24.6	0.4	44.1	28.6	21.0	22.6	15.7	10.4	5.2	6.5	35.5	0.2	10.8	14.2	17.7	0.2	16.1	17.2	15.0	19.7	12.9	11.2	8.7	37.0	14.1	12.4	212.7	10.4	11.4	1.1	12.0	14.4	40.2	35.0	16.3	31.0	45.1	15.3	32.7	16.7	44.9	39.4
ZNF467	"EZI, Zfp467"	ENSG00000181444	"Zinc finger protein 467"	Q7Z7K2	7	149764182-149773479	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Low tissue specificity"	"Detected in all"			"Cell line enhanced"	"Detected in many"		"AN3-CA: 21.7;EFO-21: 10.9;HMC-1: 12.6;MCF7: 10.5;SK-BR-3: 9.8;T-47d: 12.2"	"Low cancer specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			"Cell type enriched"	"Detected in many"	5	"neutrophil: 27.7"	"Lineage enriched"	"Detected in many"	5	"granulocytes: 27.7"	"Low region specificity"	"Detected in all"			"Low region specificity"	"Detected in all"			HPA042907	Uncertain		Approved	Mitochondria				Mitochondria		"HPA042907: AB_10966965"	"unprognostic (3.01e-1)"	"unprognostic (2.41e-1)"	"unprognostic (6.40e-4)"	"unprognostic (5.99e-2)"	"unprognostic (2.91e-1)"	"unprognostic (1.33e-1)"	"unprognostic (1.20e-1)"	"unprognostic (1.46e-1)"	"unprognostic (6.88e-2)"	"unprognostic (5.14e-2)"	"prognostic favourable (4.56e-4)"	"unprognostic (2.12e-1)"	"unprognostic (8.15e-2)"	"unprognostic (3.19e-1)"	"unprognostic (1.51e-1)"	"unprognostic (2.53e-2)"	"unprognostic (2.25e-2)"	10.6	8.2	10.5	8.8	16.5	20.1	15.2	3.5	7.4	7.9	6.7	3.2	22.1	2.9	8.5	6.4	4.2	10.0	7.5	11.6	10.1	4.6	14.9	9.2	15.8	24.2	6.3	2.9	8.9	10.8	3.5	11.0	6.2	5.8	5.1	3.7	20.4	12.3	18.4	4.3	11.8	5.2	7.0	9.9	21.4	10.4	2.3	11.0	9.6	11.8	4.0	5.6	4.6	13.3	0.0	3.5	27.7	5.4	0.1	0.4	1.4	0.0	2.7	3.1	21.7	0.1	0.0	0.0	0.0	0.0	0.3	0.0	0.7	6.7	0.1	10.9	0.1	0.3	1.6	0.0	0.1	0.1	0.3	1.1	0.0	0.0	6.7	0.0	12.6	4.5	1.1	0.0	0.1	2.3	2.0	0.5	0.0	10.5	0.4	1.1	0.3	6.8	1.6	0.0	8.0	1.5	0.0	1.2	1.0	0.0	9.8	0.0	12.2	1.3	5.3	0.1	3.6	0.0	0.0	0.5	0.0	0.1	0.1	3.7	0.1	0.0	5.4	2.2	0.2	2.2	0.1	0.0	0.2	0.2	3.5	0.0	0.4	0.1	27.7	0.1	0.7	1.6	0.0	1.4	10.5	16.5	3.5	7.4	10.1	4.6	6.3	2.9	5.8	11.0
ZNF695	SBZF3	ENSG00000197472	"Zinc finger protein 695"	Q8IW36	1	246945547-247008093	"Predicted intracellular proteins, Transcription factors"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Evidence at protein level"	"Tissue enhanced"	"Detected in some"		"lymphoid tissue: 8.3;testis: 8.3"	"Low cell line specificity"	"Detected in many"			"Low cancer specificity"	"Detected in many"			"Region enhanced"	"Detected in many"		"hippocampal formation: 5.1"	"Cell type enriched"	"Detected in single"	4	"neutrophil: 3.2"	"Lineage enriched"	"Detected in single"	12	"granulocytes: 3.2"									HPA024743	Uncertain		Approved	"Nuclear speckles"				"Nuclear speckles"		"HPA024743: AB_1859419"	"unprognostic (8.46e-3)"	"unprognostic (6.28e-2)"	"unprognostic (1.82e-1)"	"unprognostic (2.57e-4)"	"unprognostic (4.51e-2)"	"unprognostic (1.72e-1)"	"unprognostic (1.10e-2)"	"unprognostic (1.16e-1)"	"unprognostic (5.71e-5)"	"unprognostic (7.42e-4)"	"unprognostic (2.81e-3)"	"unprognostic (2.21e-2)"	"unprognostic (1.05e-9)"	"unprognostic (2.22e-1)"	"unprognostic (2.07e-1)"	"unprognostic (2.72e-1)"	"unprognostic (3.87e-1)"	0.3	0.3	0.6	3.2	2.1	3.3	1.5	1.6	1.0	0.6	1.0	0.0	0.0	0.4	0.6	0.0	1.3	0.3	0.2	0.3	5.1	0.4	0.7	0.2	0.9	1.1	0.5	0.9	0.6	1.7	0.0	0.6	2.5	0.3	0.4	1.5	0.1	1.1	0.1	0.2	0.5	2.3	1.4	0.7	0.4	0.6	8.3	0.0	8.3	0.3	0.0	2.2	0.4	0.7	0.1	0.1	3.2	0.2	0.2	0.2	0.0	6.5	0.8	4.1	10.3	0.1	0.1	10.7	2.2	0.1	3.1	4.2	6.9	0.4	5.4	4.3	1.2	2.0	11.5	0.6	3.6	0.0	4.0	3.5	1.5	4.2	0.0	0.0	1.3	0.2	0.0	3.5	2.9	1.2	4.7	0.0	3.2	2.6	7.4	3.8	7.6	4.2	4.1	9.4	0.0	0.7	3.6	3.6	6.3	3.3	2.6	1.2	2.9	4.9	0.5	0.5	5.9	3.1	0.0	0.7	1.8	0.1	0.0	0.0	2.2	0.7	0.2	0.1	0.1	0.1	0.0	0.0	0.0	0.1	0.0	0.1	0.2	0.1	3.2	0.2	0.1	0.1	0.0	0.0	0.6	2.1	1.6	1.0	5.1	0.4	0.5	0.9	0.3	0.0
